×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Ionis Pharmaceuticals Inc. (IONS) NASDAQ

$43.35 (1.31) (-2.93%)

Market Cap: $6.32B

As of 03/28/24 04:00 PM EDT. Market closed.

(IONS)

Ionis Pharmaceuticals Inc. (IONS)
NASDAQ

$43.35
(1.31) (-2.93%)

Market Cap: $6.32B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific ... read more

ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Brett Monia
Full Time Employees
817
CEO Compensation (Base)
$883,242
CEO Compensation (Total)
$7.63M
URL
Address
2855 Gazelle Ct, California, Carlsbad, 92010-6670.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Brett Monia
Full Time Employees
817
CEO Compensation (Base)
$883,242
CEO Compensation (Total)
$7.63M
Address
2855 Gazelle Ct, California, Carlsbad, 92010-6670.
PRICE CHART FOR IONIS PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$44.80
Previous Close
$44.66
Days Range
$43.32 - $44.95
52 week range
$34.32 - $54.44
Volume
1,998,960
Avg. Volume (30 days)
1,052,309
Market Cap
$6.32B
Dividend Yield
-
P/E
(17.25)
Shares Outstanding
145,751,797
Open
$44.80
Previous Close
$44.66
Days Range
$43.32 - $44.95
52 week range
$34.32 - $54.44
Volume
1,998,960
Avg. Volume (30 days)
1,052,309
Market Cap
$6.32B
Dividend Yield
-
P/E
(17.25)
Shares Outstanding
145,751,797
FINANCIAL STATEMENTS FOR IONIS PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IONIS PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Swayze EricOfficer Level 14Feb 29, 2024 Option Exercise$34.4260520,82734,929Mar 04, 2024, 07:13 PM
Monia Brett PCEO Level 15Feb 29, 2024 Option Exercise$34.4253818,521174,289Mar 04, 2024, 07:13 PM
Geary Richard SOfficer Level 14Feb 29, 2024 Option Exercise$34.4260420,79387,938Mar 04, 2024, 07:13 PM
Birchler BrianVice President Level 14Feb 29, 2024 Option Exercise$34.4260420,79345,186Mar 04, 2024, 07:13 PM
BENNETT C FRANKOfficer Level 14Feb 29, 2024 Option Exercise$34.4238313,18579,462Mar 04, 2024, 07:13 PM
Monia Brett PChief Executive OfficerFeb 16, 2024 Sale$44.4938717,219173,751Feb 16, 2024, 07:47 PM
Swayze EricEVP ResearchFeb 02, 2024 Sale$49.561,90794,51334,324Feb 02, 2024, 07:55 PM
Swayze EricEVP ResearchJan 31, 2024 Sale$52.0010,773560,19632,516Feb 02, 2024, 07:55 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrFeb 02, 2024 Sale$49.592,071102,70149,812Feb 02, 2024, 07:55 PM
O'NEIL PATRICK R.EVP CLO & General CounselFeb 02, 2024 Sale$49.671,96197,41048,661Feb 02, 2024, 07:55 PM
Monia Brett PChief Executive OfficerFeb 02, 2024 Sale$49.3723,5011,160,303174,138Feb 02, 2024, 07:55 PM
HOUGEN ELIZABETH LEVP, Finance & CFOFeb 02, 2024 Sale$49.542,125105,27292,905Feb 02, 2024, 07:55 PM
Geary Richard SEVP, Chief Development OfficerFeb 02, 2024 Sale$50.041,96198,13587,334Feb 02, 2024, 07:54 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcFeb 02, 2024 Sale$49.602,125105,40435,825Feb 02, 2024, 07:54 PM
BENNETT C FRANKEVP, Chief Scientific OfficerFeb 02, 2024 Sale$49.521,85391,75279,079Feb 02, 2024, 07:54 PM
Monia Brett PChief Executive OfficerJan 25, 2024 Sale$51.752,285118,249151,851Jan 29, 2024, 05:34 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 25, 2024 Sale$51.756,450333,78846,802Jan 29, 2024, 05:34 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcJan 17, 2024 Sale$50.425,564280,52033,810Jan 18, 2024, 06:07 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 17, 2024 Sale$50.427,744390,42953,252Jan 18, 2024, 05:59 PM
Birchler BrianEVP, Corp and Development OpsJan 17, 2024 Sale$50.424,497226,72544,582Jan 18, 2024, 05:55 PM
Swayze EricEVP ResearchJan 17, 2024 Sale$50.426,296317,42543,289Jan 18, 2024, 05:49 PM
Swayze EricEVP ResearchJan 17, 2024 Sale$50.42945485Jan 18, 2024, 05:49 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 17, 2024 Sale$50.425,482276,38647,850Jan 18, 2024, 05:48 PM
Monia Brett PChief Executive OfficerJan 17, 2024 Sale$50.4232,0591,616,319154,136Jan 18, 2024, 05:48 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 17, 2024 Sale$50.428,683437,77190,890Jan 18, 2024, 05:48 PM
Geary Richard SEVP, Chief Development OfficerJan 17, 2024 Sale$50.427,338369,96085,475Jan 18, 2024, 05:47 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJan 17, 2024 Sale$50.426,745340,06377,323Jan 18, 2024, 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 17, 2024 Sale$50.4256428,4351,640Jan 18, 2024, 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 17, 2024 Sale$50.421,46073,60912,799Jan 18, 2024, 05:44 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 12, 2024 Option Exercise$32.608,000260,80046,170Jan 17, 2024, 08:51 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 12, 2024 Sale$53.508,000427,99938,170Jan 17, 2024, 08:51 PM
Swayze EricEVP ResearchDec 28, 2023 Option Exercise$47.3427,1001,282,91459,616Jan 02, 2024, 05:54 PM
Swayze EricEVP ResearchDec 28, 2023 Sale$50.1927,1001,360,08132,516Jan 02, 2024, 05:54 PM
HOUGEN ELIZABETH LEVP, Finance & CFODec 28, 2023 Option Exercise$50.5043,7982,211,79977,086Jan 02, 2024, 05:54 PM
HOUGEN ELIZABETH LEVP, Finance & CFODec 28, 2023 Option Exercise$47.3445,2252,140,952120,884Jan 02, 2024, 05:54 PM
Birchler BrianEVP, Corp and Development OpsDec 28, 2023 Option Exercise$50.5011,029556,96536,999Jan 02, 2024, 05:54 PM
Birchler BrianEVP, Corp and Development OpsDec 28, 2023 Option Exercise$47.3411,500544,41048,028Jan 02, 2024, 05:54 PM
O'NEIL PATRICK R.EVP CLO & General CounselDec 26, 2023 Option Exercise$47.3420,825985,85661,180Dec 28, 2023, 07:18 PM
O'NEIL PATRICK R.EVP CLO & General CounselDec 26, 2023 Sale$51.4620,8251,071,71740,355Dec 28, 2023, 07:18 PM
PARSHALL B LYNNEDirectorDec 28, 2023 Option Exercise$47.3442,5252,013,134125,113Dec 28, 2023, 07:18 PM
PARSHALL B LYNNEDirectorDec 27, 2023 Option Exercise$47.3450,0002,367,000132,588Dec 28, 2023, 07:18 PM
PARSHALL B LYNNEDirectorDec 26, 2023 Option Exercise$47.3425,1131,188,849107,701Dec 28, 2023, 07:18 PM
PARSHALL B LYNNEDirectorDec 27, 2023 Sale$50.2350,0002,511,51582,588Dec 28, 2023, 07:18 PM
PARSHALL B LYNNEDirectorDec 26, 2023 Sale$51.4625,1131,292,39082,588Dec 28, 2023, 07:18 PM
PARSHALL B LYNNEDirectorDec 28, 2023 Sale$50.1942,5252,134,22382,588Dec 28, 2023, 07:18 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrDec 26, 2023 Option Exercise$47.3425,0001,183,50061,052Dec 28, 2023, 07:18 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrDec 26, 2023 Sale$51.4625,0001,286,57536,052Dec 28, 2023, 07:18 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 20, 2023 Option Exercise$47.346,500307,71072,254Dec 22, 2023, 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 21, 2023 Option Exercise$47.3416,113762,78981,867Dec 22, 2023, 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 20, 2023 Sale$49.646,500322,64365,754Dec 22, 2023, 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 21, 2023 Sale$49.2916,113794,21165,754Dec 22, 2023, 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 21, 2023 Option Exercise$47.344,112194,66277,073Dec 22, 2023, 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 20, 2023 Option Exercise$47.346,500307,71079,461Dec 22, 2023, 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 21, 2023 Sale$49.294,112202,68172,961Dec 22, 2023, 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 20, 2023 Sale$49.646,500322,64372,961Dec 22, 2023, 07:11 PM
Monia Brett PChief Executive OfficerDec 21, 2023 Option Exercise$47.3417,500828,450135,611Dec 22, 2023, 07:11 PM
Monia Brett PChief Executive OfficerDec 20, 2023 Option Exercise$47.346,500307,710124,611Dec 22, 2023, 07:11 PM
Monia Brett PChief Executive OfficerDec 21, 2023 Sale$49.2917,500862,577118,111Dec 22, 2023, 07:11 PM
Monia Brett PChief Executive OfficerDec 20, 2023 Sale$49.646,500322,643118,111Dec 22, 2023, 07:11 PM
Monia Brett PChief Executive OfficerDec 14, 2023 Option Exercise$47.3424,0001,136,160132,971Dec 18, 2023, 04:56 PM
Monia Brett PChief Executive OfficerDec 14, 2023 Sale$49.5824,0001,190,019118,111Dec 18, 2023, 04:56 PM
Geary Richard SEVP, Chief Development OfficerDec 14, 2023 Option Exercise$47.3410,613502,41979,532Dec 18, 2023, 04:55 PM
Geary Richard SEVP, Chief Development OfficerDec 14, 2023 Sale$49.5810,613526,23672,961Dec 18, 2023, 04:55 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 14, 2023 Option Exercise$47.3422,6121,070,45279,756Dec 18, 2023, 04:55 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 14, 2023 Sale$49.5822,6121,121,19565,754Dec 18, 2023, 04:55 PM
KLEIN JOSEPH IIIDirectorNov 15, 2023 Sale$50.002,000100,00016,346Nov 17, 2023, 04:58 PM
Swayze EricEVP ResearchOct 17, 2023 Sale$47.95522,49373Oct 18, 2023, 06:40 PM
Monia Brett PChief Executive OfficerOct 12, 2023 Sale$46.003,770173,420118,111Oct 16, 2023, 04:35 PM
BENNETT C FRANKEVP, Chief Scientific OfficerSep 28, 2023 Sale$46.504,460207,39065,754Sep 29, 2023, 05:20 PM
PARSHALL B LYNNEDirectorSep 26, 2023 Sale$45.1310,000451,26882,588Sep 28, 2023, 06:03 PM
KLEIN JOSEPH IIIDirectorSep 26, 2023 Sale$45.132,00090,25418,346Sep 28, 2023, 06:03 PM
BENNETT C FRANKOfficer Level 14Aug 31, 2023 Option Exercise$30.561805,50070,214Sep 05, 2023, 04:59 PM
Geary Richard SOfficer Level 14Aug 31, 2023 Option Exercise$30.5613172,961Sep 05, 2023, 04:59 PM
Monia Brett PCEO Level 15Aug 31, 2023 Option Exercise$30.561574,798121,881Sep 05, 2023, 04:59 PM
Diaz Allene M.DirectorAug 01, 2023 Sale$41.0565726,97012,676Aug 03, 2023, 05:20 PM
KLEIN JOSEPH IIIDirectorJul 18, 2023 Sale$42.003,555149,31020,346Jul 19, 2023, 06:05 PM
Monia Brett PChief Executive OfficerJul 07, 2023 Sale$42.2518,650787,953121,724Jul 11, 2023, 05:07 PM
BERTHELSEN SPENCER RDirectorJun 20, 2023 Option Exercise$28.4711,250320,287140,147Jun 22, 2023, 05:17 PM
O'NEIL PATRICK R.EVP CLO & General CounselMay 24, 2023 Sale$41.701,52763,67640,355May 24, 2023, 08:25 PM
Monia Brett PChief Executive OfficerMay 22, 2023 Sale$40.144,931197,907143,004May 24, 2023, 08:25 PM
Birchler BrianEVP, Corp and Development OpsApr 18, 2023 Sale$36.5067224,53036,528Apr 19, 2023, 08:18 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcApr 18, 2023 Sale$36.502,58294,25024,312Apr 19, 2023, 08:18 PM
Baroldi JosephEVP, Chief Business OfficerApr 18, 2023 Sale$36.503,880141,63110,571Apr 19, 2023, 08:18 PM
Swayze EricEVP ResearchFeb 28, 2023 Option Exercise$30.5157517,54632,516Mar 02, 2023, 05:19 PM
O'NEIL PATRICK R.EVP CLO & General CounselFeb 28, 2023 Option Exercise$30.513019,18541,882Mar 02, 2023, 05:19 PM
Geary Richard SEVP, Chief Development OfficerFeb 28, 2023 Option Exercise$30.5157517,54672,960Mar 02, 2023, 05:18 PM
HOUGEN ELIZABETH LEVP, Finance & CFOFeb 28, 2023 Option Exercise$30.511634,97475,659Mar 02, 2023, 05:18 PM
BENNETT C FRANKEVP, Chief Scientific OfficerFeb 28, 2023 Option Exercise$30.5138311,68770,034Mar 02, 2023, 05:18 PM
Swayze EricEVP ResearchFeb 06, 2023 Sale$40.791,81574,03131,941Feb 07, 2023, 05:37 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrFeb 06, 2023 Sale$40.671,41357,46424,946Feb 07, 2023, 05:37 PM
O'NEIL PATRICK R.EVP CLO & General CounselFeb 06, 2023 Sale$40.861,92078,46041,581Feb 07, 2023, 05:37 PM
Monia Brett PChief Executive OfficerFeb 06, 2023 Sale$40.6924,6511,003,153145,305Feb 07, 2023, 05:36 PM
HOUGEN ELIZABETH LEVP, Finance & CFOFeb 06, 2023 Sale$40.592,07984,39275,496Feb 07, 2023, 05:36 PM
Geary Richard SEVP, Chief Development OfficerFeb 06, 2023 Sale$40.661,92078,07072,385Feb 07, 2023, 05:36 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcFeb 06, 2023 Sale$40.661,45158,99721,227Feb 07, 2023, 05:36 PM
BENNETT C FRANKEVP, Chief Scientific OfficerFeb 06, 2023 Sale$40.571,81373,56069,651Feb 07, 2023, 05:36 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 31, 2023 Sale$39.714,500178,70039,679Feb 02, 2023, 01:48 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 30, 2023 Sale$39.424,500177,37244,179Feb 02, 2023, 01:48 PM
Swayze EricEVP ResearchJan 18, 2023 Sale$39.745,631223,80030,041Jan 19, 2023, 08:22 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 18, 2023 Sale$39.574,752188,05222,326Jan 19, 2023, 08:22 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 18, 2023 Sale$39.497,836309,48048,679Jan 19, 2023, 08:21 PM
Monia Brett PChief Executive OfficerJan 18, 2023 Sale$39.4925,066989,947120,863Jan 19, 2023, 08:21 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 18, 2023 Sale$39.708,280328,72173,435Jan 19, 2023, 08:19 PM
Geary Richard SEVP, Chief Development OfficerJan 18, 2023 Sale$39.577,873311,52570,483Jan 19, 2023, 08:19 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcJan 18, 2023 Sale$39.553,748148,22318,538Jan 19, 2023, 08:19 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJan 18, 2023 Sale$38.896,978271,35667,855Jan 19, 2023, 08:19 PM
Baroldi JosephEVP, Chief Business OfficerJan 18, 2023 Sale$39.7937514,920851Jan 19, 2023, 08:19 PM
KLEIN JOSEPH IIIDirectorJan 17, 2023 Sale$40.002,00080,00016,791Jan 18, 2023, 08:19 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrOct 17, 2022 Option Exercise$46.521446,69914,032Oct 18, 2022, 07:10 PM
Swayze EricEVP ResearchSep 08, 2022 Sale$44.5546020,49319,892Sep 12, 2022, 07:09 PM
O'NEIL PATRICK R.EVP CLO & General CounselAug 31, 2022 Option Exercise$28.971083,12934,644Sep 01, 2022, 07:03 PM
HOUGEN ELIZABETH LEVP, Finance & CFOAug 31, 2022 Option Exercise$28.972025,85258,561Sep 01, 2022, 07:03 PM
BENNETT C FRANKEVP, Chief Scientific OfficerAug 31, 2022 Option Exercise$28.971835,30155,416Sep 01, 2022, 07:03 PM
Swayze EricEVP ResearchAug 05, 2022 Sale$45.2014520,352Aug 09, 2022, 07:02 PM
KLEIN JOSEPH IIIDirectorJul 15, 2022 Sale$38.241,33350,97719,435Jul 19, 2022, 07:20 PM
MUTO FREDERICK TDirectorJul 01, 2022 Option Exercise$12.9411,250145,57551,599Jul 06, 2022, 05:25 PM
BERTHELSEN SPENCER RDirectorJun 07, 2022 Option Exercise$12.9411,250145,575120,899Jun 09, 2022, 05:53 PM
Swayze EricEVP ResearchApr 21, 2022 Sale$44.1537816,68920,353Apr 25, 2022, 08:56 PM
Cadoret-Manier OnaizaEVP, Chf Pdt Str & Oper OfcApr 18, 2022 Option Exercise$41.011,96080,38012,089Apr 19, 2022, 08:23 PM
O'NEIL PATRICK R.EVP CLO & General CounselApr 12, 2022 Sale$40.066,792272,05734,536Apr 14, 2022, 06:02 PM
Monia Brett PChief Executive OfficerApr 01, 2022 Sale$37.4935513,30988,662Apr 05, 2022, 06:27 PM
Swayze EricEVP ResearchFeb 28, 2022 Option Exercise$28.3762117,62020,731Mar 02, 2022, 06:43 PM
O'NEIL PATRICK R.EVP CLO & General CounselFeb 28, 2022 Option Exercise$28.3773520,85441,328Mar 02, 2022, 06:42 PM
Monia Brett PChief Executive OfficerFeb 28, 2022 Option Exercise$28.3762117,62089,017Mar 02, 2022, 06:42 PM
HOUGEN ELIZABETH LEVP, Finance & CFOFeb 28, 2022 Option Exercise$28.3738410,89558,359Mar 02, 2022, 06:42 PM
BENNETT C FRANKEVP, Chief Scientific OfficerFeb 28, 2022 Option Exercise$28.373469,81755,233Mar 02, 2022, 06:41 PM
Geary Richard SEVP, Chief Development OfficerFeb 28, 2022 Option Exercise$28.3762117,62056,373Mar 02, 2022, 06:41 PM
Monia Brett PChief Executive OfficerJan 26, 2022 Option Exercise$31.448,032252,52688,396Jan 28, 2022, 05:58 PM
PARSHALL B LYNNEDirectorJan 18, 2022 Option Exercise$30.121,65249,75877,480Jan 20, 2022, 08:21 PM
Cadoret-Manier OnaizaEVP, Chf Corp Dev and Cml OffcJan 18, 2022 Option Exercise$30.122,30569,4278,382Jan 20, 2022, 08:21 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJan 18, 2022 Option Exercise$30.126,726202,58754,887Jan 20, 2022, 08:21 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 18, 2022 Option Exercise$30.127,501225,93040,593Jan 20, 2022, 08:18 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 18, 2022 Option Exercise$30.127,828235,77957,975Jan 20, 2022, 08:18 PM
Monia Brett PChief Executive OfficerJan 18, 2022 Option Exercise$30.1219,714593,78680,230Jan 20, 2022, 08:17 PM
Geary Richard SEVP, Chief Development OfficerJan 18, 2022 Option Exercise$30.127,605229,06355,752Jan 20, 2022, 08:16 PM
Schneider EugeneEVP, Chf Clinical Develop OffcJan 18, 2022 Option Exercise$30.123,815114,90813,760Jan 20, 2022, 08:16 PM
Swayze EricEVP ResearchJan 18, 2022 Option Exercise$30.124,994150,41920,110Jan 20, 2022, 08:16 PM
Schneider EugeneEVP, Chf Clinical Develop OffcOct 15, 2021 Option Exercise$35.101455,0897,175Oct 19, 2021, 06:29 PM
Geary Richard SEVP, Chief Development OffcAug 31, 2021 Option Exercise$33.80461,55541,966Sep 02, 2021, 07:25 PM
O'NEIL PATRICK R.EVP Legal & General CounselAug 31, 2021 Option Exercise$33.8030910,44327,008Sep 02, 2021, 07:21 PM
Monia Brett PChief Executive OfficerAug 31, 2021 Option Exercise$33.8035511,99850,469Sep 02, 2021, 07:21 PM
HOUGEN ELIZABETH LEVP, Finance & CFOAug 31, 2021 Option Exercise$33.801665,61043,753Sep 02, 2021, 07:20 PM
Cadoret-Manier OnaizaChief Corp Dev and Cml OfficerAug 31, 2021 Option Exercise$33.8043114,5664,630Sep 02, 2021, 07:20 PM
BENNETT C FRANKEVP & Chief Scientific OfficerAug 31, 2021 Option Exercise$33.801515,10342,771Sep 02, 2021, 07:20 PM
KLEIN JOSEPH IIIDirectorJul 15, 2021 Sale$35.304,334152,98918,126Jul 19, 2021, 08:14 PM
BERTHELSEN SPENCER RDirectorJun 23, 2021 Option Exercise$9.3015,000139,500115,983Jun 25, 2021, 05:19 PM
BERTHELSEN SPENCER RDirectorJun 23, 2021 Sale$37.7415,000566,100100,983Jun 25, 2021, 05:19 PM
MUTO FREDERICK TDirectorJun 15, 2021 Option Exercise$9.3015,000139,50036,683Jun 17, 2021, 05:05 PM
MUTO FREDERICK TDirectorJun 15, 2021 Sale$36.6315,000549,50031,683Jun 17, 2021, 05:05 PM
Cadoret-Manier OnaizaChief Corp Dev and Cml OfficerApr 15, 2021 Option Exercise$41.031,96080,4194,199Apr 19, 2021, 05:04 PM
Swayze EricEVP, ResearchFeb 26, 2021 Option Exercise$44.5446020,48811,295Mar 02, 2021, 08:36 PM
O'NEIL PATRICK R.EVP & General CounselFeb 26, 2021 Option Exercise$44.541978,77426,699Mar 02, 2021, 08:34 PM
HOUGEN ELIZABETH LEVP, Finance & CFOFeb 26, 2021 Option Exercise$44.541165,16743,587Mar 02, 2021, 08:32 PM
Geary Richard SEVP, Chief Development OffcFeb 26, 2021 Option Exercise$44.5441418,44041,920Mar 02, 2021, 08:28 PM
Cadoret-Manier OnaizaChief Corp Dev and Cml OfficerFeb 26, 2021 Option Exercise$44.5449221,914492Mar 02, 2021, 08:27 PM
BENNETT C FRANKChief Scientific OfficerFeb 26, 2021 Option Exercise$44.541124,98842,620Mar 02, 2021, 08:25 PM
Monia Brett PChief Executive OfficerFeb 26, 2021 Option Exercise$44.5424711,00150,350Mar 02, 2021, 08:22 PM
Monia Brett PChief Executive OfficerMar 01, 2021 Sale$54.2823612,80950,114Mar 02, 2021, 08:22 PM
Monia Brett PChief Executive OfficerJan 28, 2021 Option Exercise$60.691,30679,26150,103Feb 01, 2021, 05:47 PM
CROOKE STANLEY TExec Chairman of the BoardJan 26, 2021 Sale$63.7428,3331,805,8122,021Jan 28, 2021, 07:22 PM
O'NEIL PATRICK R.EVP & General CounselJan 25, 2021 Sale$63.505,324338,07426,502Jan 27, 2021, 05:35 PM
CROOKE STANLEY TExec Chairman of the BoardJan 22, 2021 Sale$61.6740,0002,467,000494,391Jan 25, 2021, 08:24 PM
CROOKE STANLEY TExec Chairman of the BoardJan 21, 2021 Sale$61.2035,0002,142,117555,433Jan 25, 2021, 08:24 PM
CROOKE STANLEY TExec Chairman of the BoardJan 15, 2021 Option Exercise$61.281,43487,8763,111Jan 20, 2021, 07:12 PM
CROOKE STANLEY TExec Chairman of the BoardJan 15, 2021 Option Exercise$61.2818,9241,159,66330,354Jan 20, 2021, 07:12 PM
BENNETT C FRANKChief Scientific OfficerJan 15, 2021 Option Exercise$61.285,488336,30542,508Jan 20, 2021, 07:08 PM
Geary Richard SEVP, Chief Development OffcJan 15, 2021 Option Exercise$61.286,398392,06941,506Jan 20, 2021, 07:06 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 15, 2021 Option Exercise$61.286,175378,40443,471Jan 20, 2021, 07:04 PM
Monia Brett PChief Executive OfficerJan 15, 2021 Option Exercise$61.2814,927914,72748,775Jan 20, 2021, 07:02 PM
O'NEIL PATRICK R.EVP & General CounselJan 15, 2021 Option Exercise$61.285,856358,85631,826Jan 20, 2021, 07:00 PM
PARSHALL B LYNNEDirectorJan 15, 2021 Option Exercise$61.282,741167,96865,378Jan 20, 2021, 06:59 PM
Schneider EugeneEVP, Chf Clinical Develop OffcJan 15, 2021 Option Exercise$61.282,718166,5596,903Jan 20, 2021, 06:55 PM
Swayze EricEVP, ResearchJan 15, 2021 Option Exercise$61.283,216197,07610,835Jan 20, 2021, 06:53 PM
Geary Richard SEVP, Chief Development OffcJan 13, 2021 Sale$59.501418,39030,306Jan 15, 2021, 05:55 PM
Swayze EricEVP, ResearchJan 05, 2021 Sale$55.9919510,9185,107Jan 06, 2021, 09:23 PM
PARSHALL B LYNNEDirectorDec 23, 2020 Sale$60.0010,000600,00057,464Dec 28, 2020, 05:29 PM
CROOKE STANLEY TExec Chairman of the BoardDec 17, 2020 Sale$50.501,40771,054174Dec 17, 2020, 07:42 PM
CROOKE STANLEY TExec Chairman of the BoardDec 15, 2020 Sale$49.7839,0001,941,225600,391Dec 17, 2020, 07:42 PM
CROOKE STANLEY TExec Chairman of the BoardDec 07, 2020 Sale$51.6711,000568,350645,391Dec 09, 2020, 08:14 PM
Monia Brett PChief Executive OfficerDec 04, 2020 Option Exercise$39.8723,840950,50152,719Dec 08, 2020, 08:51 PM
Monia Brett PChief Executive OfficerDec 04, 2020 Sale$51.0423,8401,216,79428,879Dec 08, 2020, 08:51 PM
BENNETT C FRANKChief Scientific OfficerDec 04, 2020 Option Exercise$39.877,947316,84740,423Dec 08, 2020, 08:49 PM
BENNETT C FRANKChief Scientific OfficerDec 04, 2020 Sale$51.047,947405,61532,476Dec 08, 2020, 08:49 PM
BENNETT C FRANKChief Scientific OfficerDec 02, 2020 Option Exercise$39.877,053281,20339,529Dec 04, 2020, 08:53 PM
BENNETT C FRANKChief Scientific OfficerDec 02, 2020 Sale$51.327,053361,96032,476Dec 04, 2020, 08:53 PM
Monia Brett PChief Executive OfficerDec 02, 2020 Option Exercise$39.8721,160843,64950,039Dec 04, 2020, 08:49 PM
Monia Brett PChief Executive OfficerDec 02, 2020 Sale$51.3221,1601,085,93128,879Dec 04, 2020, 08:49 PM
HOUGEN ELIZABETH LEVP, Finance & CFONov 25, 2020 Option Exercise$39.8721,680864,38254,175Nov 30, 2020, 06:49 PM
HOUGEN ELIZABETH LEVP, Finance & CFONov 25, 2020 Sale$50.0521,6801,085,08432,495Nov 30, 2020, 06:49 PM
CROOKE STANLEY TExec Chairman of the BoardNov 25, 2020 Option Exercise$39.8712,990517,91115,011Nov 30, 2020, 06:48 PM
CROOKE STANLEY TExec Chairman of the BoardNov 25, 2020 Sale$50.0512,990650,1492,021Nov 30, 2020, 06:48 PM
Geary Richard SEVP, DevelopmentNov 25, 2020 Option Exercise$39.8711,920475,25042,367Nov 30, 2020, 06:46 PM
Geary Richard SEVP, DevelopmentNov 25, 2020 Sale$50.0511,920596,59630,447Nov 30, 2020, 06:46 PM
PARSHALL B LYNNEDirectorNov 25, 2020 Option Exercise$39.873,590143,13371,054Nov 30, 2020, 06:44 PM
PARSHALL B LYNNEDirectorNov 25, 2020 Sale$50.053,590179,67967,464Nov 30, 2020, 06:44 PM
CROOKE STANLEY TExec Chairman of the BoardNov 24, 2020 Option Exercise$39.872,590103,2634,611Nov 25, 2020, 07:04 PM
CROOKE STANLEY TExec Chairman of the BoardNov 23, 2020 Option Exercise$39.8711,600462,49213,621Nov 25, 2020, 07:04 PM
CROOKE STANLEY TExec Chairman of the BoardNov 23, 2020 Option Exercise$39.8750019,9352,081Nov 25, 2020, 07:04 PM
CROOKE STANLEY TExec Chairman of the BoardNov 23, 2020 Sale$50.1111,600581,2762,021Nov 25, 2020, 07:04 PM
CROOKE STANLEY TExec Chairman of the BoardNov 23, 2020 Sale$50.0050025,0001,581Nov 25, 2020, 07:04 PM
CROOKE STANLEY TExec Chairman of the BoardNov 24, 2020 Sale$50.832,590131,6502,021Nov 25, 2020, 07:04 PM
HOUGEN ELIZABETH LEVP, Finance & CFONov 24, 2020 Option Exercise$39.874,320172,23836,815Nov 25, 2020, 07:02 PM
HOUGEN ELIZABETH LEVP, Finance & CFONov 23, 2020 Option Exercise$39.8719,000757,53045,620Nov 25, 2020, 07:02 PM
HOUGEN ELIZABETH LEVP, Finance & CFONov 24, 2020 Sale$50.834,320219,58632,495Nov 25, 2020, 07:02 PM
HOUGEN ELIZABETH LEVP, Finance & CFONov 23, 2020 Sale$50.1119,000952,09032,495Nov 25, 2020, 07:02 PM
Geary Richard SEVP, DevelopmentNov 24, 2020 Option Exercise$39.872,38094,89132,827Nov 25, 2020, 06:58 PM
Geary Richard SEVP, DevelopmentNov 23, 2020 Option Exercise$39.8710,700426,60941,147Nov 25, 2020, 06:58 PM
Geary Richard SEVP, DevelopmentNov 24, 2020 Sale$50.832,380120,97530,447Nov 25, 2020, 06:58 PM
Geary Richard SEVP, DevelopmentNov 23, 2020 Sale$50.1110,700536,17730,447Nov 25, 2020, 06:58 PM
PARSHALL B LYNNEDirectorNov 24, 2020 Option Exercise$39.8771028,30868,174Nov 25, 2020, 06:56 PM
PARSHALL B LYNNEDirectorNov 23, 2020 Option Exercise$39.873,200127,58470,664Nov 25, 2020, 06:56 PM
PARSHALL B LYNNEDirectorNov 23, 2020 Sale$50.123,200160,38467,464Nov 25, 2020, 06:56 PM
PARSHALL B LYNNEDirectorNov 24, 2020 Sale$50.8271036,08267,464Nov 25, 2020, 06:56 PM
BENNETT C FRANKChief Scientific OfficerNov 03, 2020 Option Exercise$39.8715,000598,05047,476Nov 05, 2020, 08:26 PM
BENNETT C FRANKChief Scientific OfficerNov 03, 2020 Sale$46.7715,000701,60032,476Nov 05, 2020, 08:26 PM
KLEIN JOSEPH IIIDirectorOct 20, 2020 Sale$46.862,889135,38613,794Oct 22, 2020, 05:36 PM
CROOKE STANLEY TExec Chairman of the BoardSep 22, 2020 Sale$50.4150,0002,520,460650,391Sep 23, 2020, 06:44 PM
CROOKE STANLEY TExec Chairman of the BoardSep 21, 2020 Sale$50.182,000100,3601,581Sep 23, 2020, 06:44 PM
WENDER JOSEPH HDirectorSep 16, 2020 Option Exercise$20.7022,500465,86288,305Sep 18, 2020, 05:45 PM
HOUGEN ELIZABETH LEVP, Finance & CFOAug 31, 2020 Option Exercise$44.461215,37932,495Sep 02, 2020, 07:12 PM
O'NEIL PATRICK R.EVP & General CounselAug 31, 2020 Option Exercise$44.461697,51321,178Sep 02, 2020, 07:10 PM
Geary Richard SEVP, DevelopmentAug 31, 2020 Option Exercise$44.4614430,447Sep 02, 2020, 07:06 PM
Monia Brett PChief Executive OfficerAug 31, 2020 Option Exercise$44.4623610,49129,193Sep 02, 2020, 07:01 PM
Monia Brett PChief Executive OfficerSep 01, 2020 Sale$53.7031416,86228,879Sep 02, 2020, 07:01 PM
BENNETT C FRANKChief Scientific OfficerAug 31, 2020 Option Exercise$44.461124,97932,476Sep 02, 2020, 06:59 PM
Swayze EricEVP, ResearchAug 31, 2020 Option Exercise$44.461445,302Sep 02, 2020, 06:46 PM
MUTO FREDERICK TDirectorJun 30, 2020 Option Exercise$9.2215,000138,30027,683Jul 02, 2020, 05:11 PM
Castleman BreauxDirectorJun 25, 2020 Option Exercise$26.6610,000266,60025,183Jun 29, 2020, 09:47 PM
Castleman BreauxDirectorJun 25, 2020 Sale$60.0010,000600,00015,183Jun 29, 2020, 09:47 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJun 25, 2020 Option Exercise$39.8715,000598,05047,364Jun 29, 2020, 09:47 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJun 25, 2020 Sale$59.7715,000896,50532,364Jun 29, 2020, 09:47 PM
CROOKE STANLEY TExec Chairman of the BoardJun 25, 2020 Sale$60.119,914595,9072,021Jun 26, 2020, 07:47 PM
CROOKE STANLEY TExec Chairman of the BoardJun 24, 2020 Sale$58.805,000294,00011,935Jun 26, 2020, 07:47 PM
BERTHELSEN SPENCER RDirectorJun 23, 2020 Option Exercise$9.2215,000138,300111,983Jun 25, 2020, 07:28 PM
BERTHELSEN SPENCER RDirectorJun 23, 2020 Sale$58.7615,000881,40096,983Jun 25, 2020, 07:28 PM
CROOKE STANLEY TExec Chairman of the BoardJun 19, 2020 Sale$58.3310,000583,25016,935Jun 19, 2020, 07:03 PM
CROOKE STANLEY TExec Chairman of the BoardJun 17, 2020 Sale$58.252,000116,5003,581Jun 19, 2020, 07:03 PM
CROOKE STANLEY TExec Chairman of the BoardJun 17, 2020 Sale$57.9015,000868,52126,935Jun 19, 2020, 07:03 PM
CROOKE STANLEY TExec Chairman of the BoardMar 25, 2020 Sale$47.001,00047,0005,581Mar 27, 2020, 07:05 PM
CROOKE STANLEY TExec Chairman of the BoardMar 25, 2020 Sale$47.0015,000705,00041,935Mar 27, 2020, 07:05 PM
CROOKE STANLEY TExec Chairman of the BoardMar 17, 2020 Sale$44.7520,000895,00087,356Mar 27, 2020, 07:01 PM
CROOKE STANLEY TExec Chairman of the BoardMar 19, 2020 Sale$45.001,00045,0006,581Mar 23, 2020, 06:17 PM
CROOKE STANLEY TExec Chairman of the BoardMar 19, 2020 Sale$45.1715,000677,54661,545Mar 23, 2020, 06:17 PM
CROOKE STANLEY TExec Chairman of the BoardMar 17, 2020 Sale$44.7520,390912,35586,966Mar 19, 2020, 01:55 PM
Swayze EricSVP, ResearchFeb 29, 2020 Option Exercise$43.1637816,3165,301Mar 03, 2020, 07:18 PM
O'NEIL PATRICK R.SVP & General CounselFeb 29, 2020 Option Exercise$43.1628912,47421,009Mar 03, 2020, 07:16 PM
Monia Brett PChief Executive OfficerFeb 29, 2020 Option Exercise$43.1631413,55328,957Mar 03, 2020, 07:14 PM
HOUGEN ELIZABETH LSVP, Finance & CFOFeb 29, 2020 Option Exercise$43.161476,34532,374Mar 03, 2020, 07:12 PM
Geary Richard SSVP, DevelopmentFeb 29, 2020 Option Exercise$43.1637816,31630,446Mar 03, 2020, 07:11 PM
BENNETT C FRANKChief Scientific OfficerFeb 29, 2020 Option Exercise$43.161697,29532,364Mar 03, 2020, 07:09 PM
O'NEIL PATRICK R.SVP & General CounselFeb 10, 2020 Sale$59.603,882231,36720,720Feb 11, 2020, 05:40 PM
Swayze EricSVP, ResearchJan 15, 2020 Option Exercise$62.062,367146,8964,923Jan 17, 2020, 06:47 PM
PARSHALL B LYNNEDirectorJan 15, 2020 Option Exercise$62.063,905242,34464,797Jan 17, 2020, 06:42 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 15, 2020 Option Exercise$62.064,277265,43124,602Jan 17, 2020, 06:39 PM
Monia Brett PChief Executive OfficerJan 15, 2020 Option Exercise$62.067,563469,36028,643Jan 17, 2020, 06:36 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 15, 2020 Option Exercise$62.064,277265,43132,227Jan 17, 2020, 06:33 PM
Geary Richard SSVP, DevelopmentJan 15, 2020 Option Exercise$62.064,654288,82730,068Jan 17, 2020, 06:30 PM
CROOKE STANLEY TExecutive Chairman of BoardJan 15, 2020 Option Exercise$62.061,26878,6927,581Jan 17, 2020, 06:28 PM
CROOKE STANLEY TExecutive Chairman of BoardJan 15, 2020 Option Exercise$62.0617,3421,076,24591,935Jan 17, 2020, 06:28 PM
BENNETT C FRANKChief Scientific OfficerJan 15, 2020 Option Exercise$62.064,162258,29432,195Jan 17, 2020, 06:11 PM
Monia Brett PChief Executive OfficerJan 02, 2020 Sale$60.2517310,42316,285Jan 03, 2020, 07:04 PM
KLEIN JOSEPH IIIDirectorDec 23, 2019 Option Exercise$35.531,00035,53013,683Dec 23, 2019, 07:28 PM
KLEIN JOSEPH IIIDirectorDec 23, 2019 Sale$61.871,00061,87412,683Dec 23, 2019, 07:28 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 20, 2019 Option Exercise$61.526,229383,20824,460Dec 20, 2019, 07:23 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 20, 2019 Option Exercise$10.8210,634115,06027,251Dec 20, 2019, 07:23 PM
KLEIN JOSEPH IIIDirectorDec 16, 2019 Option Exercise$35.531,00035,53013,683Dec 18, 2019, 05:07 PM
KLEIN JOSEPH IIIDirectorDec 16, 2019 Sale$65.451,00065,44712,683Dec 18, 2019, 05:07 PM
KLEIN JOSEPH IIIDirectorDec 09, 2019 Option Exercise$35.531,00035,53013,683Dec 10, 2019, 06:54 PM
KLEIN JOSEPH IIIDirectorDec 09, 2019 Sale$63.741,00063,74512,683Dec 10, 2019, 06:54 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 04, 2019 Option Exercise$10.824,56649,40424,117Dec 05, 2019, 05:31 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 04, 2019 Sale$65.004,566296,79020,055Dec 05, 2019, 05:31 PM
Geary Richard SSVP, DevelopmentDec 04, 2019 Option Exercise$14.6910,000146,90031,583Dec 05, 2019, 05:26 PM
Geary Richard SSVP, DevelopmentDec 04, 2019 Sale$65.0010,000650,00021,583Dec 05, 2019, 05:26 PM
KLEIN JOSEPH IIIDirectorDec 02, 2019 Option Exercise$35.531,00035,53013,683Dec 04, 2019, 06:26 PM
KLEIN JOSEPH IIIDirectorDec 02, 2019 Sale$64.081,00064,08312,683Dec 04, 2019, 06:26 PM
Geary Richard SSVP, DevelopmentDec 02, 2019 Option Exercise$14.695,00073,45026,583Dec 04, 2019, 06:22 PM
Geary Richard SSVP, DevelopmentDec 02, 2019 Sale$65.065,000325,28721,583Dec 04, 2019, 06:22 PM
KLEIN JOSEPH IIIDirectorNov 25, 2019 Sale$62.9081251,07512,683Nov 26, 2019, 05:43 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 25, 2019 Option Exercise$10.824,00043,28024,055Nov 26, 2019, 05:40 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 25, 2019 Sale$62.504,000250,00020,055Nov 26, 2019, 05:40 PM
KLEIN JOSEPH IIIDirectorNov 20, 2019 Sale$60.002,000120,00013,495Nov 21, 2019, 06:40 PM
Monia Brett PCOO & SVP, Translational MedNov 20, 2019 Sale$60.015,776346,61816,458Nov 21, 2019, 06:38 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 19, 2019 Option Exercise$10.824,00043,28024,055Nov 21, 2019, 06:36 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 19, 2019 Sale$58.804,000235,20020,055Nov 21, 2019, 06:36 PM
CROOKE STANLEY TChairman and CEOAug 20, 2019 Option Exercise$39.872,00079,7407,532Aug 22, 2019, 06:41 PM
CROOKE STANLEY TChairman and CEOAug 20, 2019 Option Exercise$39.8710,000398,70079,634Aug 22, 2019, 06:41 PM
CROOKE STANLEY TChairman and CEOAug 21, 2019 Option Exercise$39.8710,000398,70079,634Aug 22, 2019, 06:41 PM
CROOKE STANLEY TChairman and CEOAug 20, 2019 Sale$71.002,000142,0005,532Aug 22, 2019, 06:41 PM
CROOKE STANLEY TChairman and CEOAug 20, 2019 Sale$71.0010,000710,00069,634Aug 22, 2019, 06:41 PM
CROOKE STANLEY TChairman and CEOAug 21, 2019 Sale$72.1510,000721,50069,634Aug 22, 2019, 06:41 PM
CROOKE STANLEY TChairman & CEOJul 18, 2019 Option Exercise$39.8710,000398,70079,634Jul 22, 2019, 05:34 PM
CROOKE STANLEY TChairman & CEOJul 18, 2019 Sale$70.2510,000702,50669,634Jul 22, 2019, 05:34 PM
McDevitt DamienChief Business OfficerJul 15, 2019 Option Exercise$67.861,22583,1292,573Jul 17, 2019, 05:39 PM
O'NEIL PATRICK R.SVP Legal & General CounselJul 01, 2019 Option Exercise$45.701617,35816,834Jul 02, 2019, 08:56 PM
Monia Brett PChief Operating OfficerJul 01, 2019 Option Exercise$45.701737,90722,444Jul 02, 2019, 08:50 PM
Monia Brett PChief Operating OfficerJul 02, 2019 Sale$66.4021013,94422,234Jul 02, 2019, 08:50 PM
HOUGEN ELIZABETH LSVP Finance & CFOJul 01, 2019 Option Exercise$45.701054,79920,055Jul 02, 2019, 08:45 PM
Geary Richard SSVP, DevelopmentJul 01, 2019 Option Exercise$45.701416,44421,583Jul 02, 2019, 08:43 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2019 Option Exercise$45.701185,39324,646Jul 02, 2019, 08:39 PM
McDevitt DamienChief Business OfficerJul 01, 2019 Option Exercise$45.7025611,700256Jul 02, 2019, 08:35 PM
BERTHELSEN SPENCER RDirectorJun 24, 2019 Option Exercise$16.3215,000244,800103,784Jun 26, 2019, 06:52 PM
BERTHELSEN SPENCER RDirectorJun 24, 2019 Sale$63.6715,000955,11394,094Jun 26, 2019, 06:52 PM
MUTO FREDERICK TDirectorJun 04, 2019 Option Exercise$16.3215,000244,80024,794Jun 06, 2019, 06:35 PM
MUTO FREDERICK TDirectorJun 04, 2019 Sale$65.2915,000979,3509,794Jun 06, 2019, 06:35 PM
MUTO FREDERICK TDirectorMay 06, 2019 Option Exercise$24.428,000195,36017,794May 08, 2019, 06:16 PM
MUTO FREDERICK TDirectorMay 06, 2019 Sale$72.758,000582,0029,794May 08, 2019, 06:16 PM
PARSHALL B LYNNEDirectorApr 29, 2019 Option Exercise$39.8750,0001,993,500102,677May 01, 2019, 05:48 PM
PARSHALL B LYNNEDirectorApr 29, 2019 Sale$75.0150,0003,750,63552,677May 01, 2019, 05:48 PM
CROOKE STANLEY TChairman and CEOApr 15, 2019 Option Exercise$10.821,00010,8206,532Apr 17, 2019, 07:30 PM
CROOKE STANLEY TChairman and CEOApr 15, 2019 Option Exercise$14.6910,000146,90079,634Apr 17, 2019, 07:30 PM
CROOKE STANLEY TChairman and CEOApr 16, 2019 Option Exercise$31.151,00031,1556,232Apr 17, 2019, 07:30 PM
CROOKE STANLEY TChairman and CEOApr 16, 2019 Option Exercise$31.4620,000629,19882,954Apr 17, 2019, 07:30 PM
CROOKE STANLEY TChairman and CEOApr 15, 2019 Sale$85.251,00085,2505,532Apr 17, 2019, 07:30 PM
CROOKE STANLEY TChairman and CEOApr 15, 2019 Sale$85.2510,000852,50069,634Apr 17, 2019, 07:30 PM
CROOKE STANLEY TChairman and CEOApr 16, 2019 Sale$84.751,00084,7505,532Apr 17, 2019, 07:30 PM
CROOKE STANLEY TChairman and CEOApr 16, 2019 Sale$84.6220,0001,692,50069,634Apr 17, 2019, 07:30 PM
Geary Richard SSVP, DevelopmentApr 08, 2019 Option Exercise$42.5346,2401,966,46645,442Apr 10, 2019, 06:24 PM
Geary Richard SSVP, DevelopmentApr 08, 2019 Sale$84.0146,2403,884,75321,442Apr 10, 2019, 06:24 PM
O'NEIL PATRICK R.SVP Legal & General CounselApr 05, 2019 Option Exercise$61.682,252138,90318,925Apr 05, 2019, 07:29 PM
O'NEIL PATRICK R.SVP Legal & General CounselApr 04, 2019 Option Exercise$56.7636,6222,078,80935,165Apr 05, 2019, 07:29 PM
O'NEIL PATRICK R.SVP Legal & General CounselApr 03, 2019 Option Exercise$61.687,654472,09927,327Apr 05, 2019, 07:29 PM
O'NEIL PATRICK R.SVP Legal & General CounselApr 05, 2019 Sale$84.752,252190,85716,673Apr 05, 2019, 07:29 PM
O'NEIL PATRICK R.SVP Legal & General CounselApr 04, 2019 Sale$83.7939,6223,319,92919,673Apr 05, 2019, 07:29 PM
O'NEIL PATRICK R.SVP Legal & General CounselApr 03, 2019 Sale$84.837,654649,28919,673Apr 05, 2019, 07:29 PM
O'NEIL PATRICK R.SVP Legal & General CounselMar 18, 2019 Option Exercise$61.5728,8001,773,21648,473Mar 20, 2019, 06:15 PM
O'NEIL PATRICK R.SVP Legal & General CounselMar 18, 2019 Sale$78.7928,8002,269,18719,673Mar 20, 2019, 06:15 PM
WENDER JOSEPH HDirectorMar 19, 2019 Sale$79.6310,000796,25858,916Mar 20, 2019, 06:05 PM
PARSHALL B LYNNEDirectorMar 12, 2019 Option Exercise$39.878,334332,27761,011Mar 14, 2019, 06:24 PM
PARSHALL B LYNNEDirectorMar 12, 2019 Sale$75.008,334625,05052,677Mar 14, 2019, 06:24 PM
PARSHALL B LYNNEDirectorFeb 27, 2019 Option Exercise$39.878,333332,23761,010Mar 01, 2019, 05:56 PM
PARSHALL B LYNNEDirectorFeb 27, 2019 Sale$70.008,333583,31052,677Mar 01, 2019, 05:56 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 27, 2019 Option Exercise$45.1126,8001,208,95233,773Mar 01, 2019, 05:40 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 27, 2019 Sale$68.0126,8001,822,58019,673Mar 01, 2019, 05:40 PM
CROOKE STANLEY TChairman and CEOFeb 26, 2019 Option Exercise$39.8737,0001,475,190106,634Feb 27, 2019, 07:31 PM
CROOKE STANLEY TChairman and CEOFeb 25, 2019 Option Exercise$39.8740,0001,594,800109,634Feb 27, 2019, 07:31 PM
CROOKE STANLEY TChairman and CEOFeb 26, 2019 Sale$61.5437,0002,276,79969,634Feb 27, 2019, 07:31 PM
CROOKE STANLEY TChairman and CEOFeb 25, 2019 Sale$60.0740,0002,402,70069,634Feb 27, 2019, 07:31 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 12, 2019 Option Exercise$39.8727510,96419,948Feb 14, 2019, 06:01 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 12, 2019 Sale$59.5027516,36319,673Feb 14, 2019, 06:01 PM
CROOKE STANLEY TChairman and CEOFeb 13, 2019 Option Exercise$33.126,904228,66610,832Feb 14, 2019, 05:57 PM
CROOKE STANLEY TChairman and CEOFeb 13, 2019 Option Exercise$39.8740,0001,594,800109,634Feb 14, 2019, 05:57 PM
CROOKE STANLEY TChairman and CEOFeb 13, 2019 Sale$60.1040,0002,404,02869,634Feb 14, 2019, 05:57 PM
CROOKE STANLEY TChairman and CEOFeb 13, 2019 Sale$60.006,904414,2405,532Feb 14, 2019, 05:57 PM
Geary Richard SSVP, DevelopmentFeb 13, 2019 Sale$60.0099959,94021,442Feb 14, 2019, 05:51 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 05, 2019 Option Exercise$39.8715,600621,97235,273Feb 05, 2019, 06:05 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 01, 2019 Option Exercise$39.874,000159,48023,673Feb 05, 2019, 06:05 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 05, 2019 Sale$59.5015,600928,20019,673Feb 05, 2019, 06:05 PM
O'NEIL PATRICK R.SVP Legal & General CounselFeb 01, 2019 Sale$58.294,000233,16019,673Feb 05, 2019, 06:05 PM
BENNETT C FRANKSVP, Antisense ResearchFeb 01, 2019 Option Exercise$14.699,013132,40133,541Feb 05, 2019, 05:59 PM
BENNETT C FRANKSVP, Antisense ResearchFeb 01, 2019 Sale$58.299,013525,36824,528Feb 05, 2019, 05:59 PM
BENNETT C FRANKSVP, Antisense ResearchJan 15, 2019 Option Exercise$58.262,818164,17724,400Jan 17, 2019, 07:39 PM
Geary Richard SSVP, DevelopmentJan 15, 2019 Option Exercise$58.262,908169,42022,034Jan 17, 2019, 07:36 PM
HOUGEN ELIZABETH LSVP Finance & CFOJan 15, 2019 Option Exercise$58.262,842165,57519,823Jan 17, 2019, 07:35 PM
Monia Brett PChief Operating OfficerJan 15, 2019 Option Exercise$58.263,572208,10522,275Jan 17, 2019, 07:34 PM
CROOKE STANLEY TChairman and CEOJan 15, 2019 Option Exercise$58.2694254,8815,532Jan 17, 2019, 07:27 PM
CROOKE STANLEY TChairman and CEOJan 15, 2019 Option Exercise$58.2612,686739,08669,634Jan 17, 2019, 07:27 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 15, 2019 Option Exercise$58.262,734159,28319,607Jan 17, 2019, 07:24 PM
PARSHALL B LYNNEDirectorJan 15, 2019 Option Exercise$58.266,159358,82352,677Jan 17, 2019, 07:19 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 01, 2019 Option Exercise$36.45662,40614,584Jan 03, 2019, 07:50 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 03, 2019 Option Exercise$37.234,400163,80818,584Jan 03, 2019, 07:50 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 03, 2019 Sale$54.804,400241,12014,584Jan 03, 2019, 07:50 PM
HOUGEN ELIZABETH LSVP Finance & CFOJan 01, 2019 Option Exercise$36.451274,62914,901Jan 03, 2019, 07:44 PM
Monia Brett PChief Operating OfficerJan 01, 2019 Option Exercise$36.452107,65416,051Jan 03, 2019, 07:42 PM
Monia Brett PChief Operating OfficerJan 02, 2019 Sale$53.5021411,44915,837Jan 03, 2019, 07:42 PM
Geary Richard SSVP, DevelopmentJan 01, 2019 Option Exercise$36.4540714,83417,264Jan 03, 2019, 07:34 PM
BENNETT C FRANKSVP, Antisense ResearchJan 01, 2019 Option Exercise$36.451284,66519,524Jan 03, 2019, 07:32 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 19, 2018 Option Exercise$7.252,06314,95716,837Dec 20, 2018, 05:55 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 18, 2018 Option Exercise$7.252,00014,50016,774Dec 20, 2018, 05:55 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 19, 2018 Sale$52.052,063107,37914,774Dec 20, 2018, 05:55 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 18, 2018 Sale$52.002,000104,00014,774Dec 20, 2018, 05:55 PM
Monia Brett PChief Operating OfficerNov 23, 2018 Option Exercise$14.6934,000499,46049,841Nov 26, 2018, 08:01 PM
Monia Brett PChief Operating OfficerNov 23, 2018 Sale$55.0034,0001,870,05815,841Nov 26, 2018, 08:01 PM
BENNETT C FRANKSVP, Antisense ResearchNov 01, 2018 Option Exercise$14.6912,500183,62531,896Nov 01, 2018, 07:34 PM
BENNETT C FRANKSVP, Antisense ResearchNov 01, 2018 Sale$49.5412,500619,24519,396Nov 01, 2018, 07:34 PM
Monia Brett PChief Operating OfficerAug 27, 2018 Option Exercise$7.2316,493119,27424,834Aug 29, 2018, 04:49 PM
Monia Brett PChief Operating OfficerAug 27, 2018 Sale$54.0016,493890,62215,841Aug 29, 2018, 04:49 PM
BENNETT C FRANKSVP, Antisense ResearchAug 08, 2018 Option Exercise$14.6812,500183,52831,883Aug 09, 2018, 06:34 PM
BENNETT C FRANKSVP, Antisense ResearchAug 08, 2018 Sale$45.0012,500562,50019,396Aug 09, 2018, 06:34 PM
Monia Brett PChief Operating OfficerJul 24, 2018 Sale$47.031567,33715,841Jul 25, 2018, 07:19 PM
WENDER JOSEPH HDirectorJul 17, 2018 Option Exercise$9.2630,000277,80068,916Jul 19, 2018, 06:45 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2018 Option Exercise$35.422829,98819,396Jul 03, 2018, 03:35 PM
Geary Richard SSVP, DevelopmentJul 01, 2018 Option Exercise$35.421776,26916,857Jul 03, 2018, 03:33 PM
HOUGEN ELIZABETH LSVP Finance & CFOJul 01, 2018 Option Exercise$35.422749,70514,774Jul 03, 2018, 03:31 PM
Monia Brett PChief Operating OfficerJul 01, 2018 Option Exercise$35.422147,58015,997Jul 03, 2018, 03:30 PM
O'NEIL PATRICK R.SVP Legal & General CounselJul 01, 2018 Option Exercise$35.42662,33814,518Jul 03, 2018, 03:28 PM
BERTHELSEN SPENCER RDirectorJun 25, 2018 Option Exercise$13.8815,000208,200100,727Jun 25, 2018, 08:28 PM
BERTHELSEN SPENCER RDirectorJun 25, 2018 Sale$42.3015,000634,54291,427Jun 25, 2018, 08:28 PM
MUTO FREDERICK TDirectorMay 31, 2018 Option Exercise$13.8815,000208,20022,127May 31, 2018, 08:02 PM
MUTO FREDERICK TDirectorMay 31, 2018 Sale$46.4515,000696,7507,127May 31, 2018, 08:02 PM
BENNETT C FRANKSVP, Antisense ResearchMay 11, 2018 Option Exercise$7.2512,50090,62531,614May 11, 2018, 09:06 PM
BENNETT C FRANKSVP, Antisense ResearchMay 11, 2018 Sale$45.0012,500562,50019,114May 11, 2018, 09:06 PM
WENDER JOSEPH HDirectorMay 11, 2018 Option Exercise$13.8815,000208,20044,839May 11, 2018, 09:00 PM
WENDER JOSEPH HDirectorMay 11, 2018 Sale$45.3115,000679,61436,249May 11, 2018, 09:00 PM
CROOKE STANLEY TChairman and CEOApr 17, 2018 Option Exercise$10.824,00043,2806,128Apr 19, 2018, 05:22 PM
CROOKE STANLEY TChairman and CEOApr 17, 2018 Option Exercise$14.699,962146,34256,714Apr 19, 2018, 05:22 PM
CROOKE STANLEY TChairman and CEOApr 17, 2018 Sale$44.404,000177,6004,128Apr 19, 2018, 05:22 PM
CROOKE STANLEY TChairman and CEOApr 17, 2018 Sale$44.409,962442,31351,733Apr 19, 2018, 05:22 PM
KLEIN JOSEPH IIIDirectorMar 29, 2018 Option Exercise$24.422,00048,84011,939Mar 30, 2018, 03:51 PM
KLEIN JOSEPH IIIDirectorMar 29, 2018 Sale$46.152,00092,3009,939Mar 30, 2018, 03:51 PM
KLEIN JOSEPH IIIDirectorMar 15, 2018 Option Exercise$24.422,00048,84010,839Mar 16, 2018, 04:19 PM
KLEIN JOSEPH IIIDirectorMar 15, 2018 Sale$51.132,000102,2589,939Mar 16, 2018, 04:19 PM
O'NEIL PATRICK R.SVP Legal & General CounselMar 12, 2018 Option Exercise$10.821,00010,82015,452Mar 13, 2018, 09:14 PM
O'NEIL PATRICK R.SVP Legal & General CounselMar 12, 2018 Sale$55.001,00055,00014,452Mar 13, 2018, 09:14 PM
KLEIN JOSEPH IIIDirectorFeb 28, 2018 Option Exercise$35.533,000106,59012,039Mar 01, 2018, 05:52 PM
KLEIN JOSEPH IIIDirectorFeb 28, 2018 Sale$51.913,000155,7279,939Mar 01, 2018, 05:52 PM
KLEIN JOSEPH IIIDirectorFeb 15, 2018 Option Exercise$35.533,000106,59011,539Feb 16, 2018, 06:00 PM
KLEIN JOSEPH IIIDirectorFeb 15, 2018 Sale$48.993,000146,9849,939Feb 16, 2018, 06:00 PM
BENNETT C FRANKSVP, Antisense ResearchFeb 01, 2018 Option Exercise$7.2512,50090,62531,614Feb 01, 2018, 07:58 PM
BENNETT C FRANKSVP, Antisense ResearchFeb 01, 2018 Sale$52.5012,500656,26019,114Feb 01, 2018, 07:58 PM
KLEIN JOSEPH IIIDirectorJan 30, 2018 Option Exercise$35.533,000106,59012,939Jan 31, 2018, 04:18 PM
KLEIN JOSEPH IIIDirectorJan 30, 2018 Sale$52.863,000158,5809,939Jan 31, 2018, 04:18 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 29, 2018 Option Exercise$10.823553,84114,752Jan 31, 2018, 04:16 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 29, 2018 Sale$55.0035519,52514,452Jan 31, 2018, 04:16 PM
CROOKE STANLEY TChairman and CEOJan 29, 2018 Option Exercise$10.821,00010,8205,128Jan 31, 2018, 04:15 PM
CROOKE STANLEY TChairman and CEOJan 29, 2018 Option Exercise$14.6910,000146,90061,733Jan 31, 2018, 04:15 PM
CROOKE STANLEY TChairman and CEOJan 29, 2018 Sale$54.1210,000541,20051,733Jan 31, 2018, 04:15 PM
CROOKE STANLEY TChairman and CEOJan 29, 2018 Sale$54.121,00054,1204,128Jan 31, 2018, 04:15 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 25, 2018 Option Exercise$10.826456,97915,097Jan 29, 2018, 04:08 PM
O'NEIL PATRICK R.SVP Legal & General CounselJan 25, 2018 Sale$55.0064535,47514,452Jan 29, 2018, 04:08 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 16, 2018 Sale$51.762,724140,99414,500Jan 17, 2018, 09:46 PM
KLEIN JOSEPH IIIDirectorJan 16, 2018 Option Exercise$35.533,000106,59011,539Jan 17, 2018, 09:28 PM
KLEIN JOSEPH IIIDirectorJan 16, 2018 Sale$52.523,000157,5669,939Jan 17, 2018, 09:28 PM
Geary Richard SSVP, DevelopmentJan 16, 2018 Sale$51.762,723140,94216,680Jan 17, 2018, 09:26 PM
PARSHALL B LYNNEDirectorJan 16, 2018 Sale$51.765,986309,83538,180Jan 17, 2018, 09:25 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 16, 2018 Sale$51.762,697139,59714,452Jan 17, 2018, 09:25 PM
Boyce SarahChief Business OfficerJan 16, 2018 Sale$51.762,196113,6658,931Jan 17, 2018, 09:23 PM
BENNETT C FRANKSVP, Antisense ResearchJan 16, 2018 Sale$51.762,696139,54519,114Jan 17, 2018, 09:22 PM
CROOKE STANLEY TChairman and CEOJan 15, 2018 Sale$51.7665633,9554,128Jan 17, 2018, 09:22 PM
CROOKE STANLEY TChairman and CEOJan 15, 2018 Sale$51.7615,893822,62251,733Jan 17, 2018, 09:22 PM
Monia Brett PCOOJan 16, 2018 Sale$51.762,821146,01515,783Jan 17, 2018, 09:21 PM
CROOKE STANLEY TChairman and CEOJan 08, 2018 Option Exercise$10.821,00010,8204,062Jan 10, 2018, 06:43 PM
CROOKE STANLEY TChairman and CEOJan 08, 2018 Option Exercise$14.6910,000146,90048,014Jan 10, 2018, 06:43 PM
CROOKE STANLEY TChairman and CEOJan 08, 2018 Sale$52.011,00052,0103,062Jan 10, 2018, 06:43 PM
CROOKE STANLEY TChairman and CEOJan 08, 2018 Sale$52.0110,000520,10038,014Jan 10, 2018, 06:43 PM
CROOKE STANLEY TChairman and CEOJan 03, 2018 Option Exercise$9.212,00018,4134,158Jan 05, 2018, 04:41 PM
CROOKE STANLEY TChairman and CEOJan 03, 2018 Option Exercise$14.6920,000293,80058,014Jan 05, 2018, 04:41 PM
CROOKE STANLEY TChairman and CEOJan 03, 2018 Sale$50.0220,0001,000,40038,014Jan 05, 2018, 04:41 PM
CROOKE STANLEY TChairman and CEOJan 03, 2018 Sale$49.882,00099,7603,062Jan 05, 2018, 04:41 PM
PARSHALL B LYNNECOOJan 01, 2018 Option Exercise$42.76863,67725,827Jan 02, 2018, 08:51 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 01, 2018 Option Exercise$42.76532,26610,486Jan 02, 2018, 08:50 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 01, 2018 Option Exercise$42.761566,67011,782Jan 02, 2018, 08:49 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 02, 2018 Sale$50.001638,15011,619Jan 02, 2018, 08:49 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 01, 2018 Option Exercise$42.761004,27610,492Jan 02, 2018, 08:49 PM
Geary Richard SSVP, DevelopmentJan 01, 2018 Option Exercise$42.7632013,68212,671Jan 02, 2018, 08:48 PM
Boyce SarahChief Business OfficerJan 01, 2018 Option Exercise$42.7649120,9935,760Jan 02, 2018, 08:45 PM
BENNETT C FRANKSVP, Antisense ResearchJan 01, 2018 Option Exercise$42.761064,53215,147Jan 02, 2018, 08:45 PM
KLEIN JOSEPH IIIDirectorDec 29, 2017 Option Exercise$28.473,00085,41012,939Jan 02, 2018, 05:50 PM
KLEIN JOSEPH IIIDirectorDec 29, 2017 Sale$50.563,000151,6809,939Jan 02, 2018, 05:50 PM
KLEIN JOSEPH IIIDirectorDec 15, 2017 Option Exercise$28.473,00085,41012,939Dec 19, 2017, 08:27 PM
KLEIN JOSEPH IIIDirectorDec 15, 2017 Sale$51.693,000155,0709,939Dec 19, 2017, 08:27 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 15, 2017 Option Exercise$10.295,00051,45015,392Dec 19, 2017, 08:20 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 15, 2017 Sale$52.555,000262,75010,392Dec 19, 2017, 08:20 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 04, 2017 Option Exercise$10.294,00041,16014,392Dec 06, 2017, 06:36 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 04, 2017 Sale$57.004,000228,00010,392Dec 06, 2017, 06:36 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 29, 2017 Option Exercise$10.296,00061,74016,392Dec 01, 2017, 07:12 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 29, 2017 Sale$53.026,000318,12010,392Dec 01, 2017, 07:12 PM
KLEIN JOSEPH IIIDirectorNov 30, 2017 Option Exercise$28.473,00085,41012,939Dec 01, 2017, 07:04 PM
KLEIN JOSEPH IIIDirectorNov 30, 2017 Sale$53.553,000160,6509,939Dec 01, 2017, 07:04 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 01, 2017 Option Exercise$10.821,00010,82011,433Dec 01, 2017, 07:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 01, 2017 Sale$55.501,00055,50010,433Dec 01, 2017, 07:03 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 16, 2017 Option Exercise$10.297,00072,03017,392Nov 17, 2017, 05:57 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 16, 2017 Sale$54.357,000380,45010,392Nov 17, 2017, 05:57 PM
KLEIN JOSEPH IIIDirectorNov 16, 2017 Option Exercise$12.942,81236,3879,939Nov 17, 2017, 05:57 PM
KLEIN JOSEPH IIIDirectorNov 15, 2017 Option Exercise$28.472,25064,0579,377Nov 17, 2017, 05:57 PM
KLEIN JOSEPH IIIDirectorNov 15, 2017 Sale$53.562,250120,5107,127Nov 17, 2017, 05:57 PM
KLEIN JOSEPH IIIDirectorNov 13, 2017 Sale$55.393,000166,1707,127Nov 14, 2017, 06:29 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 01, 2017 Option Exercise$10.821,00010,82011,433Nov 03, 2017, 05:20 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 01, 2017 Sale$58.351,00058,35010,433Nov 03, 2017, 05:20 PM
BENNETT C FRANKSVP, Antisense ResearchOct 18, 2017 Option Exercise$10.2912,250126,05227,291Oct 20, 2017, 05:35 PM
BENNETT C FRANKSVP, Antisense ResearchOct 18, 2017 Sale$65.0012,250796,25015,041Oct 20, 2017, 05:35 PM
PARSHALL B LYNNECOOOct 18, 2017 Option Exercise$27.7116,118446,59834,074Oct 20, 2017, 05:34 PM
PARSHALL B LYNNECOOOct 18, 2017 Sale$65.0016,1181,047,67025,741Oct 20, 2017, 05:34 PM
CROOKE STANLEY TChairman and CEOOct 13, 2017 Option Exercise$14.6915,000220,35053,014Oct 17, 2017, 05:36 PM
CROOKE STANLEY TChairman and CEOOct 13, 2017 Option Exercise$7.251,50010,8754,562Oct 17, 2017, 05:36 PM
CROOKE STANLEY TChairman and CEOOct 13, 2017 Sale$59.4615,000891,90038,014Oct 17, 2017, 05:36 PM
CROOKE STANLEY TChairman and CEOOct 13, 2017 Sale$59.461,50089,1903,062Oct 17, 2017, 05:36 PM
Geary Richard SSVP, DevelopmentOct 13, 2017 Option Exercise$7.427,46155,38719,386Oct 17, 2017, 05:36 PM
Geary Richard SSVP, DevelopmentOct 13, 2017 Sale$60.008,268496,08012,351Oct 17, 2017, 05:36 PM
O'NEIL PATRICK R.SVP, Legal & General CounselOct 05, 2017 Option Exercise$10.111,00010,10611,233Oct 06, 2017, 04:41 PM
O'NEIL PATRICK R.SVP, Legal & General CounselOct 05, 2017 Sale$55.001,00055,00010,433Oct 06, 2017, 04:41 PM
CROOKE STANLEY TChairman and CEOOct 02, 2017 Option Exercise$14.6915,000220,35043,014Oct 04, 2017, 07:15 PM
CROOKE STANLEY TChairman and CEOOct 04, 2017 Option Exercise$7.251,0007,2503,562Oct 04, 2017, 07:15 PM
CROOKE STANLEY TChairman and CEOOct 04, 2017 Option Exercise$14.6910,000146,90043,014Oct 04, 2017, 07:15 PM
CROOKE STANLEY TChairman and CEOOct 02, 2017 Option Exercise$7.251,50010,8753,562Oct 04, 2017, 07:15 PM
CROOKE STANLEY TChairman and CEOOct 04, 2017 Sale$54.2310,000542,25038,014Oct 04, 2017, 07:15 PM
CROOKE STANLEY TChairman and CEOOct 02, 2017 Sale$52.001,50078,0003,062Oct 04, 2017, 07:15 PM
CROOKE STANLEY TChairman and CEOOct 02, 2017 Sale$52.0015,000780,00038,014Oct 04, 2017, 07:15 PM
CROOKE STANLEY TChairman and CEOOct 04, 2017 Sale$54.231,00054,2253,062Oct 04, 2017, 07:15 PM
O'NEIL PATRICK R.SVP, Legal and General CounselSep 06, 2017 Option Exercise$7.258005,80011,233Sep 07, 2017, 08:23 PM
O'NEIL PATRICK R.SVP, Legal and General CounselSep 05, 2017 Option Exercise$7.252001,45010,633Sep 07, 2017, 08:23 PM
O'NEIL PATRICK R.SVP, Legal and General CounselSep 06, 2017 Sale$55.0080044,00010,433Sep 07, 2017, 08:23 PM
O'NEIL PATRICK R.SVP, Legal and General CounselSep 05, 2017 Sale$55.0020011,00010,433Sep 07, 2017, 08:23 PM
BENNETT C FRANKSVP, Antisense ResearchJul 24, 2017 Option Exercise$10.2910,000102,90025,041Jul 26, 2017, 08:03 PM
BENNETT C FRANKSVP, Antisense ResearchJul 24, 2017 Sale$59.2910,000592,90015,041Jul 26, 2017, 08:03 PM
CROOKE STANLEY TChairman and CEOJul 20, 2017 Option Exercise$7.251,0007,2504,062Jul 24, 2017, 05:54 PM
CROOKE STANLEY TChairman and CEOJul 20, 2017 Option Exercise$14.6910,000146,90048,014Jul 24, 2017, 05:54 PM
CROOKE STANLEY TChairman and CEOJul 20, 2017 Sale$55.351,00055,3503,062Jul 24, 2017, 05:54 PM
CROOKE STANLEY TChairman and CEOJul 20, 2017 Sale$55.3510,000553,50038,014Jul 24, 2017, 05:54 PM
CROOKE STANLEY TChairman and CEOJul 17, 2017 Option Exercise$14.6915,000220,35053,014Jul 18, 2017, 07:01 PM
CROOKE STANLEY TChairman and CEOJul 17, 2017 Option Exercise$7.251,50010,8754,562Jul 18, 2017, 07:01 PM
CROOKE STANLEY TChairman and CEOJul 17, 2017 Sale$52.4515,000786,75038,014Jul 18, 2017, 07:01 PM
CROOKE STANLEY TChairman and CEOJul 17, 2017 Sale$52.451,50078,6753,062Jul 18, 2017, 07:01 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 01, 2017 Option Exercise$40.661636,62711,935Jul 03, 2017, 05:38 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 03, 2017 Sale$51.3530915,86711,626Jul 03, 2017, 05:38 PM
PARSHALL B LYNNECOOJul 01, 2017 Option Exercise$40.66903,65925,741Jul 03, 2017, 05:38 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 01, 2017 Option Exercise$40.661345,44810,433Jul 03, 2017, 05:37 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJul 01, 2017 Option Exercise$40.661044,22810,392Jul 03, 2017, 05:36 PM
Geary Richard SSVP, DevelopmentJul 01, 2017 Option Exercise$40.661967,96813,158Jul 03, 2017, 05:36 PM
Boyce SarahChief Business OfficerJul 01, 2017 Option Exercise$40.66176915,269Jul 03, 2017, 05:35 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2017 Option Exercise$40.6625310,28615,041Jul 03, 2017, 05:35 PM
CROOKE STANLEY TChairman and CEOJul 03, 2017 Option Exercise$8.0115,000120,19351,476Jul 03, 2017, 05:34 PM
CROOKE STANLEY TChairman and CEOJul 03, 2017 Option Exercise$7.251,50010,8754,562Jul 03, 2017, 05:34 PM
CROOKE STANLEY TChairman and CEOJul 03, 2017 Sale$52.101,50078,1503,062Jul 03, 2017, 05:34 PM
CROOKE STANLEY TChairman and CEOJul 03, 2017 Sale$52.1015,000781,53838,014Jul 03, 2017, 05:34 PM
MUTO FREDERICK TDirectorMay 31, 2017 Option Exercise$9.7712,500122,12517,158Jun 02, 2017, 06:16 PM
MUTO FREDERICK TDirectorMay 31, 2017 Sale$45.2212,500565,2504,658Jun 02, 2017, 06:16 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJun 01, 2017 Option Exercise$10.827075710,369Jun 02, 2017, 06:15 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJun 01, 2017 Sale$48.00703,36010,299Jun 02, 2017, 06:15 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMay 01, 2017 Option Exercise$10.825005,41010,799May 03, 2017, 06:01 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMay 01, 2017 Sale$48.7565031,68810,299May 03, 2017, 06:01 PM
CROOKE STANLEY TChairman and CEOApr 25, 2017 Option Exercise$7.251,50010,8754,562Apr 27, 2017, 06:03 PM
CROOKE STANLEY TChairman and CEOApr 25, 2017 Option Exercise$7.2515,000108,75053,014Apr 27, 2017, 06:03 PM
CROOKE STANLEY TChairman and CEOApr 25, 2017 Sale$47.811,50071,7153,062Apr 27, 2017, 06:03 PM
CROOKE STANLEY TChairman and CEOApr 25, 2017 Sale$47.8115,000717,15038,014Apr 27, 2017, 06:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 24, 2017 Option Exercise$10.825005,41010,875Apr 26, 2017, 05:58 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 24, 2017 Sale$45.0050022,50010,449Apr 26, 2017, 05:58 PM
CROOKE STANLEY TChairman and CEOApr 19, 2017 Option Exercise$7.255003,6253,562Apr 21, 2017, 05:42 PM
CROOKE STANLEY TChairman and CEOApr 19, 2017 Option Exercise$7.255,00036,25043,014Apr 21, 2017, 05:42 PM
CROOKE STANLEY TChairman and CEOApr 19, 2017 Sale$43.2550021,6253,062Apr 21, 2017, 05:42 PM
CROOKE STANLEY TChairman and CEOApr 19, 2017 Sale$43.255,000216,25038,014Apr 21, 2017, 05:42 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 12, 2017 Sale$40.071,00040,07010,449Apr 13, 2017, 07:25 PM
CROOKE STANLEY TChairman and CEOApr 13, 2017 Option Exercise$7.2510,00072,50048,014Apr 13, 2017, 07:24 PM
CROOKE STANLEY TChairman and CEOApr 12, 2017 Option Exercise$10.291,00010,2904,062Apr 13, 2017, 07:24 PM
CROOKE STANLEY TChairman and CEOApr 12, 2017 Option Exercise$7.2510,00072,50048,014Apr 13, 2017, 07:24 PM
CROOKE STANLEY TChairman and CEOApr 13, 2017 Option Exercise$8.771,0008,7703,562Apr 13, 2017, 07:24 PM
CROOKE STANLEY TChairman and CEOApr 13, 2017 Sale$41.3010,000413,00038,014Apr 13, 2017, 07:24 PM
CROOKE STANLEY TChairman and CEOApr 12, 2017 Sale$40.071,00040,0703,062Apr 13, 2017, 07:24 PM
CROOKE STANLEY TChairman and CEOApr 12, 2017 Sale$40.0710,000400,70038,014Apr 13, 2017, 07:24 PM
CROOKE STANLEY TChairman and CEOApr 13, 2017 Sale$41.301,00041,3003,062Apr 13, 2017, 07:24 PM
BENNETT C FRANKSVP, Antisense ResearchMar 03, 2017 Option Exercise$10.295,00051,45019,788Mar 06, 2017, 07:25 PM
BENNETT C FRANKSVP, Antisense ResearchMar 03, 2017 Sale$55.005,000275,00014,788Mar 06, 2017, 07:25 PM
CROOKE STANLEY TChairman and CEOMar 02, 2017 Option Exercise$10.291,10011,3194,162Mar 06, 2017, 07:23 PM
CROOKE STANLEY TChairman and CEOMar 02, 2017 Option Exercise$7.2511,00079,75049,014Mar 06, 2017, 07:23 PM
CROOKE STANLEY TChairman and CEOMar 02, 2017 Sale$51.051,10056,1553,062Mar 06, 2017, 07:23 PM
CROOKE STANLEY TChairman and CEOMar 02, 2017 Sale$51.0511,000561,55038,014Mar 06, 2017, 07:23 PM
PARSHALL B LYNNECOOMar 01, 2017 Option Exercise$14.694,62567,94130,276Mar 02, 2017, 07:12 PM
PARSHALL B LYNNECOOMar 01, 2017 Sale$49.264,625227,82725,651Mar 02, 2017, 07:12 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 01, 2017 Option Exercise$10.825005,41012,949Mar 02, 2017, 07:11 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 01, 2017 Sale$49.291,50073,93512,449Mar 02, 2017, 07:11 PM
BERTHELSEN SPENCER RDirectorFeb 24, 2017 Option Exercise$9.7712,500122,12588,958Feb 27, 2017, 07:15 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 06, 2017 Option Exercise$10.685005,34212,930Feb 08, 2017, 06:32 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 06, 2017 Sale$46.171,50069,25412,449Feb 08, 2017, 06:32 PM
Boyce SarahChief Business OfficerJan 17, 2017 Sale$46.291,36163,0015,252Jan 18, 2017, 06:48 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 17, 2017 Sale$46.292,502115,81911,772Jan 18, 2017, 06:38 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 17, 2017 Sale$46.292,246103,96813,449Jan 18, 2017, 06:37 PM
BENNETT C FRANKSVP, Antisense ResearchJan 17, 2017 Sale$46.292,421112,06914,788Jan 18, 2017, 06:37 PM
CROOKE STANLEY TChairman and CEOJan 17, 2017 Sale$46.2957526,6173,062Jan 18, 2017, 06:36 PM
CROOKE STANLEY TChairman and CEOJan 17, 2017 Sale$46.2915,382712,02638,014Jan 18, 2017, 06:36 PM
PARSHALL B LYNNECOOJan 17, 2017 Sale$46.297,246335,41425,651Jan 18, 2017, 06:36 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 17, 2017 Sale$46.292,273105,21810,288Jan 18, 2017, 06:35 PM
Geary Richard SSVP, DevelopmentJan 17, 2017 Sale$46.292,441112,99612,962Jan 18, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 10, 2017 Option Exercise$10.291,20012,3483,370Jan 12, 2017, 06:18 PM
CROOKE STANLEY TChairman and CEOJan 10, 2017 Option Exercise$7.2512,00087,00037,029Jan 12, 2017, 06:18 PM
CROOKE STANLEY TChairman and CEOJan 10, 2017 Sale$49.251,20059,1002,170Jan 12, 2017, 06:18 PM
CROOKE STANLEY TChairman and CEOJan 10, 2017 Sale$49.2512,000591,00025,029Jan 12, 2017, 06:18 PM
CROOKE STANLEY TChairman and CEOJan 03, 2017 Option Exercise$7.2510,00072,50030,029Jan 04, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 04, 2017 Option Exercise$10.297007,2032,870Jan 04, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 04, 2017 Option Exercise$7.257,00050,75032,029Jan 04, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 03, 2017 Option Exercise$10.291,00010,2902,670Jan 04, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 04, 2017 Sale$50.1070035,0702,170Jan 04, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 04, 2017 Sale$50.107,000350,70025,029Jan 04, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 03, 2017 Sale$48.051,00048,0502,170Jan 04, 2017, 06:35 PM
CROOKE STANLEY TChairman and CEOJan 03, 2017 Sale$48.0510,000480,50025,029Jan 04, 2017, 06:35 PM
Boyce SarahChief Business OfficerJan 01, 2017 Option Exercise$20.7699220,5913,130Jan 04, 2017, 06:35 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 01, 2017 Option Exercise$20.763096,4148,181Jan 04, 2017, 06:34 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 03, 2017 Sale$48.6030915,0177,872Jan 04, 2017, 06:34 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 01, 2017 Option Exercise$20.764248,8019,950Jan 04, 2017, 06:34 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 01, 2017 Option Exercise$20.761994,1316,747Jan 04, 2017, 06:33 PM
BENNETT C FRANKSVP, Antisense ResearchJan 01, 2017 Option Exercise$20.762114,38011,014Jan 04, 2017, 06:32 PM
PARSHALL B LYNNECOOJan 01, 2017 Option Exercise$20.761713,54916,864Jan 04, 2017, 06:31 PM
Geary Richard SSVP, DevelopmentJan 01, 2017 Option Exercise$20.7664013,2849,157Jan 04, 2017, 06:30 PM
Monia Brett PSVP, Antisense Drug DiscoveryDec 20, 2016 Sale$52.481306,8227,872Dec 20, 2016, 06:48 PM
PARSHALL B LYNNECOODec 15, 2016 Option Exercise$7.251,0007,2501,000Dec 16, 2016, 07:21 PM
PARSHALL B LYNNECOODec 15, 2016 Option Exercise$7.252,00014,5001,000Dec 16, 2016, 07:21 PM
PARSHALL B LYNNECOODec 15, 2016 Option Exercise$7.251,0007,2501,000Dec 16, 2016, 07:21 PM
PARSHALL B LYNNECOODec 15, 2016 Sale$50.002,000100,0000Dec 16, 2016, 07:21 PM
PARSHALL B LYNNECOODec 15, 2016 Sale$50.001,00050,0000Dec 16, 2016, 07:21 PM
PARSHALL B LYNNECOODec 15, 2016 Sale$50.001,00050,0000Dec 16, 2016, 07:21 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 05, 2016 Option Exercise$11.272,50028,1759,048Dec 07, 2016, 07:51 PM
HOUGEN ELIZABETH LSVP, Finance & CFODec 05, 2016 Sale$46.052,500115,1256,548Dec 07, 2016, 07:51 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 05, 2016 Option Exercise$10.823503,7879,876Dec 07, 2016, 07:27 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 05, 2016 Sale$45.0035015,7509,526Dec 07, 2016, 07:27 PM
PARSHALL B LYNNECOODec 01, 2016 Option Exercise$14.6912,500183,62523,693Dec 02, 2016, 06:58 PM
PARSHALL B LYNNECOODec 01, 2016 Sale$42.2312,500527,86516,693Dec 02, 2016, 06:58 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 14, 2016 Option Exercise$10.821,00010,82010,332Nov 14, 2016, 06:53 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 14, 2016 Sale$45.001,00045,0009,526Nov 14, 2016, 06:53 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 11, 2016 Option Exercise$11.272,50028,1759,048Nov 14, 2016, 06:52 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 09, 2016 Option Exercise$11.272,50028,1759,048Nov 14, 2016, 06:52 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 11, 2016 Sale$41.002,500102,5006,548Nov 14, 2016, 06:52 PM
HOUGEN ELIZABETH LSVP, Finance & CFONov 09, 2016 Sale$38.492,50096,2256,548Nov 14, 2016, 06:52 PM
CROOKE STANLEY TChairman and CEONov 10, 2016 Option Exercise$7.2510,00072,50035,029Nov 14, 2016, 06:51 PM
CROOKE STANLEY TChairman and CEONov 09, 2016 Option Exercise$10.292,00020,5803,170Nov 14, 2016, 06:51 PM
CROOKE STANLEY TChairman and CEONov 09, 2016 Option Exercise$9.7220,000194,42735,029Nov 14, 2016, 06:51 PM
CROOKE STANLEY TChairman and CEONov 10, 2016 Option Exercise$10.291,00010,2903,170Nov 14, 2016, 06:51 PM
CROOKE STANLEY TChairman and CEONov 10, 2016 Sale$40.2310,000402,30025,029Nov 14, 2016, 06:51 PM
CROOKE STANLEY TChairman and CEONov 09, 2016 Sale$36.172,00072,3502,170Nov 14, 2016, 06:51 PM
CROOKE STANLEY TChairman and CEONov 09, 2016 Sale$36.4020,000727,99625,029Nov 14, 2016, 06:51 PM
CROOKE STANLEY TChairman and CEONov 10, 2016 Sale$42.221,00042,2202,170Nov 14, 2016, 06:51 PM
BENNETT C FRANKSVP, Antisense ResearchNov 09, 2016 Option Exercise$11.2722,805257,01228,608Nov 14, 2016, 06:51 PM
BENNETT C FRANKSVP, Antisense ResearchNov 09, 2016 Sale$37.5622,805856,60510,803Nov 14, 2016, 06:51 PM
BENNETT C FRANKSVP, Antisense ResearchNov 07, 2016 Option Exercise$11.275,00056,35015,803Nov 09, 2016, 06:22 PM
BENNETT C FRANKSVP, Antisense ResearchNov 07, 2016 Sale$34.005,000170,00010,803Nov 09, 2016, 06:22 PM
CROOKE STANLEY TChairman and CEOOct 05, 2016 Option Exercise$10.291,00010,2903,170Oct 07, 2016, 05:49 PM
CROOKE STANLEY TChairman and CEOOct 05, 2016 Option Exercise$10.2910,000102,90035,029Oct 07, 2016, 05:49 PM
CROOKE STANLEY TChairman and CEOOct 05, 2016 Sale$36.611,00036,6102,170Oct 07, 2016, 05:49 PM
CROOKE STANLEY TChairman and CEOOct 05, 2016 Sale$36.6110,000366,10025,029Oct 07, 2016, 05:49 PM
CROOKE STANLEY TChairman and CEOSep 27, 2016 Option Exercise$10.292,00020,5804,170Sep 29, 2016, 05:05 PM
CROOKE STANLEY TChairman and CEOSep 27, 2016 Option Exercise$10.2920,000205,80045,029Sep 29, 2016, 05:05 PM
CROOKE STANLEY TChairman and CEOSep 27, 2016 Sale$36.0220,000720,40025,029Sep 29, 2016, 05:05 PM
CROOKE STANLEY TChairman and CEOSep 27, 2016 Sale$36.052,00072,1002,170Sep 29, 2016, 05:05 PM
CROOKE STANLEY TChairman and CEOSep 21, 2016 Option Exercise$10.2920,000205,80045,029Sep 23, 2016, 06:31 PM
CROOKE STANLEY TChairman and CEOSep 21, 2016 Option Exercise$10.292,00020,5804,170Sep 23, 2016, 06:31 PM
CROOKE STANLEY TChairman and CEOSep 21, 2016 Sale$35.502,00071,0002,170Sep 23, 2016, 06:31 PM
CROOKE STANLEY TChairman and CEOSep 21, 2016 Sale$35.5020,000710,00025,029Sep 23, 2016, 06:31 PM
PARSHALL B LYNNECOOSep 01, 2016 Option Exercise$9.4112,500117,66925,558Sep 06, 2016, 06:52 PM
PARSHALL B LYNNECOOSep 01, 2016 Sale$29.8812,500373,54516,693Sep 06, 2016, 06:52 PM
PARSHALL B LYNNECOOJul 01, 2016 Option Exercise$20.764038,36516,693Jul 01, 2016, 08:22 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 01, 2016 Option Exercise$20.764028,3449,526Jul 01, 2016, 08:21 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 01, 2016 Option Exercise$20.763096,4148,002Jul 01, 2016, 08:20 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJul 01, 2016 Option Exercise$20.762174,5046,548Jul 01, 2016, 08:20 PM
Geary Richard SSVP, DevelopmentJul 01, 2016 Option Exercise$20.761633,3838,517Jul 01, 2016, 08:19 PM
Boyce SarahChief Business OfficerJul 01, 2016 Option Exercise$20.764038,3652,138Jul 01, 2016, 08:18 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2016 Option Exercise$20.762134,42110,803Jul 01, 2016, 08:18 PM
MUTO FREDERICK TDirectorMay 31, 2016 Option Exercise$5.9312,50074,12515,043Jun 02, 2016, 06:25 PM
MUTO FREDERICK TDirectorMay 31, 2016 Sale$22.3112,500278,9002,543Jun 02, 2016, 06:25 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 06, 2016 Option Exercise$10.821,00010,82010,124Apr 07, 2016, 06:18 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 06, 2016 Sale$45.001,00045,0009,124Apr 07, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOApr 06, 2016 Option Exercise$10.291,00010,2902,670Apr 07, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOApr 06, 2016 Option Exercise$10.2910,000102,90030,029Apr 07, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOApr 06, 2016 Sale$46.1310,000461,25025,029Apr 07, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOApr 06, 2016 Sale$46.131,00046,1252,170Apr 07, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOMar 31, 2016 Option Exercise$10.2910,000102,90030,029Apr 01, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOMar 31, 2016 Option Exercise$9.761,0009,7552,670Apr 01, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOMar 31, 2016 Sale$40.7410,000407,35025,029Apr 01, 2016, 06:18 PM
CROOKE STANLEY TChairman and CEOMar 31, 2016 Sale$40.741,00040,7352,170Apr 01, 2016, 06:18 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 23, 2016 Option Exercise$10.821,00010,82010,124Mar 24, 2016, 07:13 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 23, 2016 Sale$45.401,00045,4009,124Mar 24, 2016, 07:13 PM
BERTHELSEN SPENCER RDirectorFeb 19, 2016 Option Exercise$5.9312,50074,12574,343Feb 22, 2016, 04:10 PM
CROOKE STANLEY TChairman and CEOJan 19, 2016 Sale$41.4657623,8822,170Jan 19, 2016, 08:27 PM
CROOKE STANLEY TChairman and CEOJan 19, 2016 Sale$41.4612,825531,71625,029Jan 19, 2016, 08:27 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 19, 2016 Sale$41.461,89978,7426,331Jan 19, 2016, 08:27 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 19, 2016 Sale$41.461,87177,5749,124Jan 19, 2016, 08:12 PM
PARSHALL B LYNNECOO & SecretaryJan 19, 2016 Sale$41.465,192215,25716,290Jan 19, 2016, 08:11 PM
Geary Richard SSVP, DevelopmentJan 19, 2016 Sale$41.462,16289,6348,354Jan 19, 2016, 08:09 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 19, 2016 Sale$41.462,20891,5417,693Jan 19, 2016, 08:09 PM
Boyce SarahChief Business OfficerJan 19, 2016 Sale$41.4687236,1511,735Jan 19, 2016, 08:08 PM
BENNETT C FRANKSVP, Antisense ResearchJan 19, 2016 Sale$41.462,11087,47410,590Jan 19, 2016, 08:08 PM
CROOKE STANLEY TChairman and CEOJan 05, 2016 Option Exercise$9.225004,6101,797Jan 07, 2016, 06:52 PM
CROOKE STANLEY TChairman and CEOJan 05, 2016 Option Exercise$10.295,00051,45019,642Jan 07, 2016, 06:52 PM
CROOKE STANLEY TChairman and CEOJan 05, 2016 Sale$62.1050031,0501,297Jan 07, 2016, 06:52 PM
CROOKE STANLEY TChairman and CEOJan 05, 2016 Sale$62.105,000310,50014,642Jan 07, 2016, 06:52 PM
PARSHALL B LYNNECOO & SecretaryJan 01, 2016 Option Exercise$47.71723,4358,215Jan 04, 2016, 09:26 PM
PARSHALL B LYNNECOO & SecretaryJan 04, 2016 Option Exercise$14.6980911,8849,024Jan 04, 2016, 09:26 PM
PARSHALL B LYNNECOO & SecretaryJan 04, 2016 Sale$61.0580949,3898,215Jan 04, 2016, 09:26 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 01, 2016 Option Exercise$47.71432,0526,302Jan 04, 2016, 09:25 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 04, 2016 Option Exercise$7.791,0007,7937,150Jan 04, 2016, 09:25 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 04, 2016 Sale$61.101,00061,1006,302Jan 04, 2016, 09:25 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 01, 2016 Option Exercise$47.711306,2024,485Jan 04, 2016, 09:24 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 04, 2016 Sale$61.001277,7474,358Jan 04, 2016, 09:24 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 01, 2016 Option Exercise$47.71411,9563,468Jan 04, 2016, 09:23 PM
Geary Richard SSVP, DevelopmentJan 01, 2016 Option Exercise$47.7126912,8345,089Jan 04, 2016, 09:23 PM
CROOKE STANLEY TChairman and CEOJan 04, 2016 Option Exercise$10.2910,000102,90024,642Jan 04, 2016, 09:22 PM
CROOKE STANLEY TChairman and CEOJan 04, 2016 Option Exercise$9.221,0009,2202,297Jan 04, 2016, 09:22 PM
CROOKE STANLEY TChairman and CEOJan 04, 2016 Sale$61.051,00061,0501,297Jan 04, 2016, 09:22 PM
CROOKE STANLEY TChairman and CEOJan 04, 2016 Sale$61.0510,000610,50014,642Jan 04, 2016, 09:22 PM
Boyce SarahChief Business OfficerJan 01, 2016 Option Exercise$47.7141919,991419Jan 04, 2016, 09:21 PM
BENNETT C FRANKSVP, Antisense ResearchJan 01, 2016 Option Exercise$47.71894,2467,405Jan 04, 2016, 09:19 PM
BENNETT C FRANKSVP, Antisense ResearchDec 15, 2015 Option Exercise$14.474,00057,88011,316Dec 17, 2015, 07:23 PM
BENNETT C FRANKSVP, Antisense ResearchDec 16, 2015 Option Exercise$14.473,90956,56311,225Dec 17, 2015, 07:23 PM
BENNETT C FRANKSVP, Antisense ResearchDec 16, 2015 Sale$58.853,909230,0457,316Dec 17, 2015, 07:23 PM
BENNETT C FRANKSVP, Antisense ResearchDec 15, 2015 Sale$56.004,000224,0007,316Dec 17, 2015, 07:23 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 01, 2015 Option Exercise$7.251,0007,2507,259Dec 02, 2015, 06:49 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 01, 2015 Sale$61.501,00061,5006,259Dec 02, 2015, 06:49 PM
BENNETT C FRANKSVP, Antisense ResearchNov 10, 2015 Option Exercise$14.475,00072,35012,316Nov 12, 2015, 07:03 PM
BENNETT C FRANKSVP, Antisense ResearchNov 10, 2015 Sale$64.005,000320,0007,316Nov 12, 2015, 07:03 PM
KLEIN JOSEPH IIIDirectorNov 11, 2015 Option Exercise$10.956,87575,3129,293Nov 12, 2015, 07:02 PM
KLEIN JOSEPH IIIDirectorNov 11, 2015 Sale$64.186,875441,2345,543Nov 12, 2015, 07:02 PM
BENNETT C FRANKSVP, Antisense ResearchNov 06, 2015 Option Exercise$14.475,00072,35012,316Nov 09, 2015, 07:28 PM
BENNETT C FRANKSVP, Antisense ResearchNov 06, 2015 Sale$56.005,000280,0007,316Nov 09, 2015, 07:28 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 03, 2015 Option Exercise$7.251,0007,2507,259Nov 04, 2015, 07:00 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 03, 2015 Sale$51.951,00051,9506,259Nov 04, 2015, 07:00 PM
CROOKE STANLEY TChairman and CEOOct 21, 2015 Option Exercise$10.591,50015,8802,297Oct 23, 2015, 07:35 PM
CROOKE STANLEY TChairman and CEOOct 21, 2015 Option Exercise$11.2715,000169,05029,642Oct 23, 2015, 07:35 PM
CROOKE STANLEY TChairman and CEOOct 23, 2015 Option Exercise$9.222,50023,0503,297Oct 23, 2015, 07:35 PM
CROOKE STANLEY TChairman and CEOOct 23, 2015 Option Exercise$10.4525,000261,33030,479Oct 23, 2015, 07:35 PM
CROOKE STANLEY TChairman and CEOOct 21, 2015 Sale$43.0015,000645,00014,642Oct 23, 2015, 07:35 PM
CROOKE STANLEY TChairman and CEOOct 23, 2015 Sale$44.402,500111,0001,297Oct 23, 2015, 07:35 PM
CROOKE STANLEY TChairman and CEOOct 23, 2015 Sale$44.3525,0001,108,85514,642Oct 23, 2015, 07:35 PM
CROOKE STANLEY TChairman and CEOOct 21, 2015 Sale$43.001,50064,5001,297Oct 23, 2015, 07:35 PM
PARSHALL B LYNNECOO & SecretaryOct 01, 2015 Option Exercise$10.277,00071,86512,305Oct 05, 2015, 07:14 PM
PARSHALL B LYNNECOO & SecretaryOct 02, 2015 Option Exercise$14.695,43679,85511,579Oct 05, 2015, 07:14 PM
PARSHALL B LYNNECOO & SecretaryOct 01, 2015 Sale$40.137,000280,8808,143Oct 05, 2015, 07:14 PM
PARSHALL B LYNNECOO & SecretaryOct 02, 2015 Sale$41.555,436225,8678,143Oct 05, 2015, 07:14 PM
PARSHALL B LYNNECOO & SecretaryJul 06, 2015 Option Exercise$7.926,21849,26012,986Jul 08, 2015, 05:55 PM
PARSHALL B LYNNECOO & SecretaryJul 06, 2015 Sale$57.016,218354,4708,143Jul 08, 2015, 05:55 PM
CROOKE STANLEY TChairman and CEOJul 06, 2015 Option Exercise$11.275,00056,35019,642Jul 08, 2015, 05:54 PM
CROOKE STANLEY TChairman and CEOJul 06, 2015 Option Exercise$9.221,17510,8342,472Jul 08, 2015, 05:54 PM
CROOKE STANLEY TChairman and CEOJul 06, 2015 Sale$57.015,000285,03514,642Jul 08, 2015, 05:54 PM
CROOKE STANLEY TChairman and CEOJul 06, 2015 Sale$57.011,17566,9831,297Jul 08, 2015, 05:54 PM
PARSHALL B LYNNECOO & SecretaryJul 01, 2015 Option Exercise$48.59713,4508,143Jul 02, 2015, 06:06 PM
PARSHALL B LYNNECOO & SecretaryJul 01, 2015 Option Exercise$10.296,21863,98314,361Jul 02, 2015, 06:06 PM
PARSHALL B LYNNECOO & SecretaryJul 01, 2015 Sale$57.566,218357,9148,143Jul 02, 2015, 06:06 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 01, 2015 Option Exercise$48.59854,1306,259Jul 02, 2015, 06:05 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 01, 2015 Option Exercise$48.591276,1704,553Jul 02, 2015, 06:05 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 02, 2015 Sale$56.3019811,1474,355Jul 02, 2015, 06:05 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJul 01, 2015 Option Exercise$48.59401,9433,427Jul 02, 2015, 06:04 PM
Geary Richard SSVP, DevelopmentJul 01, 2015 Option Exercise$48.5926512,8754,820Jul 02, 2015, 06:03 PM
CROOKE STANLEY TChairman and CEOJul 01, 2015 Option Exercise$11.275,00056,35019,642Jul 02, 2015, 06:02 PM
CROOKE STANLEY TChairman and CEOJul 01, 2015 Option Exercise$9.221,17510,8342,472Jul 02, 2015, 06:02 PM
CROOKE STANLEY TChairman and CEOJul 01, 2015 Sale$57.561,17567,6341,297Jul 02, 2015, 06:02 PM
CROOKE STANLEY TChairman and CEOJul 01, 2015 Sale$57.565,000287,80514,642Jul 02, 2015, 06:02 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2015 Option Exercise$48.59874,2277,316Jul 02, 2015, 06:01 PM
Monia Brett PSVP, Antisense Drug DiscoveryJun 08, 2015 Option Exercise$10.297,60078,20412,026Jun 10, 2015, 06:36 PM
Monia Brett PSVP, Antisense Drug DiscoveryJun 08, 2015 Sale$66.227,600503,2804,426Jun 10, 2015, 06:36 PM
MUTO FREDERICK TDirectorJun 01, 2015 Option Exercise$3.9510,00039,50011,095Jun 03, 2015, 05:29 PM
MUTO FREDERICK TDirectorJun 01, 2015 Sale$66.9110,000669,1101,095Jun 03, 2015, 05:29 PM
BERTHELSEN SPENCER RDirectorApr 17, 2015 Option Exercise$3.9510,00039,50060,395Apr 17, 2015, 06:13 PM
PARSHALL B LYNNECOO & SecretaryApr 07, 2015 Option Exercise$14.695,56581,75013,637Apr 08, 2015, 05:12 PM
PARSHALL B LYNNECOO & SecretaryApr 07, 2015 Sale$63.075,565350,9908,072Apr 08, 2015, 05:12 PM
CROOKE STANLEY TChairman and CEOApr 07, 2015 Option Exercise$9.222,03418,7533,331Apr 08, 2015, 05:11 PM
CROOKE STANLEY TChairman and CEOApr 07, 2015 Option Exercise$11.2720,343229,26634,985Apr 08, 2015, 05:11 PM
CROOKE STANLEY TChairman and CEOApr 07, 2015 Sale$63.072,034128,2861,297Apr 08, 2015, 05:11 PM
CROOKE STANLEY TChairman and CEOApr 07, 2015 Sale$63.0720,3431,283,05314,642Apr 08, 2015, 05:11 PM
PARSHALL B LYNNECOO & SecretaryApr 01, 2015 Option Exercise$14.695,37778,98813,449Apr 06, 2015, 11:51 AM
PARSHALL B LYNNECOO & SecretaryApr 01, 2015 Sale$61.935,377333,0098,072Apr 06, 2015, 11:51 AM
CROOKE STANLEY TChairman and CEOApr 01, 2015 Option Exercise$9.221,96618,1273,263Apr 06, 2015, 11:50 AM
CROOKE STANLEY TChairman and CEOApr 01, 2015 Option Exercise$11.2719,657221,53434,299Apr 06, 2015, 11:50 AM
CROOKE STANLEY TChairman and CEOApr 01, 2015 Sale$61.931,966121,7591,297Apr 06, 2015, 11:50 AM
CROOKE STANLEY TChairman and CEOApr 01, 2015 Sale$61.9319,6571,217,39914,642Apr 06, 2015, 11:50 AM
BENNETT C FRANKSVP, Antisense ResearchMar 24, 2015 Option Exercise$14.479,000130,23016,229Mar 25, 2015, 04:23 PM
BENNETT C FRANKSVP, Antisense ResearchMar 23, 2015 Option Exercise$14.476,00086,82012,229Mar 25, 2015, 04:23 PM
BENNETT C FRANKSVP, Antisense ResearchMar 24, 2015 Sale$71.019,000639,0907,229Mar 25, 2015, 04:23 PM
BENNETT C FRANKSVP, Antisense ResearchMar 23, 2015 Sale$70.006,000420,0207,229Mar 25, 2015, 04:23 PM
HOUGEN ELIZABETH LSVP, Finance & CFOMar 19, 2015 Option Exercise$11.2710,000112,70013,387Mar 20, 2015, 06:58 PM
HOUGEN ELIZABETH LSVP, Finance & CFOMar 19, 2015 Sale$73.3310,000733,2603,387Mar 20, 2015, 06:58 PM
WENDER JOSEPH HDirectorMar 18, 2015 Option Exercise$5.9312,50074,12536,617Mar 20, 2015, 06:57 PM
WENDER JOSEPH HDirectorMar 18, 2015 Sale$71.4112,500892,58630,217Mar 20, 2015, 06:57 PM
Geary Richard SSVP, DevelopmentMar 19, 2015 Option Exercise$14.698,000117,52012,555Mar 20, 2015, 06:56 PM
Geary Richard SSVP, DevelopmentMar 19, 2015 Sale$75.008,000600,0324,555Mar 20, 2015, 06:56 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 19, 2015 Option Exercise$22.6230,525690,41616,699Mar 20, 2015, 06:55 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 19, 2015 Sale$74.8530,5252,284,7576,174Mar 20, 2015, 06:55 PM
Geary Richard SSVP, DevelopmentMar 05, 2015 Option Exercise$8.8815,080133,97212,555Mar 09, 2015, 07:45 PM
Geary Richard SSVP, DevelopmentMar 05, 2015 Sale$71.1518,0951,287,3824,555Mar 09, 2015, 07:45 PM
HOUGEN ELIZABETH LSVP, Finance & CFOMar 05, 2015 Option Exercise$10.5028,094295,06516,044Mar 09, 2015, 07:27 PM
HOUGEN ELIZABETH LSVP, Finance & CFOMar 05, 2015 Sale$71.5728,0942,010,8233,387Mar 09, 2015, 07:27 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 05, 2015 Option Exercise$9.635,80055,86510,307Mar 09, 2015, 07:27 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 05, 2015 Sale$71.675,800415,6746,174Mar 09, 2015, 07:27 PM
WENDER JOSEPH HDirectorMar 05, 2015 Option Exercise$9.7712,500122,12542,717Mar 09, 2015, 07:26 PM
WENDER JOSEPH HDirectorMar 05, 2015 Sale$71.6112,500895,17430,217Mar 09, 2015, 07:26 PM
KLEIN JOSEPH IIIDirectorMar 05, 2015 Option Exercise$10.1810,000101,80011,095Mar 09, 2015, 07:25 PM
KLEIN JOSEPH IIIDirectorMar 05, 2015 Sale$70.957,000496,6814,095Mar 09, 2015, 07:25 PM
WENDER JOSEPH HDirectorMar 02, 2015 Sale$65.977,000461,78530,217Mar 04, 2015, 07:15 PM
WENDER JOSEPH HDirectorFeb 12, 2015 Option Exercise$3.9510,00039,50047,217Feb 17, 2015, 05:39 PM
WENDER JOSEPH HDirectorFeb 12, 2015 Sale$62.1510,000621,46037,217Feb 17, 2015, 05:39 PM
CROOKE STANLEY TChairman and CEOJan 27, 2015 Option Exercise$11.2710,000112,70024,642Jan 29, 2015, 07:03 PM
CROOKE STANLEY TChairman and CEOJan 27, 2015 Option Exercise$9.221,0009,2202,297Jan 29, 2015, 07:03 PM
CROOKE STANLEY TChairman and CEOJan 27, 2015 Sale$72.9310,000729,26014,642Jan 29, 2015, 07:03 PM
CROOKE STANLEY TChairman and CEOJan 27, 2015 Sale$72.931,00072,9261,297Jan 29, 2015, 07:03 PM
CROOKE STANLEY TChairman and CEOJan 16, 2015 Sale$67.9641728,3411,297Jan 20, 2015, 08:00 PM
CROOKE STANLEY TChairman and CEOJan 16, 2015 Sale$67.968,637587,00714,642Jan 20, 2015, 08:00 PM
PARSHALL B LYNNECOO & SecretaryJan 16, 2015 Sale$67.964,093278,1778,072Jan 20, 2015, 07:58 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 16, 2015 Sale$67.961,534104,2574,426Jan 20, 2015, 07:57 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 16, 2015 Sale$67.961,29187,7423,387Jan 20, 2015, 07:57 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 16, 2015 Sale$67.961,29187,7426,174Jan 20, 2015, 07:56 PM
BENNETT C FRANKSVP, Antisense ResearchJan 16, 2015 Sale$67.961,518103,1697,229Jan 20, 2015, 07:55 PM
Geary Richard SSVP, DevelopmentJan 16, 2015 Sale$67.961,543104,8687,570Jan 20, 2015, 07:53 PM
CROOKE STANLEY TChairman and CEOJan 09, 2015 Option Exercise$9.221,0009,2201,627Jan 13, 2015, 06:51 PM
CROOKE STANLEY TChairman and CEOJan 09, 2015 Option Exercise$11.2710,000112,70016,941Jan 13, 2015, 06:51 PM
CROOKE STANLEY TChairman and CEOJan 09, 2015 Sale$73.571,00073,570627Jan 13, 2015, 06:51 PM
CROOKE STANLEY TChairman and CEOJan 09, 2015 Sale$73.5710,000735,7006,941Jan 13, 2015, 06:51 PM
Geary Richard SSVP, DevelopmentJan 12, 2015 Sale$73.1059743,6415,064Jan 13, 2015, 06:49 PM
CROOKE STANLEY TChairman and CEOJan 06, 2015 Option Exercise$11.2710,000112,70016,941Jan 08, 2015, 07:15 PM
CROOKE STANLEY TChairman and CEOJan 07, 2015 Option Exercise$9.221,0009,2201,627Jan 08, 2015, 07:15 PM
CROOKE STANLEY TChairman and CEOJan 07, 2015 Option Exercise$11.2710,000112,70016,941Jan 08, 2015, 07:15 PM
CROOKE STANLEY TChairman and CEOJan 06, 2015 Option Exercise$9.221,0009,2201,627Jan 08, 2015, 07:15 PM
CROOKE STANLEY TChairman and CEOJan 06, 2015 Sale$66.0410,000660,3806,941Jan 08, 2015, 07:15 PM
CROOKE STANLEY TChairman and CEOJan 07, 2015 Sale$68.051,00068,048627Jan 08, 2015, 07:15 PM
CROOKE STANLEY TChairman and CEOJan 07, 2015 Sale$68.0510,000680,4806,941Jan 08, 2015, 07:15 PM
CROOKE STANLEY TChairman and CEOJan 06, 2015 Sale$66.041,00066,038627Jan 08, 2015, 07:15 PM
PARSHALL B LYNNECOO & SecretaryJan 01, 2015 Option Exercise$30.051113,3354,417Jan 05, 2015, 08:04 PM
PARSHALL B LYNNECOO & SecretaryJan 02, 2015 Option Exercise$14.6911,200164,52815,617Jan 05, 2015, 08:04 PM
PARSHALL B LYNNECOO & SecretaryJan 02, 2015 Sale$62.1211,200695,6884,417Jan 05, 2015, 08:04 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 01, 2015 Option Exercise$30.053299,8864,082Jan 05, 2015, 08:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 02, 2015 Option Exercise$10.151,50015,2205,299Jan 05, 2015, 08:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 02, 2015 Sale$62.121,50093,1734,082Jan 05, 2015, 08:03 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 01, 2015 Option Exercise$30.05631,8931,295Jan 05, 2015, 08:01 PM
BENNETT C FRANKSVP, Antisense ResearchJan 01, 2015 Option Exercise$30.051364,0864,763Jan 05, 2015, 07:59 PM
Geary Richard SSVP, DevelopmentJan 01, 2015 Option Exercise$30.052738,2035,661Jan 05, 2015, 07:57 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 01, 2015 Option Exercise$30.051985,9492,011Jan 05, 2015, 07:56 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 02, 2015 Sale$62.75764,7691,935Jan 05, 2015, 07:56 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 01, 2014 Option Exercise$7.251,50010,8754,253Dec 03, 2014, 07:27 PM
O'NEIL PATRICK R.SVP, Legal & General CounselDec 01, 2014 Sale$51.211,50076,8153,753Dec 03, 2014, 07:27 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 03, 2014 Option Exercise$7.251,50010,8755,253Nov 05, 2014, 06:07 PM
O'NEIL PATRICK R.SVP, Legal & General CounselNov 03, 2014 Sale$46.171,50069,2553,753Nov 05, 2014, 06:07 PM
PARSHALL B LYNNECOO & SecretaryOct 30, 2014 Option Exercise$8.9411,07198,93912,867Oct 31, 2014, 06:05 PM
PARSHALL B LYNNECOO & SecretaryOct 30, 2014 Sale$45.1211,071499,5354,306Oct 31, 2014, 06:05 PM
CROOKE STANLEY TChairman and CEOOct 23, 2014 Option Exercise$9.221,60014,7522,227Oct 24, 2014, 04:57 PM
CROOKE STANLEY TChairman and CEOOct 23, 2014 Option Exercise$12.0113,000156,11016,941Oct 24, 2014, 04:57 PM
CROOKE STANLEY TChairman and CEOOct 23, 2014 Sale$42.2213,000548,8606,941Oct 24, 2014, 04:57 PM
CROOKE STANLEY TChairman and CEOOct 23, 2014 Sale$42.221,60067,552627Oct 24, 2014, 04:57 PM
CROOKE STANLEY TChairman and CEOOct 03, 2014 Option Exercise$14.4713,000188,11019,941Oct 03, 2014, 07:07 PM
CROOKE STANLEY TChairman and CEOOct 01, 2014 Option Exercise$10.452,00020,9001,827Oct 03, 2014, 07:07 PM
CROOKE STANLEY TChairman and CEOOct 01, 2014 Option Exercise$14.4720,000289,40026,941Oct 03, 2014, 07:07 PM
CROOKE STANLEY TChairman and CEOOct 03, 2014 Option Exercise$9.221,0009,2201,627Oct 03, 2014, 07:07 PM
CROOKE STANLEY TChairman and CEOOct 01, 2014 Sale$37.912,00075,822627Oct 03, 2014, 07:07 PM
CROOKE STANLEY TChairman and CEOOct 01, 2014 Sale$37.9120,000758,2206,941Oct 03, 2014, 07:07 PM
CROOKE STANLEY TChairman and CEOOct 03, 2014 Sale$39.491,00039,487627Oct 03, 2014, 07:07 PM
CROOKE STANLEY TChairman and CEOOct 03, 2014 Sale$39.4913,000513,3316,941Oct 03, 2014, 07:07 PM
O'NEIL PATRICK R.SVP, Legal & General CounselOct 01, 2014 Option Exercise$7.721,50011,5834,553Oct 03, 2014, 07:06 PM
O'NEIL PATRICK R.SVP, Legal & General CounselOct 01, 2014 Sale$38.041,50057,0603,753Oct 03, 2014, 07:06 PM
O'NEIL PATRICK R.SVP, Legal and General CounselSep 02, 2014 Option Exercise$10.291,50015,4354,553Sep 04, 2014, 07:13 PM
O'NEIL PATRICK R.SVP, Legal and General CounselSep 02, 2014 Sale$40.441,50060,6603,753Sep 04, 2014, 07:13 PM
PARSHALL B LYNNECOOSep 02, 2014 Option Exercise$10.1711,071112,57414,934Sep 04, 2014, 07:13 PM
PARSHALL B LYNNECOOSep 02, 2014 Sale$40.2411,071445,5074,306Sep 04, 2014, 07:13 PM
BENNETT C FRANKSVP, Antisense ResearchAug 27, 2014 Option Exercise$15.385,00076,9006,627Aug 28, 2014, 06:49 PM
BENNETT C FRANKSVP, Antisense ResearchAug 27, 2014 Sale$40.535,000202,6304,627Aug 28, 2014, 06:49 PM
Monia Brett PSVP, Antisense Drug DiscoveryAug 26, 2014 Option Exercise$9.2627,344253,26716,813Aug 28, 2014, 06:48 PM
Monia Brett PSVP, Antisense Drug DiscoveryAug 26, 2014 Sale$38.1427,3441,043,0101,813Aug 28, 2014, 06:48 PM
CROOKE STANLEY TChairman, President and CEOAug 13, 2014 Option Exercise$11.271,60018,0322,227Aug 15, 2014, 06:39 PM
CROOKE STANLEY TChairman, President and CEOAug 13, 2014 Option Exercise$14.4715,500224,28522,441Aug 15, 2014, 06:39 PM
CROOKE STANLEY TChairman, President and CEOAug 13, 2014 Sale$35.451,60056,726627Aug 15, 2014, 06:39 PM
CROOKE STANLEY TChairman, President and CEOAug 13, 2014 Sale$35.4515,500549,5376,941Aug 15, 2014, 06:39 PM
O'NEIL PATRICK R.SVP, Legal and General CounselAug 11, 2014 Option Exercise$10.297007,2034,453Aug 12, 2014, 06:51 PM
O'NEIL PATRICK R.SVP, Legal and General CounselAug 12, 2014 Option Exercise$10.298008,2324,553Aug 12, 2014, 06:51 PM
O'NEIL PATRICK R.SVP, Legal and General CounselAug 11, 2014 Sale$35.0070024,5003,753Aug 12, 2014, 06:51 PM
O'NEIL PATRICK R.SVP, Legal and General CounselAug 12, 2014 Sale$35.0080028,0003,753Aug 12, 2014, 06:51 PM
CROOKE STANLEY TChairman, President and CEOAug 01, 2014 Option Exercise$11.271,00011,2701,627Aug 01, 2014, 07:44 PM
CROOKE STANLEY TChairman, President and CEOAug 01, 2014 Option Exercise$14.4715,000217,05021,941Aug 01, 2014, 07:44 PM
CROOKE STANLEY TChairman, President and CEOAug 01, 2014 Sale$30.521,00030,525627Aug 01, 2014, 07:44 PM
CROOKE STANLEY TChairman, President and CEOAug 01, 2014 Sale$30.5215,000457,8756,941Aug 01, 2014, 07:44 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 31, 2014 Sale$31.50792,4891,813Aug 01, 2014, 07:16 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 01, 2014 Option Exercise$30.2040312,1713,753Jul 02, 2014, 04:09 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 01, 2014 Option Exercise$10.291,50015,4355,253Jul 02, 2014, 04:09 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 01, 2014 Sale$35.331,50053,0003,753Jul 02, 2014, 04:09 PM
CROOKE STANLEY TChairman and CEOJul 01, 2014 Option Exercise$11.592,00023,1802,427Jul 02, 2014, 04:08 PM
CROOKE STANLEY TChairman and CEOJul 01, 2014 Option Exercise$14.4715,500224,28522,441Jul 02, 2014, 04:08 PM
CROOKE STANLEY TChairman and CEOJul 01, 2014 Sale$35.552,00071,100627Jul 02, 2014, 04:08 PM
CROOKE STANLEY TChairman and CEOJul 01, 2014 Sale$35.5815,500551,4596,941Jul 02, 2014, 04:08 PM
Geary Richard SSVP, DevelopmentJul 01, 2014 Option Exercise$30.2059718,0305,552Jul 02, 2014, 04:08 PM
Geary Richard SSVP, DevelopmentJul 02, 2014 Sale$35.951645,8965,388Jul 02, 2014, 04:08 PM
PARSHALL B LYNNECOO & SecretaryJul 01, 2014 Option Exercise$30.202848,5774,306Jul 01, 2014, 08:19 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 01, 2014 Option Exercise$30.20762,2951,892Jul 01, 2014, 08:18 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2014 Option Exercise$30.202918,7884,627Jul 01, 2014, 08:17 PM
BENNETT C FRANKSVP, Antisense ResearchJun 23, 2014 Option Exercise$15.3811,200172,25610,536Jun 25, 2014, 07:47 PM
BENNETT C FRANKSVP, Antisense ResearchJun 23, 2014 Sale$36.7811,200411,9104,336Jun 25, 2014, 07:47 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJun 19, 2014 Option Exercise$10.187007,1273,650Jun 20, 2014, 04:15 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJun 19, 2014 Sale$35.3570024,7483,350Jun 20, 2014, 04:15 PM
CROOKE STANLEY TChairman, President and CEOJun 19, 2014 Option Exercise$14.4711,000159,17017,941Jun 20, 2014, 04:14 PM
CROOKE STANLEY TChairman, President and CEOJun 19, 2014 Sale$35.1011,000386,1116,941Jun 20, 2014, 04:14 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJun 16, 2014 Option Exercise$8.008006,4003,750Jun 18, 2014, 07:06 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJun 16, 2014 Sale$35.1480028,1103,350Jun 18, 2014, 07:06 PM
CROOKE STANLEY TChairman, President and CEOJun 10, 2014 Option Exercise$14.471,00014,4701,627Jun 12, 2014, 06:43 PM
CROOKE STANLEY TChairman, President and CEOJun 10, 2014 Option Exercise$14.4710,000144,70016,941Jun 12, 2014, 06:43 PM
CROOKE STANLEY TChairman, President and CEOJun 10, 2014 Sale$33.461,00033,455627Jun 12, 2014, 06:43 PM
CROOKE STANLEY TChairman, President and CEOJun 10, 2014 Sale$33.4610,000334,5506,941Jun 12, 2014, 06:43 PM
MUTO FREDERICK TDirectorJun 02, 2014 Option Exercise$5.7210,00057,20010,313Jun 03, 2014, 07:17 PM
MUTO FREDERICK TDirectorJun 02, 2014 Sale$28.5910,000285,900313Jun 03, 2014, 07:17 PM
BERTHELSEN SPENCER RDirectorApr 17, 2014 Option Exercise$5.7210,00057,20049,613Apr 17, 2014, 07:43 PM
CROOKE STANLEY TChairman, President and CEOApr 02, 2014 Option Exercise$14.471,80026,0462,427Apr 04, 2014, 07:24 PM
CROOKE STANLEY TChairman, President and CEOApr 02, 2014 Option Exercise$14.477,000101,29013,941Apr 04, 2014, 07:24 PM
CROOKE STANLEY TChairman, President and CEOApr 02, 2014 Sale$43.651,80078,566627Apr 04, 2014, 07:24 PM
CROOKE STANLEY TChairman, President and CEOApr 02, 2014 Sale$43.657,000305,5366,941Apr 04, 2014, 07:24 PM
O'NEIL PATRICK R.SVP, Legal and General CounselApr 01, 2014 Option Exercise$8.001,50012,0003,850Apr 03, 2014, 07:32 PM
O'NEIL PATRICK R.SVP, Legal and General CounselApr 01, 2014 Sale$44.401,50066,6003,350Apr 03, 2014, 07:32 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 03, 2014 Option Exercise$10.931,50016,3964,150Mar 05, 2014, 06:55 PM
O'NEIL PATRICK R.SVP, Legal & General CounselMar 03, 2014 Sale$50.001,50075,0003,350Mar 05, 2014, 06:55 PM
WENDER JOSEPH HDirectorFeb 06, 2014 Option Exercise$5.725,30030,31636,435Feb 07, 2014, 07:54 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 03, 2014 Option Exercise$11.271,50016,9054,850Feb 05, 2014, 07:30 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 03, 2014 Sale$50.451,50075,6773,350Feb 05, 2014, 07:30 PM
WENDER JOSEPH HDirectorFeb 03, 2014 Option Exercise$5.724,70026,88435,835Feb 05, 2014, 07:29 PM
WENDER JOSEPH HDirectorFeb 03, 2014 Sale$48.784,700229,27831,135Feb 05, 2014, 07:29 PM
PARSHALL B LYNNECOOJan 29, 2014 Option Exercise$7.2510,00072,5005,000Jan 31, 2014, 07:34 PM
PARSHALL B LYNNECOOJan 29, 2014 Option Exercise$10.4035,000364,04335,050Jan 31, 2014, 07:34 PM
PARSHALL B LYNNECOOJan 30, 2014 Option Exercise$9.0739,510358,29827,657Jan 31, 2014, 07:34 PM
PARSHALL B LYNNECOOJan 29, 2014 Option Exercise$7.255,00036,2505,000Jan 31, 2014, 07:34 PM
PARSHALL B LYNNECOOJan 29, 2014 Sale$48.8110,000488,0700Jan 31, 2014, 07:34 PM
PARSHALL B LYNNECOOJan 29, 2014 Sale$48.8135,0001,708,2454,022Jan 31, 2014, 07:34 PM
PARSHALL B LYNNECOOJan 30, 2014 Sale$50.3639,5101,989,8824,022Jan 31, 2014, 07:34 PM
PARSHALL B LYNNECOOJan 29, 2014 Sale$48.815,000244,0350Jan 31, 2014, 07:34 PM
KLEIN JOSEPH IIIDirectorJan 24, 2014 Option Exercise$15.4010,313158,8009,813Jan 24, 2014, 08:26 PM
KLEIN JOSEPH IIIDirectorJan 24, 2014 Sale$48.6610,313501,8382,313Jan 24, 2014, 08:26 PM
Geary Richard SSVP, DevelopmentJan 22, 2014 Option Exercise$10.0322,200222,70218,855Jan 24, 2014, 08:07 PM
Geary Richard SSVP, DevelopmentJan 22, 2014 Sale$50.0522,2001,111,0214,955Jan 24, 2014, 08:07 PM
WENDER JOSEPH HDirectorJan 22, 2014 Sale$50.9810,000509,80331,135Jan 24, 2014, 08:06 PM
BENNETT C FRANKSVP, Antisense ResearchJan 16, 2014 Sale$47.0880437,8534,336Jan 17, 2014, 07:41 PM
Geary Richard SSVP, DevelopmentJan 16, 2014 Sale$47.0882939,0304,955Jan 17, 2014, 07:41 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 16, 2014 Sale$47.0857727,1651,232Jan 17, 2014, 07:40 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 16, 2014 Sale$47.0882138,6531,816Jan 17, 2014, 07:39 PM
PARSHALL B LYNNECOO & SecretaryJan 16, 2014 Sale$47.081,64177,2624,022Jan 17, 2014, 07:38 PM
CROOKE STANLEY TChairman and CEOJan 16, 2014 Sale$47.0828113,230627Jan 17, 2014, 07:37 PM
CROOKE STANLEY TChairman and CEOJan 16, 2014 Sale$47.083,246152,8256,941Jan 17, 2014, 07:37 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 16, 2014 Sale$47.0857727,1663,350Jan 17, 2014, 07:36 PM
CROOKE STANLEY TChairman, President and CEOJan 08, 2014 Option Exercise$14.471,50021,7051,674Jan 10, 2014, 07:24 PM
CROOKE STANLEY TChairman, President and CEOJan 08, 2014 Option Exercise$14.4711,000159,17012,661Jan 10, 2014, 07:24 PM
CROOKE STANLEY TChairman, President and CEOJan 08, 2014 Sale$40.051,50060,078174Jan 10, 2014, 07:24 PM
CROOKE STANLEY TChairman, President and CEOJan 08, 2014 Sale$40.0511,000440,5721,661Jan 10, 2014, 07:24 PM
Geary Richard SSVP, DevelopmentJan 06, 2014 Option Exercise$11.277,40083,39811,010Jan 08, 2014, 07:40 PM
Geary Richard SSVP, DevelopmentJan 08, 2014 Option Exercise$10.297,60078,20411,210Jan 08, 2014, 07:40 PM
Geary Richard SSVP, DevelopmentJan 06, 2014 Sale$38.837,400287,3643,610Jan 08, 2014, 07:40 PM
Geary Richard SSVP, DevelopmentJan 08, 2014 Sale$42.027,600319,3523,610Jan 08, 2014, 07:40 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 01, 2014 Option Exercise$24.20791,912848Jan 03, 2014, 07:58 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 02, 2014 Sale$39.2536214,210486Jan 03, 2014, 07:58 PM
BENNETT C FRANKSVP, Antisense ResearchJan 01, 2014 Option Exercise$24.201643,9693,030Jan 03, 2014, 07:50 PM
CROOKE STANLEY TChairman, President and CEOJan 02, 2014 Option Exercise$14.472,50036,1752,674Jan 03, 2014, 07:46 PM
CROOKE STANLEY TChairman, President and CEOJan 02, 2014 Option Exercise$14.4729,000419,63026,661Jan 03, 2014, 07:46 PM
CROOKE STANLEY TChairman, President and CEOJan 02, 2014 Sale$39.3629,0001,141,3251,661Jan 03, 2014, 07:46 PM
CROOKE STANLEY TChairman, President and CEOJan 02, 2014 Sale$39.252,50098,132174Jan 03, 2014, 07:46 PM
Geary Richard SSVP, DevelopmentJan 01, 2014 Option Exercise$24.201643,9693,610Jan 03, 2014, 07:46 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJan 01, 2014 Option Exercise$24.203959,5592,418Jan 03, 2014, 07:45 PM
PARSHALL B LYNNECOOJan 01, 2014 Option Exercise$24.203979,6071,353Jan 03, 2014, 07:44 PM
PARSHALL B LYNNECOODec 26, 2013 Option Exercise$11.2737,811426,13038,767Dec 30, 2013, 06:29 PM
PARSHALL B LYNNECOODec 26, 2013 Sale$40.9137,8111,546,772956Dec 30, 2013, 06:29 PM
PARSHALL B LYNNECOO & SecretaryDec 24, 2013 Option Exercise$11.2720,000225,40020,956Dec 24, 2013, 03:21 PM
PARSHALL B LYNNECOO & SecretaryDec 23, 2013 Option Exercise$14.3650,000717,83349,185Dec 24, 2013, 03:21 PM
PARSHALL B LYNNECOO & SecretaryDec 24, 2013 Sale$41.0020,000819,920956Dec 24, 2013, 03:21 PM
PARSHALL B LYNNECOO & SecretaryDec 23, 2013 Sale$41.6850,0002,084,050956Dec 24, 2013, 03:21 PM
WENDER JOSEPH HDirectorDec 19, 2013 Option Exercise$16.3215,000244,80060,866Dec 20, 2013, 09:27 PM
WENDER JOSEPH HDirectorDec 20, 2013 Sale$40.0110,000400,12541,135Dec 20, 2013, 09:27 PM
WENDER JOSEPH HDirectorDec 19, 2013 Sale$39.139,731380,81351,135Dec 20, 2013, 09:27 PM
BENNETT C FRANKSVP, Antisense ResearchDec 05, 2013 Option Exercise$15.3810,000153,8007,416Dec 06, 2013, 07:39 PM
BENNETT C FRANKSVP, Antisense ResearchDec 05, 2013 Sale$39.9210,000399,1822,866Dec 06, 2013, 07:39 PM
WENDER JOSEPH HDirectorNov 26, 2013 Sale$36.6310,000366,33645,866Nov 27, 2013, 04:41 PM
KLEIN JOSEPH IIIDirectorNov 25, 2013 Sale$36.866,000221,1562,313Nov 27, 2013, 04:40 PM
CROOKE STANLEY TChairman and CEOSep 19, 2013 Option Exercise$11.1250,000556,00031,661Sep 23, 2013, 07:39 PM
CROOKE STANLEY TChairman and CEOSep 20, 2013 Option Exercise$11.128,74097,18910,401Sep 23, 2013, 07:39 PM
CROOKE STANLEY TChairman and CEOSep 19, 2013 Sale$35.0650,0001,753,0801,661Sep 23, 2013, 07:39 PM
CROOKE STANLEY TChairman and CEOSep 20, 2013 Sale$35.908,740313,7491,661Sep 23, 2013, 07:39 PM
PARSHALL B LYNNECOO & SecretarySep 20, 2013 Option Exercise$14.7040,000587,90030,956Sep 23, 2013, 07:38 PM
PARSHALL B LYNNECOO & SecretarySep 19, 2013 Option Exercise$16.0250,000801,10030,956Sep 23, 2013, 07:38 PM
PARSHALL B LYNNECOO & SecretarySep 20, 2013 Sale$35.9040,0001,435,920956Sep 23, 2013, 07:38 PM
PARSHALL B LYNNECOO & SecretarySep 19, 2013 Sale$35.0650,0001,753,080956Sep 23, 2013, 07:38 PM
Monia Brett PSVP, Antisense Drug DiscoverySep 20, 2013 Option Exercise$11.2718,281206,02719,050Sep 23, 2013, 07:37 PM
Monia Brett PSVP, Antisense Drug DiscoverySep 19, 2013 Option Exercise$14.7550,000737,40023,269Sep 23, 2013, 07:37 PM
Monia Brett PSVP, Antisense Drug DiscoverySep 19, 2013 Sale$33.5950,0001,679,700769Sep 23, 2013, 07:37 PM
Monia Brett PSVP, Antisense Drug DiscoverySep 20, 2013 Sale$35.8918,281656,105769Sep 23, 2013, 07:37 PM
BENNETT C FRANKSVP, Antisense ResearchSep 19, 2013 Option Exercise$15.3810,000153,80012,866Sep 23, 2013, 07:36 PM
BENNETT C FRANKSVP, Antisense ResearchSep 19, 2013 Sale$35.0210,000350,2002,866Sep 23, 2013, 07:36 PM
CROOKE STANLEY TCOO, PresidentSep 09, 2013 Option Exercise$11.1226,615295,95928,276Sep 11, 2013, 07:27 PM
CROOKE STANLEY TCOO, PresidentSep 10, 2013 Sale$31.6530,000949,440745,391Sep 11, 2013, 07:27 PM
CROOKE STANLEY TCOO, PresidentSep 09, 2013 Sale$30.4226,615809,4951,661Sep 11, 2013, 07:27 PM
CROOKE STANLEY TCOO, PresidentSep 11, 2013 Sale$31.1820,000623,620725,391Sep 11, 2013, 07:27 PM
BENNETT C FRANKSVP, Antisense ResearchSep 09, 2013 Option Exercise$15.3810,000153,80012,866Sep 11, 2013, 07:26 PM
BENNETT C FRANKSVP, Antisense ResearchSep 09, 2013 Sale$30.2310,000302,2502,866Sep 11, 2013, 07:26 PM
PARSHALL B LYNNECOOSep 11, 2013 Option Exercise$15.381,52023,3784,461Sep 11, 2013, 07:26 PM
PARSHALL B LYNNECOOSep 10, 2013 Option Exercise$15.3830,000461,40032,941Sep 11, 2013, 07:26 PM
PARSHALL B LYNNECOOSep 09, 2013 Option Exercise$15.3830,000461,40032,941Sep 11, 2013, 07:26 PM
PARSHALL B LYNNECOOSep 10, 2013 Sale$31.6530,000949,4402,941Sep 11, 2013, 07:26 PM
PARSHALL B LYNNECOOSep 09, 2013 Sale$30.4230,000912,4502,941Sep 11, 2013, 07:26 PM
PARSHALL B LYNNECOOSep 11, 2013 Sale$31.183,505109,2892,941Sep 11, 2013, 07:26 PM
O'NEIL PATRICK R.SVP, Legal & General CounselSep 04, 2013 Option Exercise$11.292,50028,2363,340Sep 06, 2013, 07:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselSep 04, 2013 Sale$27.092,50067,7312,023Sep 06, 2013, 07:03 PM
Monia Brett PSVP, Antisense Drug DiscoveryAug 26, 2013 Sale$25.582,90974,403769Aug 28, 2013, 07:19 PM
KLEIN JOSEPH IIIDirectorAug 09, 2013 Option Exercise$10.1818,750190,95015,813Aug 13, 2013, 07:45 PM
KLEIN JOSEPH IIIDirectorAug 09, 2013 Sale$28.2218,750529,1268,313Aug 13, 2013, 07:45 PM
CROOKE STANLEY TCOO, PresidentJul 23, 2013 Option Exercise$11.1211,500127,88013,161Jul 25, 2013, 08:18 PM
CROOKE STANLEY TCOO, PresidentJul 23, 2013 Sale$30.0011,500345,0001,661Jul 25, 2013, 08:18 PM
CROOKE STANLEY TChairman and CEOJul 22, 2013 Option Exercise$14.9820,000299,57011,661Jul 22, 2013, 07:51 PM
CROOKE STANLEY TChairman and CEOJul 19, 2013 Option Exercise$15.3822,200341,43611,661Jul 22, 2013, 07:51 PM
CROOKE STANLEY TChairman and CEOJul 18, 2013 Option Exercise$11.1220,000222,40011,661Jul 22, 2013, 07:51 PM
CROOKE STANLEY TChairman and CEOJul 19, 2013 Sale$30.6122,200679,6501,661Jul 22, 2013, 07:51 PM
CROOKE STANLEY TChairman and CEOJul 18, 2013 Sale$30.1120,000602,2201,661Jul 22, 2013, 07:51 PM
CROOKE STANLEY TChairman and CEOJul 22, 2013 Sale$30.7720,000615,4501,661Jul 22, 2013, 07:51 PM
CROOKE STANLEY TChairman and CEOJul 16, 2013 Option Exercise$11.1218,000200,1607,661Jul 17, 2013, 07:41 PM
CROOKE STANLEY TChairman and CEOJul 15, 2013 Option Exercise$11.1290,0001,000,80011,661Jul 17, 2013, 07:41 PM
CROOKE STANLEY TChairman and CEOJul 17, 2013 Option Exercise$13.3339,900531,7628,430Jul 17, 2013, 07:41 PM
CROOKE STANLEY TChairman and CEOJul 16, 2013 Sale$33.3118,000599,5261,661Jul 17, 2013, 07:41 PM
CROOKE STANLEY TChairman and CEOJul 15, 2013 Sale$33.8190,0003,042,5401,661Jul 17, 2013, 07:41 PM
CROOKE STANLEY TChairman and CEOJul 17, 2013 Sale$31.5039,9001,256,876174Jul 17, 2013, 07:41 PM
CROOKE STANLEY TChairman and CEOJul 11, 2013 Option Exercise$15.3830,000461,400311,661Jul 12, 2013, 07:44 PM
CROOKE STANLEY TChairman and CEOJul 10, 2013 Option Exercise$15.3830,000461,40031,661Jul 12, 2013, 07:44 PM
CROOKE STANLEY TChairman and CEOJul 12, 2013 Option Exercise$11.9730,000359,16013,661Jul 12, 2013, 07:44 PM
CROOKE STANLEY TChairman and CEOJul 11, 2013 Sale$32.0030,000960,0901,661Jul 12, 2013, 07:44 PM
CROOKE STANLEY TChairman and CEOJul 10, 2013 Sale$30.0530,000901,4401,661Jul 12, 2013, 07:44 PM
CROOKE STANLEY TChairman and CEOJul 12, 2013 Sale$33.2030,000995,9981,661Jul 12, 2013, 07:44 PM
Geary Richard SSVP, DevelopmentJul 11, 2013 Option Exercise$11.129,000100,08012,446Jul 12, 2013, 07:43 PM
Geary Richard SSVP, DevelopmentJul 11, 2013 Sale$31.909,000287,1003,446Jul 12, 2013, 07:43 PM
Geary Richard SSVP, DevelopmentJul 09, 2013 Option Exercise$10.2910,358106,58413,804Jul 09, 2013, 08:35 PM
Geary Richard SSVP, DevelopmentJul 08, 2013 Option Exercise$11.0430,000331,18121,379Jul 09, 2013, 08:35 PM
Geary Richard SSVP, DevelopmentJul 05, 2013 Option Exercise$15.1324,180365,83120,406Jul 09, 2013, 08:35 PM
Geary Richard SSVP, DevelopmentJul 09, 2013 Sale$30.0410,358311,1853,446Jul 09, 2013, 08:35 PM
Geary Richard SSVP, DevelopmentJul 08, 2013 Sale$30.0830,000902,3803,446Jul 09, 2013, 08:35 PM
Geary Richard SSVP, DevelopmentJul 05, 2013 Sale$29.9725,805773,2943,446Jul 09, 2013, 08:35 PM
CROOKE STANLEY TChairman and CEOJul 09, 2013 Option Exercise$15.3830,000461,40031,661Jul 09, 2013, 07:38 PM
CROOKE STANLEY TChairman and CEOJul 08, 2013 Option Exercise$15.385,00877,0236,669Jul 09, 2013, 07:38 PM
CROOKE STANLEY TChairman and CEOJul 05, 2013 Option Exercise$15.3824,180371,88825,841Jul 09, 2013, 07:38 PM
CROOKE STANLEY TChairman and CEOJul 08, 2013 Sale$23.4054,9921,286,75626,653Jul 09, 2013, 07:38 PM
CROOKE STANLEY TChairman and CEOJul 05, 2013 Sale$30.0124,180725,7631,661Jul 09, 2013, 07:38 PM
CROOKE STANLEY TChairman and CEOJul 09, 2013 Sale$30.0430,000901,2901,661Jul 09, 2013, 07:38 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 01, 2013 Option Exercise$9.209768,9762,300Jul 05, 2013, 06:01 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJul 05, 2013 Sale$29.252778,1022,023Jul 05, 2013, 06:01 PM
Geary Richard SSVP, DevelopmentJul 01, 2013 Option Exercise$9.208177,5145,071Jul 03, 2013, 05:16 PM
Geary Richard SSVP, DevelopmentJul 03, 2013 Option Exercise$19.085,00095,40010,071Jul 03, 2013, 05:16 PM
Geary Richard SSVP, DevelopmentJul 03, 2013 Sale$29.025,000145,1005,071Jul 03, 2013, 05:16 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 01, 2013 Option Exercise$9.203623,3296,057Jul 03, 2013, 05:15 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 02, 2013 Sale$28.692156,1695,842Jul 03, 2013, 05:15 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2013 Option Exercise$9.207566,9532,866Jul 03, 2013, 05:13 PM
CROOKE STANLEY TChairman and CEOJun 28, 2013 Option Exercise$9.2110,68398,4306,132Jul 01, 2013, 07:33 PM
CROOKE STANLEY TChairman and CEOJun 28, 2013 Option Exercise$6.8110,00068,10011,661Jul 01, 2013, 07:33 PM
CROOKE STANLEY TChairman and CEOJun 27, 2013 Option Exercise$6.8120,000136,20011,661Jul 01, 2013, 07:33 PM
CROOKE STANLEY TChairman and CEOJun 28, 2013 Sale$27.0710,000270,7001,661Jul 01, 2013, 07:33 PM
CROOKE STANLEY TChairman and CEOJun 27, 2013 Sale$27.8520,000557,0001,661Jul 01, 2013, 07:33 PM
CROOKE STANLEY TChairman and CEOJul 01, 2013 Sale$28.1710,000281,700775,391Jul 01, 2013, 07:33 PM
CROOKE STANLEY TChairman and CEOJun 28, 2013 Sale$27.3110,683291,753174Jul 01, 2013, 07:33 PM
CROOKE STANLEY TChairman and CEOJun 26, 2013 Option Exercise$6.8120,000136,20021,661Jun 26, 2013, 07:46 PM
CROOKE STANLEY TChairman and CEOJun 25, 2013 Option Exercise$6.8130,000204,30021,226Jun 26, 2013, 07:46 PM
CROOKE STANLEY TChairman and CEOJun 25, 2013 Sale$28.0230,000840,6981,661Jun 26, 2013, 07:46 PM
CROOKE STANLEY TChairman and CEOJun 24, 2013 Sale$25.1930,000755,624809,121Jun 26, 2013, 07:46 PM
CROOKE STANLEY TChairman and CEOJun 26, 2013 Sale$26.7010,000267,000785,391Jun 26, 2013, 07:46 PM
CROOKE STANLEY TChairman and CEOJun 26, 2013 Sale$27.1020,000542,0201,661Jun 26, 2013, 07:46 PM
Geary Richard SSVP, DevelopmentJun 24, 2013 Option Exercise$15.5030,000465,10017,984Jun 26, 2013, 07:45 PM
Geary Richard SSVP, DevelopmentJun 25, 2013 Option Exercise$14.2117,049242,30414,689Jun 26, 2013, 07:45 PM
Geary Richard SSVP, DevelopmentJun 24, 2013 Sale$25.1930,000755,6244,254Jun 26, 2013, 07:45 PM
Geary Richard SSVP, DevelopmentJun 25, 2013 Sale$27.9917,049477,2834,254Jun 26, 2013, 07:45 PM
WENDER JOSEPH HDirectorJun 20, 2013 Option Exercise$5.1710,00051,70061,000Jun 24, 2013, 08:33 PM
WENDER JOSEPH HDirectorJun 20, 2013 Sale$20.935,447114,00655,553Jun 24, 2013, 08:33 PM
Monia Brett PSVP, Antisense Drug DiscoveryJun 11, 2013 Option Exercise$15.759,375147,65615,070Jun 13, 2013, 07:58 PM
Monia Brett PSVP, Antisense Drug DiscoveryJun 11, 2013 Sale$23.769,375222,7505,695Jun 13, 2013, 07:58 PM
MUTO FREDERICK TDirectorMay 30, 2013 Option Exercise$5.1710,00051,70010,000May 31, 2013, 07:15 PM
MUTO FREDERICK TDirectorMay 30, 2013 Sale$21.9610,000219,6000May 31, 2013, 07:15 PM
BENNETT C FRANKSVP, Antisense ResearchMay 01, 2013 Option Exercise$7.6929,945230,41025,910May 02, 2013, 07:48 PM
BENNETT C FRANKSVP, Antisense ResearchApr 30, 2013 Option Exercise$11.1230,000333,60032,110May 02, 2013, 07:48 PM
BENNETT C FRANKSVP, Antisense ResearchApr 30, 2013 Sale$22.5130,000675,1532,110May 02, 2013, 07:48 PM
BENNETT C FRANKSVP, Antisense ResearchMay 01, 2013 Sale$22.2629,945666,6062,110May 02, 2013, 07:48 PM
PARSHALL B LYNNECOO, SecretaryApr 24, 2013 Option Exercise$11.1230,000333,60032,941Apr 26, 2013, 07:06 PM
PARSHALL B LYNNECOO, SecretaryApr 25, 2013 Option Exercise$8.0525,854208,19221,341Apr 26, 2013, 07:06 PM
PARSHALL B LYNNECOO, SecretaryApr 25, 2013 Sale$22.5025,854581,5862,941Apr 26, 2013, 07:06 PM
PARSHALL B LYNNECOO, SecretaryApr 24, 2013 Sale$22.1230,000663,6002,941Apr 26, 2013, 07:06 PM
HOUGEN ELIZABETH LSVP, Finance & CFOApr 24, 2013 Option Exercise$15.3810,417160,21310,717Apr 26, 2013, 07:02 PM
HOUGEN ELIZABETH LSVP, Finance & CFOApr 24, 2013 Sale$22.3810,417233,132300Apr 26, 2013, 07:02 PM
CROOKE STANLEY TChairman, CEO and PresidentApr 24, 2013 Sale$22.1210,000221,200825,391Apr 26, 2013, 07:01 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 19, 2013 Option Exercise$14.9415,000224,0407,324Apr 23, 2013, 09:04 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 23, 2013 Option Exercise$13.2227,320361,10111,984Apr 23, 2013, 09:04 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 19, 2013 Sale$20.3615,000305,4361,324Apr 23, 2013, 09:04 PM
O'NEIL PATRICK R.SVP, Legal & General CounselApr 23, 2013 Sale$22.1327,320604,5921,324Apr 23, 2013, 09:04 PM
PARSHALL B LYNNECOO, SecretaryApr 22, 2013 Option Exercise$11.1230,000333,60032,941Apr 23, 2013, 08:48 PM
PARSHALL B LYNNECOO, SecretaryApr 19, 2013 Option Exercise$7.2630,000217,80032,941Apr 23, 2013, 08:48 PM
PARSHALL B LYNNECOO, SecretaryApr 23, 2013 Option Exercise$6.8120,000136,20010,000Apr 23, 2013, 08:48 PM
PARSHALL B LYNNECOO, SecretaryApr 23, 2013 Option Exercise$11.1210,000111,20012,941Apr 23, 2013, 08:48 PM
PARSHALL B LYNNECOO, SecretaryApr 19, 2013 Sale$20.0130,000600,1802,941Apr 23, 2013, 08:48 PM
PARSHALL B LYNNECOO, SecretaryApr 23, 2013 Sale$22.1020,000441,9340Apr 23, 2013, 08:48 PM
PARSHALL B LYNNECOO, SecretaryApr 23, 2013 Sale$22.1010,000220,9672,941Apr 23, 2013, 08:48 PM
PARSHALL B LYNNECOO, SecretaryApr 22, 2013 Sale$20.9930,000629,7002,941Apr 23, 2013, 08:48 PM
Monia Brett PSVP, Antisense Drug DiscoveryApr 19, 2013 Option Exercise$11.122,50027,8008,195Apr 23, 2013, 08:47 PM
Monia Brett PSVP, Antisense Drug DiscoveryApr 22, 2013 Option Exercise$11.1217,000189,04022,695Apr 23, 2013, 08:47 PM
Monia Brett PSVP, Antisense Drug DiscoveryApr 22, 2013 Sale$21.2617,000361,4205,695Apr 23, 2013, 08:47 PM
Monia Brett PSVP, Antisense Drug DiscoveryApr 19, 2013 Sale$21.252,50053,1255,695Apr 23, 2013, 08:47 PM
CROOKE STANLEY TChairman, CEO and PresidentApr 22, 2013 Option Exercise$7.2620,000145,20021,661Apr 23, 2013, 08:46 PM
CROOKE STANLEY TChairman, CEO and PresidentApr 19, 2013 Option Exercise$7.2630,000217,80031,661Apr 23, 2013, 08:46 PM
CROOKE STANLEY TChairman, CEO and PresidentApr 23, 2013 Sale$22.1030,000662,901835,391Apr 23, 2013, 08:46 PM
CROOKE STANLEY TChairman, CEO and PresidentApr 22, 2013 Sale$20.9910,000209,900865,391Apr 23, 2013, 08:46 PM
CROOKE STANLEY TChairman, CEO and PresidentApr 22, 2013 Sale$20.9920,000419,8001,661Apr 23, 2013, 08:46 PM
CROOKE STANLEY TChairman, CEO and PresidentApr 19, 2013 Sale$20.0130,000600,1801,661Apr 23, 2013, 08:46 PM
HOUGEN ELIZABETH LSVP, Finance & CFOApr 22, 2013 Option Exercise$14.8717,656262,59210,143Apr 23, 2013, 08:45 PM
HOUGEN ELIZABETH LSVP, Finance & CFOApr 22, 2013 Sale$21.4617,656378,814300Apr 23, 2013, 08:45 PM
Geary Richard SSVP, DevelopmentApr 19, 2013 Option Exercise$11.122,04222,7076,296Apr 23, 2013, 08:44 PM
Geary Richard SSVP, DevelopmentApr 19, 2013 Sale$20.802,04242,4744,254Apr 23, 2013, 08:44 PM
O'NEIL PATRICK R.SVP, Legal and General CounselApr 12, 2013 Option Exercise$14.245,46077,7515,654Apr 15, 2013, 07:09 PM
O'NEIL PATRICK R.SVP, Legal and General CounselApr 12, 2013 Sale$19.615,460107,0961,324Apr 15, 2013, 07:09 PM
Geary Richard SSr VP, DevelopmentApr 11, 2013 Option Exercise$11.127,00077,84011,254Apr 15, 2013, 07:07 PM
Geary Richard SSr VP, DevelopmentApr 11, 2013 Sale$19.527,000136,6404,254Apr 15, 2013, 07:07 PM
Geary Richard SSr VP, DevelopmentMar 21, 2013 Option Exercise$11.121,00011,1205,254Mar 22, 2013, 07:57 PM
Geary Richard SSr VP, DevelopmentMar 21, 2013 Sale$19.501,00019,5004,254Mar 22, 2013, 07:57 PM
O'NEIL PATRICK R.SVP, Legal and General CounselMar 21, 2013 Option Exercise$14.189,000127,62010,324Mar 22, 2013, 07:56 PM
O'NEIL PATRICK R.SVP, Legal and General CounselMar 21, 2013 Sale$19.269,000173,3401,324Mar 22, 2013, 07:56 PM
HOUGEN ELIZABETH LSVP, Finance and CFOMar 20, 2013 Option Exercise$11.1214,376159,8619,884Mar 21, 2013, 08:25 PM
HOUGEN ELIZABETH LSVP, Finance and CFOMar 20, 2013 Sale$18.1314,376260,637300Mar 21, 2013, 08:25 PM
KLEIN JOSEPH IIIDirectorMar 20, 2013 Option Exercise$13.603,92453,3572,500Mar 21, 2013, 08:25 PM
KLEIN JOSEPH IIIDirectorMar 20, 2013 Sale$18.003,92470,6320Mar 21, 2013, 08:25 PM
KLEIN JOSEPH IIIDirectorMar 19, 2013 Option Exercise$5.937,45344,1963,826Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 20, 2013 Option Exercise$12.3411,841146,1184,167Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 20, 2013 Option Exercise$12.0919,756238,8644,266Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 19, 2013 Option Exercise$5.933,72622,0953,726Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 19, 2013 Sale$18.007,453134,154100Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 20, 2013 Sale$18.0011,841213,1380Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 20, 2013 Sale$18.0019,756355,608100Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 19, 2013 Sale$18.003,72667,0680Mar 21, 2013, 08:24 PM
KLEIN JOSEPH IIIDirectorMar 13, 2013 Option Exercise$5.206,93336,0466,667Mar 14, 2013, 09:00 PM
KLEIN JOSEPH IIIDirectorMar 13, 2013 Option Exercise$5.2013,86772,0986,766Mar 14, 2013, 09:00 PM
KLEIN JOSEPH IIIDirectorMar 13, 2013 Sale$18.016,933124,8420Mar 14, 2013, 09:00 PM
KLEIN JOSEPH IIIDirectorMar 13, 2013 Sale$18.0113,867249,702100Mar 14, 2013, 09:00 PM
HOUGEN ELIZABETH LSVP, Finance and CFOMar 05, 2013 Option Exercise$6.815,04034,3225,340Mar 07, 2013, 08:16 PM
HOUGEN ELIZABETH LSVP, Finance and CFOMar 05, 2013 Sale$16.865,04084,960300Mar 07, 2013, 08:16 PM
Monia Brett PSVP, Antisense Drug DiscoveryMar 05, 2013 Option Exercise$6.8118,240124,21423,935Mar 07, 2013, 08:16 PM
Monia Brett PSVP, Antisense Drug DiscoveryMar 05, 2013 Sale$16.8618,240307,5995,695Mar 07, 2013, 08:16 PM
O'NEIL PATRICK R.SVP, Legal and General CounselMar 04, 2013 Option Exercise$11.2511,700131,65711,674Mar 04, 2013, 08:05 PM
O'NEIL PATRICK R.SVP, Legal and General CounselMar 04, 2013 Sale$15.8211,700185,0591,324Mar 04, 2013, 08:05 PM
BERTHELSEN SPENCER RDirectorFeb 21, 2013 Option Exercise$5.1710,00051,70039,300Feb 22, 2013, 07:17 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 19, 2013 Option Exercise$10.291,60016,4642,924Feb 20, 2013, 07:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 15, 2013 Option Exercise$10.293503,6011,574Feb 20, 2013, 07:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 15, 2013 Sale$14.813505,1851,324Feb 20, 2013, 07:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 19, 2013 Sale$14.801,60023,6801,324Feb 20, 2013, 07:03 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 13, 2013 Option Exercise$7.366,10044,9006,663Feb 14, 2013, 08:35 PM
O'NEIL PATRICK R.SVP, Legal & General CounselFeb 13, 2013 Sale$14.176,23988,4071,463Feb 14, 2013, 08:35 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJan 30, 2013 Option Exercise$10.292,00020,5803,463Jan 31, 2013, 07:57 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJan 29, 2013 Sale$13.403004,0201,463Jan 31, 2013, 07:57 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJan 30, 2013 Sale$14.822,00029,6401,463Jan 31, 2013, 07:57 PM
BENNETT C FRANKSVP, Antisense ResearchJan 16, 2013 Sale$14.003094,3262,110Jan 17, 2013, 08:40 PM
Geary Richard SSVP, DevelopmentJan 16, 2013 Sale$14.003454,8304,254Jan 17, 2013, 08:40 PM
CROOKE STANLEY TChairman, CEO and PresidentJan 16, 2013 Sale$14.001432,002174Jan 17, 2013, 08:39 PM
CROOKE STANLEY TChairman, CEO and PresidentJan 16, 2013 Sale$14.001,31718,4381,661Jan 17, 2013, 08:39 PM
Monia Brett PSVP, Antisense Drug DiscoveryJan 16, 2013 Sale$14.003304,6205,695Jan 17, 2013, 08:38 PM
HOUGEN ELIZABETH LSVP, Finance & CFOJan 16, 2013 Sale$14.002423,388300Jan 17, 2013, 08:37 PM
PARSHALL B LYNNECOO, SecretaryJan 16, 2013 Sale$14.0075910,6262,941Jan 17, 2013, 08:36 PM
O'NEIL PATRICK R.SVP, Legal & General CounselJan 17, 2013 Sale$14.162423,4271,763Jan 17, 2013, 08:35 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJan 04, 2013 Sale$10.761,29613,9451,463Jan 04, 2013, 08:00 PM
O'NEIL PATRICK R.SVP, Legal and General CounselJan 01, 2013 Option Exercise$8.874313,8252,759Jan 03, 2013, 08:52 PM
Monia Brett PVP, Antisense Drug DiscoveryJan 01, 2013 Option Exercise$8.872151,9085,599Jan 03, 2013, 07:46 PM
Monia Brett PVP, Antisense Drug DiscoveryJan 03, 2013 Sale$10.843113,3715,288Jan 03, 2013, 07:46 PM
BENNETT C FRANKSVP, Antisense ResearchJan 01, 2013 Option Exercise$8.874473,9671,724Jan 03, 2013, 07:45 PM
Geary Richard SSr VP, DevelopmentJan 01, 2013 Option Exercise$8.878987,9694,088Jan 03, 2013, 07:44 PM
Geary Richard SSr VP, DevelopmentJan 03, 2013 Sale$10.842652,8733,823Jan 03, 2013, 07:44 PM
Geary Richard SSr VP, DevelopmentDec 13, 2012 Option Exercise$5.256,00031,5009,190Dec 17, 2012, 08:03 PM
Geary Richard SSr VP, DevelopmentDec 13, 2012 Sale$9.636,00057,7513,190Dec 17, 2012, 08:03 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 20, 2012 Option Exercise$6.3430,000190,15520,538Sep 21, 2012, 07:20 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 19, 2012 Option Exercise$5.2530,000157,50030,000Sep 21, 2012, 07:20 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 21, 2012 Option Exercise$6.8429,462201,52029,462Sep 21, 2012, 07:20 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 20, 2012 Sale$15.0130,000450,2400Sep 21, 2012, 07:20 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 19, 2012 Sale$14.8130,000444,4500Sep 21, 2012, 07:20 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 21, 2012 Sale$14.0629,462414,2360Sep 21, 2012, 07:20 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 13, 2012 Option Exercise$5.2527,074142,13927,074Sep 17, 2012, 06:36 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 13, 2012 Sale$14.5527,074393,9270Sep 17, 2012, 06:36 PM
PARSHALL B LYNNECOO, SecretarySep 07, 2012 Option Exercise$6.842,50617,1414,491Sep 11, 2012, 06:31 PM
PARSHALL B LYNNECOO, SecretarySep 07, 2012 Option Exercise$6.8410,00068,4005,000Sep 11, 2012, 06:31 PM
PARSHALL B LYNNECOO, SecretarySep 07, 2012 Sale$15.1210,000151,2000Sep 11, 2012, 06:31 PM
PARSHALL B LYNNECOO, SecretarySep 07, 2012 Sale$15.122,50637,8911,985Sep 11, 2012, 06:31 PM
PARSHALL B LYNNECOO, SecretarySep 04, 2012 Option Exercise$5.2520,000105,00010,000Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 06, 2012 Option Exercise$5.7815,00086,7005,000Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 04, 2012 Option Exercise$5.2510,00052,50011,985Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 06, 2012 Option Exercise$5.6510,00056,4656,985Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 05, 2012 Option Exercise$5.252,00010,5003,985Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 06, 2012 Option Exercise$6.845,00034,2005,000Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 06, 2012 Sale$15.0220,000300,3700Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 04, 2012 Sale$15.0010,000150,0101,985Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 06, 2012 Sale$15.0210,000150,1851,985Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 05, 2012 Sale$15.002,00030,0001,985Sep 06, 2012, 09:49 PM
PARSHALL B LYNNECOO, SecretarySep 04, 2012 Sale$15.0020,000300,0200Sep 06, 2012, 09:49 PM
REED JOHN CDirectorSep 04, 2012 Option Exercise$5.175,10026,3675,100Sep 06, 2012, 09:39 PM
REED JOHN CDirectorSep 06, 2012 Option Exercise$5.174,90025,3334,900Sep 06, 2012, 09:39 PM
REED JOHN CDirectorSep 06, 2012 Sale$15.184,90074,3580Sep 06, 2012, 09:39 PM
REED JOHN CDirectorSep 04, 2012 Sale$15.175,10077,3670Sep 06, 2012, 09:39 PM
Monia Brett PVP, Antisense Drug DiscoverySep 06, 2012 Option Exercise$5.2512,03163,16317,415Sep 06, 2012, 09:39 PM
Monia Brett PVP, Antisense Drug DiscoverySep 06, 2012 Sale$15.2512,031183,4735,384Sep 06, 2012, 09:39 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 06, 2012 Option Exercise$5.2517,38891,2878,694Sep 06, 2012, 09:38 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 05, 2012 Option Exercise$5.2515,00078,75015,000Sep 06, 2012, 09:38 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 04, 2012 Option Exercise$5.2530,000157,50030,000Sep 06, 2012, 09:38 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 06, 2012 Option Exercise$5.4912,61269,2746,000Sep 06, 2012, 09:38 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 05, 2012 Sale$14.8215,000222,3450Sep 06, 2012, 09:38 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 04, 2012 Sale$14.1130,000423,2550Sep 06, 2012, 09:38 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 06, 2012 Sale$15.0212,612189,4130Sep 06, 2012, 09:38 PM
CROOKE STANLEY TChairman, CEO and PresidentSep 06, 2012 Sale$15.0217,388261,1420Sep 06, 2012, 09:38 PM
BENNETT C FRANKSVP, Antisense ResearchJul 09, 2012 Option Exercise$6.8310,50071,6706,777Jul 11, 2012, 04:46 PM
BENNETT C FRANKSVP, Antisense ResearchJul 09, 2012 Sale$13.5110,500141,8551,277Jul 11, 2012, 04:46 PM
Geary Richard SSr VP, DevelopmentJul 09, 2012 Option Exercise$5.255,68629,8525,876Jul 11, 2012, 04:45 PM
Geary Richard SSr VP, DevelopmentJul 09, 2012 Sale$13.475,68676,6103,190Jul 11, 2012, 04:45 PM
REED JOHN CDirectorJul 09, 2012 Option Exercise$3.9510,00039,50010,000Jul 11, 2012, 04:43 PM
REED JOHN CDirectorJul 09, 2012 Sale$13.9910,000139,9000Jul 11, 2012, 04:43 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 01, 2012 Option Exercise$6.133111,9065,971Jul 03, 2012, 07:06 PM
Monia Brett PSVP, Antisense Drug DiscoveryJul 03, 2012 Sale$12.925877,5845,384Jul 03, 2012, 07:06 PM
BENNETT C FRANKSVP, Antisense ResearchJul 01, 2012 Option Exercise$6.136483,9711,277Jul 03, 2012, 07:06 PM
BENNETT C FRANKSVP, Antisense ResearchJul 03, 2012 Option Exercise$6.846,00041,0407,277Jul 03, 2012, 07:06 PM
BENNETT C FRANKSVP, Antisense ResearchJul 03, 2012 Sale$12.916,00077,4601,277Jul 03, 2012, 07:06 PM
Geary Richard SSr VP, DevelopmentJul 01, 2012 Option Exercise$6.131,3007,9675,624Jul 03, 2012, 07:05 PM
Geary Richard SSr VP, DevelopmentJul 03, 2012 Sale$12.912,43431,4233,190Jul 03, 2012, 07:05 PM
BERTHELSEN SPENCER RDirectorJun 25, 2012 Option Exercise$8.1510,00081,50032,800Jun 25, 2012, 08:56 PM
BERTHELSEN SPENCER RDirectorJun 25, 2012 Sale$11.5710,000115,66929,300Jun 25, 2012, 08:56 PM
REED JOHN CDirectorJun 22, 2012 Option Exercise$8.1510,00081,50010,000Jun 22, 2012, 07:46 PM
REED JOHN CDirectorJun 22, 2012 Sale$11.0610,000110,6000Jun 22, 2012, 07:46 PM
Geary Richard SSr VP, DevelopmentJun 14, 2012 Sale$10.861,57917,1484,324Jun 14, 2012, 08:16 PM
WENDER JOSEPH HDirectorJun 12, 2012 Option Exercise$8.1510,00081,50051,000Jun 13, 2012, 08:02 PM
BERTHELSEN SPENCER RDirectorMay 21, 2012 Option Exercise$9.402,73125,67132,031May 22, 2012, 07:51 PM
BERTHELSEN SPENCER RDirectorMay 22, 2012 Option Exercise$9.4017,269162,32946,569May 22, 2012, 07:51 PM
BERTHELSEN SPENCER RDirectorMay 21, 2012 Sale$9.422,73125,72629,300May 22, 2012, 07:51 PM
BERTHELSEN SPENCER RDirectorMay 22, 2012 Sale$9.5617,269165,09229,300May 22, 2012, 07:51 PM
BENNETT C FRANKSenior Vice PresidentJan 01, 2012 Option Exercise$6.133241,986629Mar 07, 2012, 03:04 PM
Geary Richard SSenior Vice PresidentJan 01, 2012 Option Exercise$6.131,6259,9595,903Jan 03, 2012, 06:34 PM
BENNETT C FRANKSenior Vice PresidentDec 01, 2011 Option Exercise$6.133241,986629Jan 03, 2012, 06:27 PM
Monia Brett PSenior Vice PresidentJan 01, 2012 Option Exercise$6.135873,5975,660Jan 03, 2012, 05:49 PM
Geary Richard SSenior Vice PresidentDec 21, 2011 Option Exercise$5.801,1446,6355,422Dec 22, 2011, 05:21 PM
Geary Richard SSenior Vice PresidentDec 21, 2011 Sale$6.921,1447,9164,278Dec 22, 2011, 05:21 PM
CROOKE STANLEY TChairman, President, CEODec 21, 2011 Option Exercise$5.801,0806,2641,080Dec 22, 2011, 05:21 PM
CROOKE STANLEY TChairman, President, CEODec 21, 2011 Option Exercise$5.8016,72096,97616,720Dec 22, 2011, 05:21 PM
CROOKE STANLEY TChairman, President, CEODec 21, 2011 Sale$6.921,0807,4740Dec 22, 2011, 05:21 PM
CROOKE STANLEY TChairman, President, CEODec 21, 2011 Sale$6.9216,720115,7020Dec 22, 2011, 05:21 PM
PARSHALL B LYNNEDirector, COODec 21, 2011 Option Exercise$5.804,40025,5202,200Dec 22, 2011, 05:20 PM
PARSHALL B LYNNEDirector, COODec 21, 2011 Option Exercise$5.802,36313,7054,348Dec 22, 2011, 05:20 PM
PARSHALL B LYNNEDirector, COODec 21, 2011 Sale$6.922,36316,3521,985Dec 22, 2011, 05:20 PM
PARSHALL B LYNNEDirector, COODec 21, 2011 Sale$6.924,40030,4480Dec 22, 2011, 05:20 PM
BENNETT C FRANKSenior Vice PresidentDec 21, 2011 Option Exercise$5.801,5559,0191,860Dec 22, 2011, 05:20 PM
BENNETT C FRANKSenior Vice PresidentDec 21, 2011 Sale$6.921,55510,761305Dec 22, 2011, 05:20 PM
CROOKE STANLEY TChairman, President, CEODec 16, 2011 Option Exercise$5.8015,00087,00015,000Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 19, 2011 Option Exercise$5.801,1006,380982Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 19, 2011 Option Exercise$5.8017,00098,60015,178Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 20, 2011 Option Exercise$5.801,7009,8601,400Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 16, 2011 Option Exercise$5.801,5008,7001,500Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 20, 2011 Option Exercise$5.8027,000156,60022,000Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 19, 2011 Sale$6.831,1007,5110Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 19, 2011 Sale$6.8317,000116,0860Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 20, 2011 Sale$6.841,70011,6240Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 16, 2011 Sale$6.791,50010,1850Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 20, 2011 Sale$6.8427,000184,6400Dec 20, 2011, 09:09 PM
CROOKE STANLEY TChairman, President, CEODec 16, 2011 Sale$6.7915,000101,8500Dec 20, 2011, 09:09 PM
BENNETT C FRANKSenior Vice PresidentDec 16, 2011 Option Exercise$5.801,5008,7001,805Dec 20, 2011, 09:08 PM
BENNETT C FRANKSenior Vice PresidentDec 20, 2011 Option Exercise$5.802,50014,5002,305Dec 20, 2011, 09:08 PM
BENNETT C FRANKSenior Vice PresidentDec 19, 2011 Option Exercise$5.801,5008,7001,645Dec 20, 2011, 09:08 PM
BENNETT C FRANKSenior Vice PresidentDec 20, 2011 Sale$6.842,50017,100305Dec 20, 2011, 09:08 PM
BENNETT C FRANKSenior Vice PresidentDec 19, 2011 Sale$6.831,50010,243305Dec 20, 2011, 09:08 PM
BENNETT C FRANKSenior Vice PresidentDec 16, 2011 Sale$6.791,50010,185305Dec 20, 2011, 09:08 PM
Geary Richard SSenior Vice PresidentDec 20, 2011 Option Exercise$5.801,80010,4405,778Dec 20, 2011, 09:06 PM
Geary Richard SSenior Vice PresidentDec 19, 2011 Option Exercise$5.801,1006,3805,260Dec 20, 2011, 09:06 PM
Geary Richard SSenior Vice PresidentDec 16, 2011 Option Exercise$5.801,0005,8005,278Dec 20, 2011, 09:06 PM
Geary Richard SSenior Vice PresidentDec 20, 2011 Sale$6.841,80012,3064,278Dec 20, 2011, 09:06 PM
Geary Richard SSenior Vice PresidentDec 19, 2011 Sale$6.831,1007,5114,278Dec 20, 2011, 09:06 PM
Geary Richard SSenior Vice PresidentDec 16, 2011 Sale$6.791,0006,7904,278Dec 20, 2011, 09:06 PM
PARSHALL B LYNNEDirector, COODec 16, 2011 Option Exercise$5.802,00011,6003,985Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 19, 2011 Option Exercise$5.802,30013,3404,039Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 16, 2011 Option Exercise$5.802,00011,6002,000Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 20, 2011 Option Exercise$5.807,00040,6002,800Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 19, 2011 Option Exercise$184.506,6001,217,6872,054Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 20, 2011 Option Exercise$5.803,60020,8804,885Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 19, 2011 Sale$6.832,30015,7061,985Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 20, 2011 Sale$6.836,30043,0360Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 20, 2011 Sale$6.927004,8440Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 16, 2011 Sale$6.794,00027,1600Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 20, 2011 Sale$6.843,60024,6221,985Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 16, 2011 Sale$6.792,00013,5801,985Dec 20, 2011, 09:05 PM
PARSHALL B LYNNEDirector, COODec 19, 2011 Sale$6.834,60031,4110Dec 20, 2011, 09:05 PM
BENNETT C FRANKSenior Vice PresidentAug 04, 2011 Option Exercise$5.2510,00052,50010,305Aug 05, 2011, 05:40 PM
BENNETT C FRANKSenior Vice PresidentAug 04, 2011 Sale$7.6210,00076,206305Aug 05, 2011, 05:40 PM
BENNETT C FRANKSenior Vice PresidentJul 28, 2011 Sale$8.601,0008,600305Jul 29, 2011, 06:11 PM
BENNETT C FRANKSenior Vice PresidentJul 01, 2011 Option Exercise$7.912511,9841,305Jul 01, 2011, 06:27 PM
Geary Richard SSenior Vice PresidentJul 01, 2011 Option Exercise$7.912652,0954,278Jul 01, 2011, 06:26 PM
BENNETT C FRANKSenior Vice PresidentJan 01, 2011 Option Exercise$7.794933,8431,054Jan 03, 2011, 05:44 PM
Geary Richard SSenior Vice PresidentJan 01, 2011 Option Exercise$7.792,43418,9724,013Jan 03, 2011, 05:05 PM
Geary Richard SSenior Vice PresidentDec 29, 2010 Option Exercise$9.631,98019,0583,559Dec 29, 2010, 08:15 PM
Geary Richard SSenior Vice PresidentDec 27, 2010 Option Exercise$9.633,30031,7634,879Dec 29, 2010, 08:15 PM
Geary Richard SSenior Vice PresidentDec 29, 2010 Sale$10.311,98020,4241,579Dec 29, 2010, 08:15 PM
Geary Richard SSenior Vice PresidentDec 27, 2010 Sale$10.423,30034,3861,579Dec 29, 2010, 08:15 PM
PARSHALL B LYNNEDirector, COODec 29, 2010 Option Exercise$9.636,40061,6008,385Dec 29, 2010, 08:14 PM
PARSHALL B LYNNEDirector, COODec 27, 2010 Option Exercise$9.6310,800103,95012,785Dec 29, 2010, 08:14 PM
PARSHALL B LYNNEDirector, COODec 27, 2010 Sale$10.4210,800112,5361,985Dec 29, 2010, 08:14 PM
PARSHALL B LYNNEDirector, COODec 29, 2010 Sale$10.316,40066,0161,985Dec 29, 2010, 08:14 PM
BENNETT C FRANKSenior Vice PresidentDec 29, 2010 Option Exercise$9.634,60044,2755,161Dec 29, 2010, 08:09 PM
BENNETT C FRANKSenior Vice PresidentDec 27, 2010 Option Exercise$9.637,70074,1138,261Dec 29, 2010, 08:09 PM
BENNETT C FRANKSenior Vice PresidentDec 29, 2010 Sale$10.314,60047,449561Dec 29, 2010, 08:09 PM
BENNETT C FRANKSenior Vice PresidentDec 27, 2010 Sale$10.427,70080,234561Dec 29, 2010, 08:09 PM
CROOKE STANLEY TChairman, President, CEODec 29, 2010 Option Exercise$9.632,00019,2502,000Dec 29, 2010, 07:22 PM
CROOKE STANLEY TChairman, President, CEODec 29, 2010 Option Exercise$9.6310,00096,25010,000Dec 29, 2010, 07:22 PM
CROOKE STANLEY TChairman, President, CEODec 27, 2010 Option Exercise$9.6320,000192,50020,000Dec 29, 2010, 07:22 PM
CROOKE STANLEY TChairman, President, CEODec 29, 2010 Sale$10.312,00020,6300Dec 29, 2010, 07:22 PM
CROOKE STANLEY TChairman, President, CEODec 29, 2010 Sale$10.3110,000103,1500Dec 29, 2010, 07:22 PM
CROOKE STANLEY TChairman, President, CEODec 27, 2010 Sale$10.4220,000208,4000Dec 29, 2010, 07:22 PM
Geary Richard SSenior Vice PresidentDec 23, 2010 Option Exercise$9.632001,9251,779Dec 28, 2010, 07:40 PM
Geary Richard SSenior Vice PresidentDec 23, 2010 Sale$10.522002,1051,579Dec 28, 2010, 07:40 PM
PARSHALL B LYNNECOODec 23, 2010 Option Exercise$9.638007,7002,785Dec 27, 2010, 04:10 PM
PARSHALL B LYNNECOODec 23, 2010 Option Exercise$9.631,30012,513650Dec 27, 2010, 04:10 PM
PARSHALL B LYNNECOODec 22, 2010 Option Exercise$9.9213,050129,5004,350Dec 27, 2010, 04:10 PM
PARSHALL B LYNNECOODec 23, 2010 Sale$10.528008,4201,985Dec 27, 2010, 04:10 PM
PARSHALL B LYNNECOODec 23, 2010 Sale$10.521,30013,6820Dec 27, 2010, 04:10 PM
PARSHALL B LYNNECOODec 22, 2010 Sale$10.524,35045,7620Dec 27, 2010, 04:10 PM
Geary Richard SSenior Vice PresidentDec 22, 2010 Option Exercise$9.632,60025,0254,179Dec 27, 2010, 04:09 PM
Geary Richard SSenior Vice PresidentDec 23, 2010 Option Exercise$9.634003,8501,979Dec 27, 2010, 04:09 PM
Geary Richard SSenior Vice PresidentDec 22, 2010 Sale$10.522,60027,3521,579Dec 27, 2010, 04:09 PM
Geary Richard SSenior Vice PresidentDec 23, 2010 Sale$10.524004,2101,579Dec 27, 2010, 04:09 PM
BENNETT C FRANKSenior Vice PresidentDec 23, 2010 Option Exercise$9.631,50014,4382,061Dec 27, 2010, 04:09 PM
BENNETT C FRANKSenior Vice PresidentDec 22, 2010 Option Exercise$9.636,20059,6756,761Dec 27, 2010, 04:09 PM
BENNETT C FRANKSenior Vice PresidentDec 23, 2010 Sale$10.521,50015,787561Dec 27, 2010, 04:09 PM
BENNETT C FRANKSenior Vice PresidentDec 22, 2010 Sale$10.526,20065,224561Dec 27, 2010, 04:09 PM
CROOKE STANLEY TChairman, President, CEODec 23, 2010 Option Exercise$9.634,00038,5004,000Dec 27, 2010, 04:09 PM
CROOKE STANLEY TChairman, President, CEODec 22, 2010 Option Exercise$9.6316,000154,00016,000Dec 27, 2010, 04:09 PM
CROOKE STANLEY TChairman, President, CEODec 23, 2010 Sale$10.524,00042,1000Dec 27, 2010, 04:09 PM
CROOKE STANLEY TChairman, President, CEODec 22, 2010 Sale$10.5216,000168,3200Dec 27, 2010, 04:09 PM
BENNETT C FRANKSenior Vice PresidentJul 23, 2010 Sale$9.601,10010,560561Jul 26, 2010, 04:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Swayze EricOfficer Level 1402/29/202420,827
Monia Brett PCEO Level 1502/29/202418,521
Geary Richard SOfficer Level 1402/29/202420,793
Birchler BrianVice President Level 1402/29/202420,793
BENNETT C FRANKOfficer Level 1402/29/202413,185
Monia Brett PChief Executive Officer02/16/202417,219
Swayze EricEVP Research02/02/202494,513
Swayze EricEVP Research01/31/2024560,196
Schneider EugeneEVP, Chf Clinical Develop Ofcr02/02/2024102,701
O'NEIL PATRICK R.EVP CLO & General Counsel02/02/202497,410
Monia Brett PChief Executive Officer02/02/20241,160,303
HOUGEN ELIZABETH LEVP, Finance & CFO02/02/2024105,272
Geary Richard SEVP, Chief Development Officer02/02/202498,135
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper Ofc02/02/2024105,404
BENNETT C FRANKEVP, Chief Scientific Officer02/02/202491,752
Monia Brett PChief Executive Officer01/25/2024118,249
O'NEIL PATRICK R.EVP CLO & General Counsel01/25/2024333,788
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper Ofc01/17/2024280,520
O'NEIL PATRICK R.EVP CLO & General Counsel01/17/2024390,429
Birchler BrianEVP, Corp and Development Ops01/17/2024226,725
Swayze EricEVP Research01/17/2024317,425
Swayze EricEVP Research01/17/2024454
Schneider EugeneEVP, Chf Clinical Develop Ofcr01/17/2024276,386
Monia Brett PChief Executive Officer01/17/20241,616,319
HOUGEN ELIZABETH LEVP, Finance & CFO01/17/2024437,771
Geary Richard SEVP, Chief Development Officer01/17/2024369,960
BENNETT C FRANKEVP, Chief Scientific Officer01/17/2024340,063
Baroldi JosephEVP, Chief Business Officer01/17/202428,435
Baroldi JosephEVP, Chief Business Officer01/17/202473,609
Schneider EugeneEVP, Chf Clinical Develop Ofcr01/12/2024260,800
Schneider EugeneEVP, Chf Clinical Develop Ofcr01/12/2024427,999
Swayze EricEVP Research12/28/20231,282,914
Swayze EricEVP Research12/28/20231,360,081
HOUGEN ELIZABETH LEVP, Finance & CFO12/28/20232,211,799
HOUGEN ELIZABETH LEVP, Finance & CFO12/28/20232,140,952
Birchler BrianEVP, Corp and Development Ops12/28/2023556,965
Birchler BrianEVP, Corp and Development Ops12/28/2023544,410
O'NEIL PATRICK R.EVP CLO & General Counsel12/26/2023985,856
O'NEIL PATRICK R.EVP CLO & General Counsel12/26/20231,071,717
PARSHALL B LYNNEDirector12/28/20232,013,134
PARSHALL B LYNNEDirector12/27/20232,367,000
PARSHALL B LYNNEDirector12/26/20231,188,849
PARSHALL B LYNNEDirector12/27/20232,511,515
PARSHALL B LYNNEDirector12/26/20231,292,390
PARSHALL B LYNNEDirector12/28/20232,134,223
Schneider EugeneEVP, Chf Clinical Develop Ofcr12/26/20231,183,500
Schneider EugeneEVP, Chf Clinical Develop Ofcr12/26/20231,286,575
BENNETT C FRANKEVP, Chief Scientific Officer12/20/2023307,710
BENNETT C FRANKEVP, Chief Scientific Officer12/21/2023762,789
BENNETT C FRANKEVP, Chief Scientific Officer12/20/2023322,643
BENNETT C FRANKEVP, Chief Scientific Officer12/21/2023794,211
Geary Richard SEVP, Chief Development Officer12/21/2023194,662
Geary Richard SEVP, Chief Development Officer12/20/2023307,710
Geary Richard SEVP, Chief Development Officer12/21/2023202,681
Geary Richard SEVP, Chief Development Officer12/20/2023322,643
Monia Brett PChief Executive Officer12/21/2023828,450
Monia Brett PChief Executive Officer12/20/2023307,710
Monia Brett PChief Executive Officer12/21/2023862,577
Monia Brett PChief Executive Officer12/20/2023322,643
Monia Brett PChief Executive Officer12/14/20231,136,160
Monia Brett PChief Executive Officer12/14/20231,190,019
Geary Richard SEVP, Chief Development Officer12/14/2023502,419
Geary Richard SEVP, Chief Development Officer12/14/2023526,236
BENNETT C FRANKEVP, Chief Scientific Officer12/14/20231,070,452
BENNETT C FRANKEVP, Chief Scientific Officer12/14/20231,121,195
KLEIN JOSEPH IIIDirector11/15/2023100,000
Swayze EricEVP Research10/17/20232,493
Monia Brett PChief Executive Officer10/12/2023173,420
BENNETT C FRANKEVP, Chief Scientific Officer09/28/2023207,390
PARSHALL B LYNNEDirector09/26/2023451,268
KLEIN JOSEPH IIIDirector09/26/202390,254
BENNETT C FRANKOfficer Level 1408/31/20235,500
Geary Richard SOfficer Level 1408/31/202331
Monia Brett PCEO Level 1508/31/20234,798
Diaz Allene M.Director08/01/202326,970
KLEIN JOSEPH IIIDirector07/18/2023149,310
Monia Brett PChief Executive Officer07/07/2023787,953
BERTHELSEN SPENCER RDirector06/20/2023320,287
O'NEIL PATRICK R.EVP CLO & General Counsel05/24/202363,676
Monia Brett PChief Executive Officer05/22/2023197,907
Birchler BrianEVP, Corp and Development Ops04/18/202324,530
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper Ofc04/18/202394,250
Baroldi JosephEVP, Chief Business Officer04/18/2023141,631
Swayze EricEVP Research02/28/202317,546
O'NEIL PATRICK R.EVP CLO & General Counsel02/28/20239,185
Geary Richard SEVP, Chief Development Officer02/28/202317,546
HOUGEN ELIZABETH LEVP, Finance & CFO02/28/20234,974
BENNETT C FRANKEVP, Chief Scientific Officer02/28/202311,687
Swayze EricEVP Research02/06/202374,031
Schneider EugeneEVP, Chf Clinical Develop Ofcr02/06/202357,464
O'NEIL PATRICK R.EVP CLO & General Counsel02/06/202378,460
Monia Brett PChief Executive Officer02/06/20231,003,153
HOUGEN ELIZABETH LEVP, Finance & CFO02/06/202384,392
Geary Richard SEVP, Chief Development Officer02/06/202378,070
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper Ofc02/06/202358,997
BENNETT C FRANKEVP, Chief Scientific Officer02/06/202373,560
O'NEIL PATRICK R.EVP CLO & General Counsel01/31/2023178,700
O'NEIL PATRICK R.EVP CLO & General Counsel01/30/2023177,372
Swayze EricEVP Research01/18/2023223,800
Schneider EugeneEVP, Chf Clinical Develop Ofcr01/18/2023188,052
O'NEIL PATRICK R.EVP CLO & General Counsel01/18/2023309,480
Monia Brett PChief Executive Officer01/18/2023989,947
HOUGEN ELIZABETH LEVP, Finance & CFO01/18/2023328,721
Geary Richard SEVP, Chief Development Officer01/18/2023311,525
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper Ofc01/18/2023148,223
BENNETT C FRANKEVP, Chief Scientific Officer01/18/2023271,356
Baroldi JosephEVP, Chief Business Officer01/18/202314,920
KLEIN JOSEPH IIIDirector01/17/202380,000
Schneider EugeneEVP, Chf Clinical Develop Ofcr10/17/20226,699
Swayze EricEVP Research09/08/202220,493
O'NEIL PATRICK R.EVP CLO & General Counsel08/31/20223,129
HOUGEN ELIZABETH LEVP, Finance & CFO08/31/20225,852
BENNETT C FRANKEVP, Chief Scientific Officer08/31/20225,301
Swayze EricEVP Research08/05/202245
KLEIN JOSEPH IIIDirector07/15/202250,977
MUTO FREDERICK TDirector07/01/2022145,575
BERTHELSEN SPENCER RDirector06/07/2022145,575
Swayze EricEVP Research04/21/202216,689
Cadoret-Manier OnaizaEVP, Chf Pdt Str & Oper Ofc04/18/202280,380
O'NEIL PATRICK R.EVP CLO & General Counsel04/12/2022272,057
Monia Brett PChief Executive Officer04/01/202213,309
Swayze EricEVP Research02/28/202217,620
O'NEIL PATRICK R.EVP CLO & General Counsel02/28/202220,854
Monia Brett PChief Executive Officer02/28/202217,620
HOUGEN ELIZABETH LEVP, Finance & CFO02/28/202210,895
BENNETT C FRANKEVP, Chief Scientific Officer02/28/20229,817
Geary Richard SEVP, Chief Development Officer02/28/202217,620
Monia Brett PChief Executive Officer01/26/2022252,526
PARSHALL B LYNNEDirector01/18/202249,758
Cadoret-Manier OnaizaEVP, Chf Corp Dev and Cml Offc01/18/202269,427
BENNETT C FRANKEVP, Chief Scientific Officer01/18/2022202,587
O'NEIL PATRICK R.EVP CLO & General Counsel01/18/2022225,930
HOUGEN ELIZABETH LEVP, Finance & CFO01/18/2022235,779
Monia Brett PChief Executive Officer01/18/2022593,786
Geary Richard SEVP, Chief Development Officer01/18/2022229,063
Schneider EugeneEVP, Chf Clinical Develop Offc01/18/2022114,908
Swayze EricEVP Research01/18/2022150,419
Schneider EugeneEVP, Chf Clinical Develop Offc10/15/20215,089
Geary Richard SEVP, Chief Development Offc08/31/20211,555
O'NEIL PATRICK R.EVP Legal & General Counsel08/31/202110,443
Monia Brett PChief Executive Officer08/31/202111,998
HOUGEN ELIZABETH LEVP, Finance & CFO08/31/20215,610
Cadoret-Manier OnaizaChief Corp Dev and Cml Officer08/31/202114,566
BENNETT C FRANKEVP & Chief Scientific Officer08/31/20215,103
KLEIN JOSEPH IIIDirector07/15/2021152,989
BERTHELSEN SPENCER RDirector06/23/2021139,500
BERTHELSEN SPENCER RDirector06/23/2021566,100
MUTO FREDERICK TDirector06/15/2021139,500
MUTO FREDERICK TDirector06/15/2021549,500
Cadoret-Manier OnaizaChief Corp Dev and Cml Officer04/15/202180,419
Swayze EricEVP, Research02/26/202120,488
O'NEIL PATRICK R.EVP & General Counsel02/26/20218,774
HOUGEN ELIZABETH LEVP, Finance & CFO02/26/20215,167
Geary Richard SEVP, Chief Development Offc02/26/202118,440
Cadoret-Manier OnaizaChief Corp Dev and Cml Officer02/26/202121,914
BENNETT C FRANKChief Scientific Officer02/26/20214,988
Monia Brett PChief Executive Officer02/26/202111,001
Monia Brett PChief Executive Officer03/01/202112,809
Monia Brett PChief Executive Officer01/28/202179,261
CROOKE STANLEY TExec Chairman of the Board01/26/20211,805,812
O'NEIL PATRICK R.EVP & General Counsel01/25/2021338,074
CROOKE STANLEY TExec Chairman of the Board01/22/20212,467,000
CROOKE STANLEY TExec Chairman of the Board01/21/20212,142,117
CROOKE STANLEY TExec Chairman of the Board01/15/202187,876
CROOKE STANLEY TExec Chairman of the Board01/15/20211,159,663
BENNETT C FRANKChief Scientific Officer01/15/2021336,305
Geary Richard SEVP, Chief Development Offc01/15/2021392,069
HOUGEN ELIZABETH LEVP, Finance & CFO01/15/2021378,404
Monia Brett PChief Executive Officer01/15/2021914,727
O'NEIL PATRICK R.EVP & General Counsel01/15/2021358,856
PARSHALL B LYNNEDirector01/15/2021167,968
Schneider EugeneEVP, Chf Clinical Develop Offc01/15/2021166,559
Swayze EricEVP, Research01/15/2021197,076
Geary Richard SEVP, Chief Development Offc01/13/20218,390
Swayze EricEVP, Research01/05/202110,918
PARSHALL B LYNNEDirector12/23/2020600,000
CROOKE STANLEY TExec Chairman of the Board12/17/202071,054
CROOKE STANLEY TExec Chairman of the Board12/15/20201,941,225
CROOKE STANLEY TExec Chairman of the Board12/07/2020568,350
Monia Brett PChief Executive Officer12/04/2020950,501
Monia Brett PChief Executive Officer12/04/20201,216,794
BENNETT C FRANKChief Scientific Officer12/04/2020316,847
BENNETT C FRANKChief Scientific Officer12/04/2020405,615
BENNETT C FRANKChief Scientific Officer12/02/2020281,203
BENNETT C FRANKChief Scientific Officer12/02/2020361,960
Monia Brett PChief Executive Officer12/02/2020843,649
Monia Brett PChief Executive Officer12/02/20201,085,931
HOUGEN ELIZABETH LEVP, Finance & CFO11/25/2020864,382
HOUGEN ELIZABETH LEVP, Finance & CFO11/25/20201,085,084
CROOKE STANLEY TExec Chairman of the Board11/25/2020517,911
CROOKE STANLEY TExec Chairman of the Board11/25/2020650,149
Geary Richard SEVP, Development11/25/2020475,250
Geary Richard SEVP, Development11/25/2020596,596
PARSHALL B LYNNEDirector11/25/2020143,133
PARSHALL B LYNNEDirector11/25/2020179,679
CROOKE STANLEY TExec Chairman of the Board11/24/2020103,263
CROOKE STANLEY TExec Chairman of the Board11/23/2020462,492
CROOKE STANLEY TExec Chairman of the Board11/23/202019,935
CROOKE STANLEY TExec Chairman of the Board11/23/2020581,276
CROOKE STANLEY TExec Chairman of the Board11/23/202025,000
CROOKE STANLEY TExec Chairman of the Board11/24/2020131,650
HOUGEN ELIZABETH LEVP, Finance & CFO11/24/2020172,238
HOUGEN ELIZABETH LEVP, Finance & CFO11/23/2020757,530
HOUGEN ELIZABETH LEVP, Finance & CFO11/24/2020219,586
HOUGEN ELIZABETH LEVP, Finance & CFO11/23/2020952,090
Geary Richard SEVP, Development11/24/202094,891
Geary Richard SEVP, Development11/23/2020426,609
Geary Richard SEVP, Development11/24/2020120,975
Geary Richard SEVP, Development11/23/2020536,177
PARSHALL B LYNNEDirector11/24/202028,308
PARSHALL B LYNNEDirector11/23/2020127,584
PARSHALL B LYNNEDirector11/23/2020160,384
PARSHALL B LYNNEDirector11/24/202036,082
BENNETT C FRANKChief Scientific Officer11/03/2020598,050
BENNETT C FRANKChief Scientific Officer11/03/2020701,600
KLEIN JOSEPH IIIDirector10/20/2020135,386
CROOKE STANLEY TExec Chairman of the Board09/22/20202,520,460
CROOKE STANLEY TExec Chairman of the Board09/21/2020100,360
WENDER JOSEPH HDirector09/16/2020465,862
HOUGEN ELIZABETH LEVP, Finance & CFO08/31/20205,379
O'NEIL PATRICK R.EVP & General Counsel08/31/20207,513
Geary Richard SEVP, Development08/31/202044
Monia Brett PChief Executive Officer08/31/202010,491
Monia Brett PChief Executive Officer09/01/202016,862
BENNETT C FRANKChief Scientific Officer08/31/20204,979
Swayze EricEVP, Research08/31/202044
MUTO FREDERICK TDirector06/30/2020138,300
Castleman BreauxDirector06/25/2020266,600
Castleman BreauxDirector06/25/2020600,000
BENNETT C FRANKEVP, Chief Scientific Officer06/25/2020598,050
BENNETT C FRANKEVP, Chief Scientific Officer06/25/2020896,505
CROOKE STANLEY TExec Chairman of the Board06/25/2020595,907
CROOKE STANLEY TExec Chairman of the Board06/24/2020294,000
BERTHELSEN SPENCER RDirector06/23/2020138,300
BERTHELSEN SPENCER RDirector06/23/2020881,400
CROOKE STANLEY TExec Chairman of the Board06/19/2020583,250
CROOKE STANLEY TExec Chairman of the Board06/17/2020116,500
CROOKE STANLEY TExec Chairman of the Board06/17/2020868,521
CROOKE STANLEY TExec Chairman of the Board03/25/202047,000
CROOKE STANLEY TExec Chairman of the Board03/25/2020705,000
CROOKE STANLEY TExec Chairman of the Board03/17/2020895,000
CROOKE STANLEY TExec Chairman of the Board03/19/202045,000
CROOKE STANLEY TExec Chairman of the Board03/19/2020677,546
CROOKE STANLEY TExec Chairman of the Board03/17/2020912,355
Swayze EricSVP, Research02/29/202016,316
O'NEIL PATRICK R.SVP & General Counsel02/29/202012,474
Monia Brett PChief Executive Officer02/29/202013,553
HOUGEN ELIZABETH LSVP, Finance & CFO02/29/20206,345
Geary Richard SSVP, Development02/29/202016,316
BENNETT C FRANKChief Scientific Officer02/29/20207,295
O'NEIL PATRICK R.SVP & General Counsel02/10/2020231,367
Swayze EricSVP, Research01/15/2020146,896
PARSHALL B LYNNEDirector01/15/2020242,344
O'NEIL PATRICK R.SVP, Legal & General Counsel01/15/2020265,431
Monia Brett PChief Executive Officer01/15/2020469,360
HOUGEN ELIZABETH LSVP, Finance & CFO01/15/2020265,431
Geary Richard SSVP, Development01/15/2020288,827
CROOKE STANLEY TExecutive Chairman of Board01/15/202078,692
CROOKE STANLEY TExecutive Chairman of Board01/15/20201,076,245
BENNETT C FRANKChief Scientific Officer01/15/2020258,294
Monia Brett PChief Executive Officer01/02/202010,423
KLEIN JOSEPH IIIDirector12/23/201935,530
KLEIN JOSEPH IIIDirector12/23/201961,874
HOUGEN ELIZABETH LSVP, Finance & CFO12/20/2019383,208
HOUGEN ELIZABETH LSVP, Finance & CFO12/20/2019115,060
KLEIN JOSEPH IIIDirector12/16/201935,530
KLEIN JOSEPH IIIDirector12/16/201965,447
KLEIN JOSEPH IIIDirector12/09/201935,530
KLEIN JOSEPH IIIDirector12/09/201963,745
HOUGEN ELIZABETH LSVP, Finance & CFO12/04/201949,404
HOUGEN ELIZABETH LSVP, Finance & CFO12/04/2019296,790
Geary Richard SSVP, Development12/04/2019146,900
Geary Richard SSVP, Development12/04/2019650,000
KLEIN JOSEPH IIIDirector12/02/201935,530
KLEIN JOSEPH IIIDirector12/02/201964,083
Geary Richard SSVP, Development12/02/201973,450
Geary Richard SSVP, Development12/02/2019325,287
KLEIN JOSEPH IIIDirector11/25/201951,075
HOUGEN ELIZABETH LSVP, Finance & CFO11/25/201943,280
HOUGEN ELIZABETH LSVP, Finance & CFO11/25/2019250,000
KLEIN JOSEPH IIIDirector11/20/2019120,000
Monia Brett PCOO & SVP, Translational Med11/20/2019346,618
HOUGEN ELIZABETH LSVP, Finance & CFO11/19/201943,280
HOUGEN ELIZABETH LSVP, Finance & CFO11/19/2019235,200
CROOKE STANLEY TChairman and CEO08/20/201979,740
CROOKE STANLEY TChairman and CEO08/20/2019398,700
CROOKE STANLEY TChairman and CEO08/21/2019398,700
CROOKE STANLEY TChairman and CEO08/20/2019142,000
CROOKE STANLEY TChairman and CEO08/20/2019710,000
CROOKE STANLEY TChairman and CEO08/21/2019721,500
CROOKE STANLEY TChairman & CEO07/18/2019398,700
CROOKE STANLEY TChairman & CEO07/18/2019702,506
McDevitt DamienChief Business Officer07/15/201983,129
O'NEIL PATRICK R.SVP Legal & General Counsel07/01/20197,358
Monia Brett PChief Operating Officer07/01/20197,907
Monia Brett PChief Operating Officer07/02/201913,944
HOUGEN ELIZABETH LSVP Finance & CFO07/01/20194,799
Geary Richard SSVP, Development07/01/20196,444
BENNETT C FRANKSVP, Antisense Research07/01/20195,393
McDevitt DamienChief Business Officer07/01/201911,700
BERTHELSEN SPENCER RDirector06/24/2019244,800
BERTHELSEN SPENCER RDirector06/24/2019955,113
MUTO FREDERICK TDirector06/04/2019244,800
MUTO FREDERICK TDirector06/04/2019979,350
MUTO FREDERICK TDirector05/06/2019195,360
MUTO FREDERICK TDirector05/06/2019582,002
PARSHALL B LYNNEDirector04/29/20191,993,500
PARSHALL B LYNNEDirector04/29/20193,750,635
CROOKE STANLEY TChairman and CEO04/15/201910,820
CROOKE STANLEY TChairman and CEO04/15/2019146,900
CROOKE STANLEY TChairman and CEO04/16/201931,155
CROOKE STANLEY TChairman and CEO04/16/2019629,198
CROOKE STANLEY TChairman and CEO04/15/201985,250
CROOKE STANLEY TChairman and CEO04/15/2019852,500
CROOKE STANLEY TChairman and CEO04/16/201984,750
CROOKE STANLEY TChairman and CEO04/16/20191,692,500
Geary Richard SSVP, Development04/08/20191,966,466
Geary Richard SSVP, Development04/08/20193,884,753
O'NEIL PATRICK R.SVP Legal & General Counsel04/05/2019138,903
O'NEIL PATRICK R.SVP Legal & General Counsel04/04/20192,078,809
O'NEIL PATRICK R.SVP Legal & General Counsel04/03/2019472,099
O'NEIL PATRICK R.SVP Legal & General Counsel04/05/2019190,857
O'NEIL PATRICK R.SVP Legal & General Counsel04/04/20193,319,929
O'NEIL PATRICK R.SVP Legal & General Counsel04/03/2019649,289
O'NEIL PATRICK R.SVP Legal & General Counsel03/18/20191,773,216
O'NEIL PATRICK R.SVP Legal & General Counsel03/18/20192,269,187
WENDER JOSEPH HDirector03/19/2019796,258
PARSHALL B LYNNEDirector03/12/2019332,277
PARSHALL B LYNNEDirector03/12/2019625,050
PARSHALL B LYNNEDirector02/27/2019332,237
PARSHALL B LYNNEDirector02/27/2019583,310
O'NEIL PATRICK R.SVP Legal & General Counsel02/27/20191,208,952
O'NEIL PATRICK R.SVP Legal & General Counsel02/27/20191,822,580
CROOKE STANLEY TChairman and CEO02/26/20191,475,190
CROOKE STANLEY TChairman and CEO02/25/20191,594,800
CROOKE STANLEY TChairman and CEO02/26/20192,276,799
CROOKE STANLEY TChairman and CEO02/25/20192,402,700
O'NEIL PATRICK R.SVP Legal & General Counsel02/12/201910,964
O'NEIL PATRICK R.SVP Legal & General Counsel02/12/201916,363
CROOKE STANLEY TChairman and CEO02/13/2019228,666
CROOKE STANLEY TChairman and CEO02/13/20191,594,800
CROOKE STANLEY TChairman and CEO02/13/20192,404,028
CROOKE STANLEY TChairman and CEO02/13/2019414,240
Geary Richard SSVP, Development02/13/201959,940
O'NEIL PATRICK R.SVP Legal & General Counsel02/05/2019621,972
O'NEIL PATRICK R.SVP Legal & General Counsel02/01/2019159,480
O'NEIL PATRICK R.SVP Legal & General Counsel02/05/2019928,200
O'NEIL PATRICK R.SVP Legal & General Counsel02/01/2019233,160
BENNETT C FRANKSVP, Antisense Research02/01/2019132,401
BENNETT C FRANKSVP, Antisense Research02/01/2019525,368
BENNETT C FRANKSVP, Antisense Research01/15/2019164,177
Geary Richard SSVP, Development01/15/2019169,420
HOUGEN ELIZABETH LSVP Finance & CFO01/15/2019165,575
Monia Brett PChief Operating Officer01/15/2019208,105
CROOKE STANLEY TChairman and CEO01/15/201954,881
CROOKE STANLEY TChairman and CEO01/15/2019739,086
O'NEIL PATRICK R.SVP Legal & General Counsel01/15/2019159,283
PARSHALL B LYNNEDirector01/15/2019358,823
O'NEIL PATRICK R.SVP Legal & General Counsel01/01/20192,406
O'NEIL PATRICK R.SVP Legal & General Counsel01/03/2019163,808
O'NEIL PATRICK R.SVP Legal & General Counsel01/03/2019241,120
HOUGEN ELIZABETH LSVP Finance & CFO01/01/20194,629
Monia Brett PChief Operating Officer01/01/20197,654
Monia Brett PChief Operating Officer01/02/201911,449
Geary Richard SSVP, Development01/01/201914,834
BENNETT C FRANKSVP, Antisense Research01/01/20194,665
HOUGEN ELIZABETH LSVP, Finance & CFO12/19/201814,957
HOUGEN ELIZABETH LSVP, Finance & CFO12/18/201814,500
HOUGEN ELIZABETH LSVP, Finance & CFO12/19/2018107,379
HOUGEN ELIZABETH LSVP, Finance & CFO12/18/2018104,000
Monia Brett PChief Operating Officer11/23/2018499,460
Monia Brett PChief Operating Officer11/23/20181,870,058
BENNETT C FRANKSVP, Antisense Research11/01/2018183,625
BENNETT C FRANKSVP, Antisense Research11/01/2018619,245
Monia Brett PChief Operating Officer08/27/2018119,274
Monia Brett PChief Operating Officer08/27/2018890,622
BENNETT C FRANKSVP, Antisense Research08/08/2018183,528
BENNETT C FRANKSVP, Antisense Research08/08/2018562,500
Monia Brett PChief Operating Officer07/24/20187,337
WENDER JOSEPH HDirector07/17/2018277,800
BENNETT C FRANKSVP, Antisense Research07/01/20189,988
Geary Richard SSVP, Development07/01/20186,269
HOUGEN ELIZABETH LSVP Finance & CFO07/01/20189,705
Monia Brett PChief Operating Officer07/01/20187,580
O'NEIL PATRICK R.SVP Legal & General Counsel07/01/20182,338
BERTHELSEN SPENCER RDirector06/25/2018208,200
BERTHELSEN SPENCER RDirector06/25/2018634,542
MUTO FREDERICK TDirector05/31/2018208,200
MUTO FREDERICK TDirector05/31/2018696,750
BENNETT C FRANKSVP, Antisense Research05/11/201890,625
BENNETT C FRANKSVP, Antisense Research05/11/2018562,500
WENDER JOSEPH HDirector05/11/2018208,200
WENDER JOSEPH HDirector05/11/2018679,614
CROOKE STANLEY TChairman and CEO04/17/201843,280
CROOKE STANLEY TChairman and CEO04/17/2018146,342
CROOKE STANLEY TChairman and CEO04/17/2018177,600
CROOKE STANLEY TChairman and CEO04/17/2018442,313
KLEIN JOSEPH IIIDirector03/29/201848,840
KLEIN JOSEPH IIIDirector03/29/201892,300
KLEIN JOSEPH IIIDirector03/15/201848,840
KLEIN JOSEPH IIIDirector03/15/2018102,258
O'NEIL PATRICK R.SVP Legal & General Counsel03/12/201810,820
O'NEIL PATRICK R.SVP Legal & General Counsel03/12/201855,000
KLEIN JOSEPH IIIDirector02/28/2018106,590
KLEIN JOSEPH IIIDirector02/28/2018155,727
KLEIN JOSEPH IIIDirector02/15/2018106,590
KLEIN JOSEPH IIIDirector02/15/2018146,984
BENNETT C FRANKSVP, Antisense Research02/01/201890,625
BENNETT C FRANKSVP, Antisense Research02/01/2018656,260
KLEIN JOSEPH IIIDirector01/30/2018106,590
KLEIN JOSEPH IIIDirector01/30/2018158,580
O'NEIL PATRICK R.SVP Legal & General Counsel01/29/20183,841
O'NEIL PATRICK R.SVP Legal & General Counsel01/29/201819,525
CROOKE STANLEY TChairman and CEO01/29/201810,820
CROOKE STANLEY TChairman and CEO01/29/2018146,900
CROOKE STANLEY TChairman and CEO01/29/2018541,200
CROOKE STANLEY TChairman and CEO01/29/201854,120
O'NEIL PATRICK R.SVP Legal & General Counsel01/25/20186,979
O'NEIL PATRICK R.SVP Legal & General Counsel01/25/201835,475
HOUGEN ELIZABETH LSVP, Finance & CFO01/16/2018140,994
KLEIN JOSEPH IIIDirector01/16/2018106,590
KLEIN JOSEPH IIIDirector01/16/2018157,566
Geary Richard SSVP, Development01/16/2018140,942
PARSHALL B LYNNEDirector01/16/2018309,835
O'NEIL PATRICK R.SVP, Legal & General Counsel01/16/2018139,597
Boyce SarahChief Business Officer01/16/2018113,665
BENNETT C FRANKSVP, Antisense Research01/16/2018139,545
CROOKE STANLEY TChairman and CEO01/15/201833,955
CROOKE STANLEY TChairman and CEO01/15/2018822,622
Monia Brett PCOO01/16/2018146,015
CROOKE STANLEY TChairman and CEO01/08/201810,820
CROOKE STANLEY TChairman and CEO01/08/2018146,900
CROOKE STANLEY TChairman and CEO01/08/201852,010
CROOKE STANLEY TChairman and CEO01/08/2018520,100
CROOKE STANLEY TChairman and CEO01/03/201818,413
CROOKE STANLEY TChairman and CEO01/03/2018293,800
CROOKE STANLEY TChairman and CEO01/03/20181,000,400
CROOKE STANLEY TChairman and CEO01/03/201899,760
PARSHALL B LYNNECOO01/01/20183,677
O'NEIL PATRICK R.SVP, Legal & General Counsel01/01/20182,266
Monia Brett PSVP, Antisense Drug Discovery01/01/20186,670
Monia Brett PSVP, Antisense Drug Discovery01/02/20188,150
HOUGEN ELIZABETH LSVP, Finance & CFO01/01/20184,276
Geary Richard SSVP, Development01/01/201813,682
Boyce SarahChief Business Officer01/01/201820,993
BENNETT C FRANKSVP, Antisense Research01/01/20184,532
KLEIN JOSEPH IIIDirector12/29/201785,410
KLEIN JOSEPH IIIDirector12/29/2017151,680
KLEIN JOSEPH IIIDirector12/15/201785,410
KLEIN JOSEPH IIIDirector12/15/2017155,070
HOUGEN ELIZABETH LSVP, Finance & CFO12/15/201751,450
HOUGEN ELIZABETH LSVP, Finance & CFO12/15/2017262,750
HOUGEN ELIZABETH LSVP, Finance & CFO12/04/201741,160
HOUGEN ELIZABETH LSVP, Finance & CFO12/04/2017228,000
HOUGEN ELIZABETH LSVP, Finance & CFO11/29/201761,740
HOUGEN ELIZABETH LSVP, Finance & CFO11/29/2017318,120
KLEIN JOSEPH IIIDirector11/30/201785,410
KLEIN JOSEPH IIIDirector11/30/2017160,650
O'NEIL PATRICK R.SVP, Legal & General Counsel12/01/201710,820
O'NEIL PATRICK R.SVP, Legal & General Counsel12/01/201755,500
HOUGEN ELIZABETH LSVP, Finance & CFO11/16/201772,030
HOUGEN ELIZABETH LSVP, Finance & CFO11/16/2017380,450
KLEIN JOSEPH IIIDirector11/16/201736,387
KLEIN JOSEPH IIIDirector11/15/201764,057
KLEIN JOSEPH IIIDirector11/15/2017120,510
KLEIN JOSEPH IIIDirector11/13/2017166,170
O'NEIL PATRICK R.SVP, Legal & General Counsel11/01/201710,820
O'NEIL PATRICK R.SVP, Legal & General Counsel11/01/201758,350
BENNETT C FRANKSVP, Antisense Research10/18/2017126,052
BENNETT C FRANKSVP, Antisense Research10/18/2017796,250
PARSHALL B LYNNECOO10/18/2017446,598
PARSHALL B LYNNECOO10/18/20171,047,670
CROOKE STANLEY TChairman and CEO10/13/2017220,350
CROOKE STANLEY TChairman and CEO10/13/201710,875
CROOKE STANLEY TChairman and CEO10/13/2017891,900
CROOKE STANLEY TChairman and CEO10/13/201789,190
Geary Richard SSVP, Development10/13/201755,387
Geary Richard SSVP, Development10/13/2017496,080
O'NEIL PATRICK R.SVP, Legal & General Counsel10/05/201710,106
O'NEIL PATRICK R.SVP, Legal & General Counsel10/05/201755,000
CROOKE STANLEY TChairman and CEO10/02/2017220,350
CROOKE STANLEY TChairman and CEO10/04/20177,250
CROOKE STANLEY TChairman and CEO10/04/2017146,900
CROOKE STANLEY TChairman and CEO10/02/201710,875
CROOKE STANLEY TChairman and CEO10/04/2017542,250
CROOKE STANLEY TChairman and CEO10/02/201778,000
CROOKE STANLEY TChairman and CEO10/02/2017780,000
CROOKE STANLEY TChairman and CEO10/04/201754,225
O'NEIL PATRICK R.SVP, Legal and General Counsel09/06/20175,800
O'NEIL PATRICK R.SVP, Legal and General Counsel09/05/20171,450
O'NEIL PATRICK R.SVP, Legal and General Counsel09/06/201744,000
O'NEIL PATRICK R.SVP, Legal and General Counsel09/05/201711,000
BENNETT C FRANKSVP, Antisense Research07/24/2017102,900
BENNETT C FRANKSVP, Antisense Research07/24/2017592,900
CROOKE STANLEY TChairman and CEO07/20/20177,250
CROOKE STANLEY TChairman and CEO07/20/2017146,900
CROOKE STANLEY TChairman and CEO07/20/201755,350
CROOKE STANLEY TChairman and CEO07/20/2017553,500
CROOKE STANLEY TChairman and CEO07/17/2017220,350
CROOKE STANLEY TChairman and CEO07/17/201710,875
CROOKE STANLEY TChairman and CEO07/17/2017786,750
CROOKE STANLEY TChairman and CEO07/17/201778,675
Monia Brett PSVP, Antisense Drug Discovery07/01/20176,627
Monia Brett PSVP, Antisense Drug Discovery07/03/201715,867
PARSHALL B LYNNECOO07/01/20173,659
O'NEIL PATRICK R.SVP, Legal & General Counsel07/01/20175,448
HOUGEN ELIZABETH LSVP, Finance & CFO07/01/20174,228
Geary Richard SSVP, Development07/01/20177,968
Boyce SarahChief Business Officer07/01/2017691
BENNETT C FRANKSVP, Antisense Research07/01/201710,286
CROOKE STANLEY TChairman and CEO07/03/2017120,193
CROOKE STANLEY TChairman and CEO07/03/201710,875
CROOKE STANLEY TChairman and CEO07/03/201778,150
CROOKE STANLEY TChairman and CEO07/03/2017781,538
MUTO FREDERICK TDirector05/31/2017122,125
MUTO FREDERICK TDirector05/31/2017565,250
O'NEIL PATRICK R.SVP, Legal & General Counsel06/01/2017757
O'NEIL PATRICK R.SVP, Legal & General Counsel06/01/20173,360
O'NEIL PATRICK R.SVP, Legal & General Counsel05/01/20175,410
O'NEIL PATRICK R.SVP, Legal & General Counsel05/01/201731,688
CROOKE STANLEY TChairman and CEO04/25/201710,875
CROOKE STANLEY TChairman and CEO04/25/2017108,750
CROOKE STANLEY TChairman and CEO04/25/201771,715
CROOKE STANLEY TChairman and CEO04/25/2017717,150
O'NEIL PATRICK R.SVP, Legal & General Counsel04/24/20175,410
O'NEIL PATRICK R.SVP, Legal & General Counsel04/24/201722,500
CROOKE STANLEY TChairman and CEO04/19/20173,625
CROOKE STANLEY TChairman and CEO04/19/201736,250
CROOKE STANLEY TChairman and CEO04/19/201721,625
CROOKE STANLEY TChairman and CEO04/19/2017216,250
O'NEIL PATRICK R.SVP, Legal & General Counsel04/12/201740,070
CROOKE STANLEY TChairman and CEO04/13/201772,500
CROOKE STANLEY TChairman and CEO04/12/201710,290
CROOKE STANLEY TChairman and CEO04/12/201772,500
CROOKE STANLEY TChairman and CEO04/13/20178,770
CROOKE STANLEY TChairman and CEO04/13/2017413,000
CROOKE STANLEY TChairman and CEO04/12/201740,070
CROOKE STANLEY TChairman and CEO04/12/2017400,700
CROOKE STANLEY TChairman and CEO04/13/201741,300
BENNETT C FRANKSVP, Antisense Research03/03/201751,450
BENNETT C FRANKSVP, Antisense Research03/03/2017275,000
CROOKE STANLEY TChairman and CEO03/02/201711,319
CROOKE STANLEY TChairman and CEO03/02/201779,750
CROOKE STANLEY TChairman and CEO03/02/201756,155
CROOKE STANLEY TChairman and CEO03/02/2017561,550
PARSHALL B LYNNECOO03/01/201767,941
PARSHALL B LYNNECOO03/01/2017227,827
O'NEIL PATRICK R.SVP, Legal & General Counsel03/01/20175,410
O'NEIL PATRICK R.SVP, Legal & General Counsel03/01/201773,935
BERTHELSEN SPENCER RDirector02/24/2017122,125
O'NEIL PATRICK R.SVP, Legal & General Counsel02/06/20175,342
O'NEIL PATRICK R.SVP, Legal & General Counsel02/06/201769,254
Boyce SarahChief Business Officer01/17/201763,001
Monia Brett PSVP, Antisense Drug Discovery01/17/2017115,819
O'NEIL PATRICK R.SVP, Legal & General Counsel01/17/2017103,968
BENNETT C FRANKSVP, Antisense Research01/17/2017112,069
CROOKE STANLEY TChairman and CEO01/17/201726,617
CROOKE STANLEY TChairman and CEO01/17/2017712,026
PARSHALL B LYNNECOO01/17/2017335,414
HOUGEN ELIZABETH LSVP, Finance & CFO01/17/2017105,218
Geary Richard SSVP, Development01/17/2017112,996
CROOKE STANLEY TChairman and CEO01/10/201712,348
CROOKE STANLEY TChairman and CEO01/10/201787,000
CROOKE STANLEY TChairman and CEO01/10/201759,100
CROOKE STANLEY TChairman and CEO01/10/2017591,000
CROOKE STANLEY TChairman and CEO01/03/201772,500
CROOKE STANLEY TChairman and CEO01/04/20177,203
CROOKE STANLEY TChairman and CEO01/04/201750,750
CROOKE STANLEY TChairman and CEO01/03/201710,290
CROOKE STANLEY TChairman and CEO01/04/201735,070
CROOKE STANLEY TChairman and CEO01/04/2017350,700
CROOKE STANLEY TChairman and CEO01/03/201748,050
CROOKE STANLEY TChairman and CEO01/03/2017480,500
Boyce SarahChief Business Officer01/01/201720,591
Monia Brett PSVP, Antisense Drug Discovery01/01/20176,414
Monia Brett PSVP, Antisense Drug Discovery01/03/201715,017
O'NEIL PATRICK R.SVP, Legal & General Counsel01/01/20178,801
HOUGEN ELIZABETH LSVP, Finance & CFO01/01/20174,131
BENNETT C FRANKSVP, Antisense Research01/01/20174,380
PARSHALL B LYNNECOO01/01/20173,549
Geary Richard SSVP, Development01/01/201713,284
Monia Brett PSVP, Antisense Drug Discovery12/20/20166,822
PARSHALL B LYNNECOO12/15/20167,250
PARSHALL B LYNNECOO12/15/201614,500
PARSHALL B LYNNECOO12/15/20167,250
PARSHALL B LYNNECOO12/15/2016100,000
PARSHALL B LYNNECOO12/15/201650,000
PARSHALL B LYNNECOO12/15/201650,000
HOUGEN ELIZABETH LSVP, Finance & CFO12/05/201628,175
HOUGEN ELIZABETH LSVP, Finance & CFO12/05/2016115,125
O'NEIL PATRICK R.SVP, Legal & General Counsel12/05/20163,787
O'NEIL PATRICK R.SVP, Legal & General Counsel12/05/201615,750
PARSHALL B LYNNECOO12/01/2016183,625
PARSHALL B LYNNECOO12/01/2016527,865
O'NEIL PATRICK R.SVP, Legal & General Counsel11/14/201610,820
O'NEIL PATRICK R.SVP, Legal & General Counsel11/14/201645,000
HOUGEN ELIZABETH LSVP, Finance & CFO11/11/201628,175
HOUGEN ELIZABETH LSVP, Finance & CFO11/09/201628,175
HOUGEN ELIZABETH LSVP, Finance & CFO11/11/2016102,500
HOUGEN ELIZABETH LSVP, Finance & CFO11/09/201696,225
CROOKE STANLEY TChairman and CEO11/10/201672,500
CROOKE STANLEY TChairman and CEO11/09/201620,580
CROOKE STANLEY TChairman and CEO11/09/2016194,427
CROOKE STANLEY TChairman and CEO11/10/201610,290
CROOKE STANLEY TChairman and CEO11/10/2016402,300
CROOKE STANLEY TChairman and CEO11/09/201672,350
CROOKE STANLEY TChairman and CEO11/09/2016727,996
CROOKE STANLEY TChairman and CEO11/10/201642,220
BENNETT C FRANKSVP, Antisense Research11/09/2016257,012
BENNETT C FRANKSVP, Antisense Research11/09/2016856,605
BENNETT C FRANKSVP, Antisense Research11/07/201656,350
BENNETT C FRANKSVP, Antisense Research11/07/2016170,000
CROOKE STANLEY TChairman and CEO10/05/201610,290
CROOKE STANLEY TChairman and CEO10/05/2016102,900
CROOKE STANLEY TChairman and CEO10/05/201636,610
CROOKE STANLEY TChairman and CEO10/05/2016366,100
CROOKE STANLEY TChairman and CEO09/27/201620,580
CROOKE STANLEY TChairman and CEO09/27/2016205,800
CROOKE STANLEY TChairman and CEO09/27/2016720,400
CROOKE STANLEY TChairman and CEO09/27/201672,100
CROOKE STANLEY TChairman and CEO09/21/2016205,800
CROOKE STANLEY TChairman and CEO09/21/201620,580
CROOKE STANLEY TChairman and CEO09/21/201671,000
CROOKE STANLEY TChairman and CEO09/21/2016710,000
PARSHALL B LYNNECOO09/01/2016117,669
PARSHALL B LYNNECOO09/01/2016373,545
PARSHALL B LYNNECOO07/01/20168,365
O'NEIL PATRICK R.SVP, Legal & General Counsel07/01/20168,344
Monia Brett PSVP, Antisense Drug Discovery07/01/20166,414
HOUGEN ELIZABETH LSVP, Finance & CFO07/01/20164,504
Geary Richard SSVP, Development07/01/20163,383
Boyce SarahChief Business Officer07/01/20168,365
BENNETT C FRANKSVP, Antisense Research07/01/20164,421
MUTO FREDERICK TDirector05/31/201674,125
MUTO FREDERICK TDirector05/31/2016278,900
O'NEIL PATRICK R.SVP, Legal & General Counsel04/06/201610,820
O'NEIL PATRICK R.SVP, Legal & General Counsel04/06/201645,000
CROOKE STANLEY TChairman and CEO04/06/201610,290
CROOKE STANLEY TChairman and CEO04/06/2016102,900
CROOKE STANLEY TChairman and CEO04/06/2016461,250
CROOKE STANLEY TChairman and CEO04/06/201646,125
CROOKE STANLEY TChairman and CEO03/31/2016102,900
CROOKE STANLEY TChairman and CEO03/31/20169,755
CROOKE STANLEY TChairman and CEO03/31/2016407,350
CROOKE STANLEY TChairman and CEO03/31/201640,735
O'NEIL PATRICK R.SVP, Legal & General Counsel03/23/201610,820
O'NEIL PATRICK R.SVP, Legal & General Counsel03/23/201645,400
BERTHELSEN SPENCER RDirector02/19/201674,125
CROOKE STANLEY TChairman and CEO01/19/201623,882
CROOKE STANLEY TChairman and CEO01/19/2016531,716
HOUGEN ELIZABETH LSVP, Finance & CFO01/19/201678,742
O'NEIL PATRICK R.SVP, Legal & General Counsel01/19/201677,574
PARSHALL B LYNNECOO & Secretary01/19/2016215,257
Geary Richard SSVP, Development01/19/201689,634
Monia Brett PSVP, Antisense Drug Discovery01/19/201691,541
Boyce SarahChief Business Officer01/19/201636,151
BENNETT C FRANKSVP, Antisense Research01/19/201687,474
CROOKE STANLEY TChairman and CEO01/05/20164,610
CROOKE STANLEY TChairman and CEO01/05/201651,450
CROOKE STANLEY TChairman and CEO01/05/201631,050
CROOKE STANLEY TChairman and CEO01/05/2016310,500
PARSHALL B LYNNECOO & Secretary01/01/20163,435
PARSHALL B LYNNECOO & Secretary01/04/201611,884
PARSHALL B LYNNECOO & Secretary01/04/201649,389
O'NEIL PATRICK R.SVP, Legal & General Counsel01/01/20162,052
O'NEIL PATRICK R.SVP, Legal & General Counsel01/04/20167,793
O'NEIL PATRICK R.SVP, Legal & General Counsel01/04/201661,100
Monia Brett PSVP, Antisense Drug Discovery01/01/20166,202
Monia Brett PSVP, Antisense Drug Discovery01/04/20167,747
HOUGEN ELIZABETH LSVP, Finance & CFO01/01/20161,956
Geary Richard SSVP, Development01/01/201612,834
CROOKE STANLEY TChairman and CEO01/04/2016102,900
CROOKE STANLEY TChairman and CEO01/04/20169,220
CROOKE STANLEY TChairman and CEO01/04/201661,050
CROOKE STANLEY TChairman and CEO01/04/2016610,500
Boyce SarahChief Business Officer01/01/201619,991
BENNETT C FRANKSVP, Antisense Research01/01/20164,246
BENNETT C FRANKSVP, Antisense Research12/15/201557,880
BENNETT C FRANKSVP, Antisense Research12/16/201556,563
BENNETT C FRANKSVP, Antisense Research12/16/2015230,045
BENNETT C FRANKSVP, Antisense Research12/15/2015224,000
O'NEIL PATRICK R.SVP, Legal & General Counsel12/01/20157,250
O'NEIL PATRICK R.SVP, Legal & General Counsel12/01/201561,500
BENNETT C FRANKSVP, Antisense Research11/10/201572,350
BENNETT C FRANKSVP, Antisense Research11/10/2015320,000
KLEIN JOSEPH IIIDirector11/11/201575,312
KLEIN JOSEPH IIIDirector11/11/2015441,234
BENNETT C FRANKSVP, Antisense Research11/06/201572,350
BENNETT C FRANKSVP, Antisense Research11/06/2015280,000
O'NEIL PATRICK R.SVP, Legal & General Counsel11/03/20157,250
O'NEIL PATRICK R.SVP, Legal & General Counsel11/03/201551,950
CROOKE STANLEY TChairman and CEO10/21/201515,880
CROOKE STANLEY TChairman and CEO10/21/2015169,050
CROOKE STANLEY TChairman and CEO10/23/201523,050
CROOKE STANLEY TChairman and CEO10/23/2015261,330
CROOKE STANLEY TChairman and CEO10/21/2015645,000
CROOKE STANLEY TChairman and CEO10/23/2015111,000
CROOKE STANLEY TChairman and CEO10/23/20151,108,855
CROOKE STANLEY TChairman and CEO10/21/201564,500
PARSHALL B LYNNECOO & Secretary10/01/201571,865
PARSHALL B LYNNECOO & Secretary10/02/201579,855
PARSHALL B LYNNECOO & Secretary10/01/2015280,880
PARSHALL B LYNNECOO & Secretary10/02/2015225,867
PARSHALL B LYNNECOO & Secretary07/06/201549,260
PARSHALL B LYNNECOO & Secretary07/06/2015354,470
CROOKE STANLEY TChairman and CEO07/06/201556,350
CROOKE STANLEY TChairman and CEO07/06/201510,834
CROOKE STANLEY TChairman and CEO07/06/2015285,035
CROOKE STANLEY TChairman and CEO07/06/201566,983
PARSHALL B LYNNECOO & Secretary07/01/20153,450
PARSHALL B LYNNECOO & Secretary07/01/201563,983
PARSHALL B LYNNECOO & Secretary07/01/2015357,914
O'NEIL PATRICK R.SVP, Legal & General Counsel07/01/20154,130
Monia Brett PSVP, Antisense Drug Discovery07/01/20156,170
Monia Brett PSVP, Antisense Drug Discovery07/02/201511,147
HOUGEN ELIZABETH LSVP, Finance & CFO07/01/20151,943
Geary Richard SSVP, Development07/01/201512,875
CROOKE STANLEY TChairman and CEO07/01/201556,350
CROOKE STANLEY TChairman and CEO07/01/201510,834
CROOKE STANLEY TChairman and CEO07/01/201567,634
CROOKE STANLEY TChairman and CEO07/01/2015287,805
BENNETT C FRANKSVP, Antisense Research07/01/20154,227
Monia Brett PSVP, Antisense Drug Discovery06/08/201578,204
Monia Brett PSVP, Antisense Drug Discovery06/08/2015503,280
MUTO FREDERICK TDirector06/01/201539,500
MUTO FREDERICK TDirector06/01/2015669,110
BERTHELSEN SPENCER RDirector04/17/201539,500
PARSHALL B LYNNECOO & Secretary04/07/201581,750
PARSHALL B LYNNECOO & Secretary04/07/2015350,990
CROOKE STANLEY TChairman and CEO04/07/201518,753
CROOKE STANLEY TChairman and CEO04/07/2015229,266
CROOKE STANLEY TChairman and CEO04/07/2015128,286
CROOKE STANLEY TChairman and CEO04/07/20151,283,053
PARSHALL B LYNNECOO & Secretary04/01/201578,988
PARSHALL B LYNNECOO & Secretary04/01/2015333,009
CROOKE STANLEY TChairman and CEO04/01/201518,127
CROOKE STANLEY TChairman and CEO04/01/2015221,534
CROOKE STANLEY TChairman and CEO04/01/2015121,759
CROOKE STANLEY TChairman and CEO04/01/20151,217,399
BENNETT C FRANKSVP, Antisense Research03/24/2015130,230
BENNETT C FRANKSVP, Antisense Research03/23/201586,820
BENNETT C FRANKSVP, Antisense Research03/24/2015639,090
BENNETT C FRANKSVP, Antisense Research03/23/2015420,020
HOUGEN ELIZABETH LSVP, Finance & CFO03/19/2015112,700
HOUGEN ELIZABETH LSVP, Finance & CFO03/19/2015733,260
WENDER JOSEPH HDirector03/18/201574,125
WENDER JOSEPH HDirector03/18/2015892,586
Geary Richard SSVP, Development03/19/2015117,520
Geary Richard SSVP, Development03/19/2015600,032
O'NEIL PATRICK R.SVP, Legal & General Counsel03/19/2015690,416
O'NEIL PATRICK R.SVP, Legal & General Counsel03/19/20152,284,757
Geary Richard SSVP, Development03/05/2015133,972
Geary Richard SSVP, Development03/05/20151,287,382
HOUGEN ELIZABETH LSVP, Finance & CFO03/05/2015295,065
HOUGEN ELIZABETH LSVP, Finance & CFO03/05/20152,010,823
O'NEIL PATRICK R.SVP, Legal & General Counsel03/05/201555,865
O'NEIL PATRICK R.SVP, Legal & General Counsel03/05/2015415,674
WENDER JOSEPH HDirector03/05/2015122,125
WENDER JOSEPH HDirector03/05/2015895,174
KLEIN JOSEPH IIIDirector03/05/2015101,800
KLEIN JOSEPH IIIDirector03/05/2015496,681
WENDER JOSEPH HDirector03/02/2015461,785
WENDER JOSEPH HDirector02/12/201539,500
WENDER JOSEPH HDirector02/12/2015621,460
CROOKE STANLEY TChairman and CEO01/27/2015112,700
CROOKE STANLEY TChairman and CEO01/27/20159,220
CROOKE STANLEY TChairman and CEO01/27/2015729,260
CROOKE STANLEY TChairman and CEO01/27/201572,926
CROOKE STANLEY TChairman and CEO01/16/201528,341
CROOKE STANLEY TChairman and CEO01/16/2015587,007
PARSHALL B LYNNECOO & Secretary01/16/2015278,177
Monia Brett PSVP, Antisense Drug Discovery01/16/2015104,257
HOUGEN ELIZABETH LSVP, Finance & CFO01/16/201587,742
O'NEIL PATRICK R.SVP, Legal & General Counsel01/16/201587,742
BENNETT C FRANKSVP, Antisense Research01/16/2015103,169
Geary Richard SSVP, Development01/16/2015104,868
CROOKE STANLEY TChairman and CEO01/09/20159,220
CROOKE STANLEY TChairman and CEO01/09/2015112,700
CROOKE STANLEY TChairman and CEO01/09/201573,570
CROOKE STANLEY TChairman and CEO01/09/2015735,700
Geary Richard SSVP, Development01/12/201543,641
CROOKE STANLEY TChairman and CEO01/06/2015112,700
CROOKE STANLEY TChairman and CEO01/07/20159,220
CROOKE STANLEY TChairman and CEO01/07/2015112,700
CROOKE STANLEY TChairman and CEO01/06/20159,220
CROOKE STANLEY TChairman and CEO01/06/2015660,380
CROOKE STANLEY TChairman and CEO01/07/201568,048
CROOKE STANLEY TChairman and CEO01/07/2015680,480
CROOKE STANLEY TChairman and CEO01/06/201566,038
PARSHALL B LYNNECOO & Secretary01/01/20153,335
PARSHALL B LYNNECOO & Secretary01/02/2015164,528
PARSHALL B LYNNECOO & Secretary01/02/2015695,688
O'NEIL PATRICK R.SVP, Legal & General Counsel01/01/20159,886
O'NEIL PATRICK R.SVP, Legal & General Counsel01/02/201515,220
O'NEIL PATRICK R.SVP, Legal & General Counsel01/02/201593,173
HOUGEN ELIZABETH LSVP, Finance & CFO01/01/20151,893
BENNETT C FRANKSVP, Antisense Research01/01/20154,086
Geary Richard SSVP, Development01/01/20158,203
Monia Brett PSVP, Antisense Drug Discovery01/01/20155,949
Monia Brett PSVP, Antisense Drug Discovery01/02/20154,769
O'NEIL PATRICK R.SVP, Legal & General Counsel12/01/201410,875
O'NEIL PATRICK R.SVP, Legal & General Counsel12/01/201476,815
O'NEIL PATRICK R.SVP, Legal & General Counsel11/03/201410,875
O'NEIL PATRICK R.SVP, Legal & General Counsel11/03/201469,255
PARSHALL B LYNNECOO & Secretary10/30/201498,939
PARSHALL B LYNNECOO & Secretary10/30/2014499,535
CROOKE STANLEY TChairman and CEO10/23/201414,752
CROOKE STANLEY TChairman and CEO10/23/2014156,110
CROOKE STANLEY TChairman and CEO10/23/2014548,860
CROOKE STANLEY TChairman and CEO10/23/201467,552
CROOKE STANLEY TChairman and CEO10/03/2014188,110
CROOKE STANLEY TChairman and CEO10/01/201420,900
CROOKE STANLEY TChairman and CEO10/01/2014289,400
CROOKE STANLEY TChairman and CEO10/03/20149,220
CROOKE STANLEY TChairman and CEO10/01/201475,822
CROOKE STANLEY TChairman and CEO10/01/2014758,220
CROOKE STANLEY TChairman and CEO10/03/201439,487
CROOKE STANLEY TChairman and CEO10/03/2014513,331
O'NEIL PATRICK R.SVP, Legal & General Counsel10/01/201411,583
O'NEIL PATRICK R.SVP, Legal & General Counsel10/01/201457,060
O'NEIL PATRICK R.SVP, Legal and General Counsel09/02/201415,435
O'NEIL PATRICK R.SVP, Legal and General Counsel09/02/201460,660
PARSHALL B LYNNECOO09/02/2014112,574
PARSHALL B LYNNECOO09/02/2014445,507
BENNETT C FRANKSVP, Antisense Research08/27/201476,900
BENNETT C FRANKSVP, Antisense Research08/27/2014202,630
Monia Brett PSVP, Antisense Drug Discovery08/26/2014253,267
Monia Brett PSVP, Antisense Drug Discovery08/26/20141,043,010
CROOKE STANLEY TChairman, President and CEO08/13/201418,032
CROOKE STANLEY TChairman, President and CEO08/13/2014224,285
CROOKE STANLEY TChairman, President and CEO08/13/201456,726
CROOKE STANLEY TChairman, President and CEO08/13/2014549,537
O'NEIL PATRICK R.SVP, Legal and General Counsel08/11/20147,203
O'NEIL PATRICK R.SVP, Legal and General Counsel08/12/20148,232
O'NEIL PATRICK R.SVP, Legal and General Counsel08/11/201424,500
O'NEIL PATRICK R.SVP, Legal and General Counsel08/12/201428,000
CROOKE STANLEY TChairman, President and CEO08/01/201411,270
CROOKE STANLEY TChairman, President and CEO08/01/2014217,050
CROOKE STANLEY TChairman, President and CEO08/01/201430,525
CROOKE STANLEY TChairman, President and CEO08/01/2014457,875
Monia Brett PSVP, Antisense Drug Discovery07/31/20142,489
O'NEIL PATRICK R.SVP, Legal & General Counsel07/01/201412,171
O'NEIL PATRICK R.SVP, Legal & General Counsel07/01/201415,435
O'NEIL PATRICK R.SVP, Legal & General Counsel07/01/201453,000
CROOKE STANLEY TChairman and CEO07/01/201423,180
CROOKE STANLEY TChairman and CEO07/01/2014224,285
CROOKE STANLEY TChairman and CEO07/01/201471,100
CROOKE STANLEY TChairman and CEO07/01/2014551,459
Geary Richard SSVP, Development07/01/201418,030
Geary Richard SSVP, Development07/02/20145,896
PARSHALL B LYNNECOO & Secretary07/01/20148,577
Monia Brett PSVP, Antisense Drug Discovery07/01/20142,295
BENNETT C FRANKSVP, Antisense Research07/01/20148,788
BENNETT C FRANKSVP, Antisense Research06/23/2014172,256
BENNETT C FRANKSVP, Antisense Research06/23/2014411,910
O'NEIL PATRICK R.SVP, Legal and General Counsel06/19/20147,127
O'NEIL PATRICK R.SVP, Legal and General Counsel06/19/201424,748
CROOKE STANLEY TChairman, President and CEO06/19/2014159,170
CROOKE STANLEY TChairman, President and CEO06/19/2014386,111
O'NEIL PATRICK R.SVP, Legal and General Counsel06/16/20146,400
O'NEIL PATRICK R.SVP, Legal and General Counsel06/16/201428,110
CROOKE STANLEY TChairman, President and CEO06/10/201414,470
CROOKE STANLEY TChairman, President and CEO06/10/2014144,700
CROOKE STANLEY TChairman, President and CEO06/10/201433,455
CROOKE STANLEY TChairman, President and CEO06/10/2014334,550
MUTO FREDERICK TDirector06/02/201457,200
MUTO FREDERICK TDirector06/02/2014285,900
BERTHELSEN SPENCER RDirector04/17/201457,200
CROOKE STANLEY TChairman, President and CEO04/02/201426,046
CROOKE STANLEY TChairman, President and CEO04/02/2014101,290
CROOKE STANLEY TChairman, President and CEO04/02/201478,566
CROOKE STANLEY TChairman, President and CEO04/02/2014305,536
O'NEIL PATRICK R.SVP, Legal and General Counsel04/01/201412,000
O'NEIL PATRICK R.SVP, Legal and General Counsel04/01/201466,600
O'NEIL PATRICK R.SVP, Legal & General Counsel03/03/201416,396
O'NEIL PATRICK R.SVP, Legal & General Counsel03/03/201475,000
WENDER JOSEPH HDirector02/06/201430,316
O'NEIL PATRICK R.SVP, Legal & General Counsel02/03/201416,905
O'NEIL PATRICK R.SVP, Legal & General Counsel02/03/201475,677
WENDER JOSEPH HDirector02/03/201426,884
WENDER JOSEPH HDirector02/03/2014229,278
PARSHALL B LYNNECOO01/29/201472,500
PARSHALL B LYNNECOO01/29/2014364,043
PARSHALL B LYNNECOO01/30/2014358,298
PARSHALL B LYNNECOO01/29/201436,250
PARSHALL B LYNNECOO01/29/2014488,070
PARSHALL B LYNNECOO01/29/20141,708,245
PARSHALL B LYNNECOO01/30/20141,989,882
PARSHALL B LYNNECOO01/29/2014244,035
KLEIN JOSEPH IIIDirector01/24/2014158,800
KLEIN JOSEPH IIIDirector01/24/2014501,838
Geary Richard SSVP, Development01/22/2014222,702
Geary Richard SSVP, Development01/22/20141,111,021
WENDER JOSEPH HDirector01/22/2014509,803
BENNETT C FRANKSVP, Antisense Research01/16/201437,853
Geary Richard SSVP, Development01/16/201439,030
HOUGEN ELIZABETH LSVP, Finance & CFO01/16/201427,165
Monia Brett PSVP, Antisense Drug Discovery01/16/201438,653
PARSHALL B LYNNECOO & Secretary01/16/201477,262
CROOKE STANLEY TChairman and CEO01/16/201413,230
CROOKE STANLEY TChairman and CEO01/16/2014152,825
O'NEIL PATRICK R.SVP, Legal & General Counsel01/16/201427,166
CROOKE STANLEY TChairman, President and CEO01/08/201421,705
CROOKE STANLEY TChairman, President and CEO01/08/2014159,170
CROOKE STANLEY TChairman, President and CEO01/08/201460,078
CROOKE STANLEY TChairman, President and CEO01/08/2014440,572
Geary Richard SSVP, Development01/06/201483,398
Geary Richard SSVP, Development01/08/201478,204
Geary Richard SSVP, Development01/06/2014287,364
Geary Richard SSVP, Development01/08/2014319,352
Monia Brett PSVP, Antisense Drug Discovery01/01/20141,912
Monia Brett PSVP, Antisense Drug Discovery01/02/201414,210
BENNETT C FRANKSVP, Antisense Research01/01/20143,969
CROOKE STANLEY TChairman, President and CEO01/02/201436,175
CROOKE STANLEY TChairman, President and CEO01/02/2014419,630
CROOKE STANLEY TChairman, President and CEO01/02/20141,141,325
CROOKE STANLEY TChairman, President and CEO01/02/201498,132
Geary Richard SSVP, Development01/01/20143,969
O'NEIL PATRICK R.SVP, Legal and General Counsel01/01/20149,559
PARSHALL B LYNNECOO01/01/20149,607
PARSHALL B LYNNECOO12/26/2013426,130
PARSHALL B LYNNECOO12/26/20131,546,772
PARSHALL B LYNNECOO & Secretary12/24/2013225,400
PARSHALL B LYNNECOO & Secretary12/23/2013717,833
PARSHALL B LYNNECOO & Secretary12/24/2013819,920
PARSHALL B LYNNECOO & Secretary12/23/20132,084,050
WENDER JOSEPH HDirector12/19/2013244,800
WENDER JOSEPH HDirector12/20/2013400,125
WENDER JOSEPH HDirector12/19/2013380,813
BENNETT C FRANKSVP, Antisense Research12/05/2013153,800
BENNETT C FRANKSVP, Antisense Research12/05/2013399,182
WENDER JOSEPH HDirector11/26/2013366,336
KLEIN JOSEPH IIIDirector11/25/2013221,156
CROOKE STANLEY TChairman and CEO09/19/2013556,000
CROOKE STANLEY TChairman and CEO09/20/201397,189
CROOKE STANLEY TChairman and CEO09/19/20131,753,080
CROOKE STANLEY TChairman and CEO09/20/2013313,749
PARSHALL B LYNNECOO & Secretary09/20/2013587,900
PARSHALL B LYNNECOO & Secretary09/19/2013801,100
PARSHALL B LYNNECOO & Secretary09/20/20131,435,920
PARSHALL B LYNNECOO & Secretary09/19/20131,753,080
Monia Brett PSVP, Antisense Drug Discovery09/20/2013206,027
Monia Brett PSVP, Antisense Drug Discovery09/19/2013737,400
Monia Brett PSVP, Antisense Drug Discovery09/19/20131,679,700
Monia Brett PSVP, Antisense Drug Discovery09/20/2013656,105
BENNETT C FRANKSVP, Antisense Research09/19/2013153,800
BENNETT C FRANKSVP, Antisense Research09/19/2013350,200
CROOKE STANLEY TCOO, President09/09/2013295,959
CROOKE STANLEY TCOO, President09/10/2013949,440
CROOKE STANLEY TCOO, President09/09/2013809,495
CROOKE STANLEY TCOO, President09/11/2013623,620
BENNETT C FRANKSVP, Antisense Research09/09/2013153,800
BENNETT C FRANKSVP, Antisense Research09/09/2013302,250
PARSHALL B LYNNECOO09/11/201323,378
PARSHALL B LYNNECOO09/10/2013461,400
PARSHALL B LYNNECOO09/09/2013461,400
PARSHALL B LYNNECOO09/10/2013949,440
PARSHALL B LYNNECOO09/09/2013912,450
PARSHALL B LYNNECOO09/11/2013109,289
O'NEIL PATRICK R.SVP, Legal & General Counsel09/04/201328,236
O'NEIL PATRICK R.SVP, Legal & General Counsel09/04/201367,731
Monia Brett PSVP, Antisense Drug Discovery08/26/201374,403
KLEIN JOSEPH IIIDirector08/09/2013190,950
KLEIN JOSEPH IIIDirector08/09/2013529,126
CROOKE STANLEY TCOO, President07/23/2013127,880
CROOKE STANLEY TCOO, President07/23/2013345,000
CROOKE STANLEY TChairman and CEO07/22/2013299,570
CROOKE STANLEY TChairman and CEO07/19/2013341,436
CROOKE STANLEY TChairman and CEO07/18/2013222,400
CROOKE STANLEY TChairman and CEO07/19/2013679,650
CROOKE STANLEY TChairman and CEO07/18/2013602,220
CROOKE STANLEY TChairman and CEO07/22/2013615,450
CROOKE STANLEY TChairman and CEO07/16/2013200,160
CROOKE STANLEY TChairman and CEO07/15/20131,000,800
CROOKE STANLEY TChairman and CEO07/17/2013531,762
CROOKE STANLEY TChairman and CEO07/16/2013599,526
CROOKE STANLEY TChairman and CEO07/15/20133,042,540
CROOKE STANLEY TChairman and CEO07/17/20131,256,876
CROOKE STANLEY TChairman and CEO07/11/2013461,400
CROOKE STANLEY TChairman and CEO07/10/2013461,400
CROOKE STANLEY TChairman and CEO07/12/2013359,160
CROOKE STANLEY TChairman and CEO07/11/2013960,090
CROOKE STANLEY TChairman and CEO07/10/2013901,440
CROOKE STANLEY TChairman and CEO07/12/2013995,998
Geary Richard SSVP, Development07/11/2013100,080
Geary Richard SSVP, Development07/11/2013287,100
Geary Richard SSVP, Development07/09/2013106,584
Geary Richard SSVP, Development07/08/2013331,181
Geary Richard SSVP, Development07/05/2013365,831
Geary Richard SSVP, Development07/09/2013311,185
Geary Richard SSVP, Development07/08/2013902,380
Geary Richard SSVP, Development07/05/2013773,294
CROOKE STANLEY TChairman and CEO07/09/2013461,400
CROOKE STANLEY TChairman and CEO07/08/201377,023
CROOKE STANLEY TChairman and CEO07/05/2013371,888
CROOKE STANLEY TChairman and CEO07/08/20131,286,756
CROOKE STANLEY TChairman and CEO07/05/2013725,763
CROOKE STANLEY TChairman and CEO07/09/2013901,290
O'NEIL PATRICK R.SVP, Legal & General Counsel07/01/20138,976
O'NEIL PATRICK R.SVP, Legal & General Counsel07/05/20138,102
Geary Richard SSVP, Development07/01/20137,514
Geary Richard SSVP, Development07/03/201395,400
Geary Richard SSVP, Development07/03/2013145,100
Monia Brett PSVP, Antisense Drug Discovery07/01/20133,329
Monia Brett PSVP, Antisense Drug Discovery07/02/20136,169
BENNETT C FRANKSVP, Antisense Research07/01/20136,953
CROOKE STANLEY TChairman and CEO06/28/201398,430
CROOKE STANLEY TChairman and CEO06/28/201368,100
CROOKE STANLEY TChairman and CEO06/27/2013136,200
CROOKE STANLEY TChairman and CEO06/28/2013270,700
CROOKE STANLEY TChairman and CEO06/27/2013557,000
CROOKE STANLEY TChairman and CEO07/01/2013281,700
CROOKE STANLEY TChairman and CEO06/28/2013291,753
CROOKE STANLEY TChairman and CEO06/26/2013136,200
CROOKE STANLEY TChairman and CEO06/25/2013204,300
CROOKE STANLEY TChairman and CEO06/25/2013840,698
CROOKE STANLEY TChairman and CEO06/24/2013755,624
CROOKE STANLEY TChairman and CEO06/26/2013267,000
CROOKE STANLEY TChairman and CEO06/26/2013542,020
Geary Richard SSVP, Development06/24/2013465,100
Geary Richard SSVP, Development06/25/2013242,304
Geary Richard SSVP, Development06/24/2013755,624
Geary Richard SSVP, Development06/25/2013477,283
WENDER JOSEPH HDirector06/20/201351,700
WENDER JOSEPH HDirector06/20/2013114,006
Monia Brett PSVP, Antisense Drug Discovery06/11/2013147,656
Monia Brett PSVP, Antisense Drug Discovery06/11/2013222,750
MUTO FREDERICK TDirector05/30/201351,700
MUTO FREDERICK TDirector05/30/2013219,600
BENNETT C FRANKSVP, Antisense Research05/01/2013230,410
BENNETT C FRANKSVP, Antisense Research04/30/2013333,600
BENNETT C FRANKSVP, Antisense Research04/30/2013675,153
BENNETT C FRANKSVP, Antisense Research05/01/2013666,606
PARSHALL B LYNNECOO, Secretary04/24/2013333,600
PARSHALL B LYNNECOO, Secretary04/25/2013208,192
PARSHALL B LYNNECOO, Secretary04/25/2013581,586
PARSHALL B LYNNECOO, Secretary04/24/2013663,600
HOUGEN ELIZABETH LSVP, Finance & CFO04/24/2013160,213
HOUGEN ELIZABETH LSVP, Finance & CFO04/24/2013233,132
CROOKE STANLEY TChairman, CEO and President04/24/2013221,200
O'NEIL PATRICK R.SVP, Legal & General Counsel04/19/2013224,040
O'NEIL PATRICK R.SVP, Legal & General Counsel04/23/2013361,101
O'NEIL PATRICK R.SVP, Legal & General Counsel04/19/2013305,436
O'NEIL PATRICK R.SVP, Legal & General Counsel04/23/2013604,592
PARSHALL B LYNNECOO, Secretary04/22/2013333,600
PARSHALL B LYNNECOO, Secretary04/19/2013217,800
PARSHALL B LYNNECOO, Secretary04/23/2013136,200
PARSHALL B LYNNECOO, Secretary04/23/2013111,200
PARSHALL B LYNNECOO, Secretary04/19/2013600,180
PARSHALL B LYNNECOO, Secretary04/23/2013441,934
PARSHALL B LYNNECOO, Secretary04/23/2013220,967
PARSHALL B LYNNECOO, Secretary04/22/2013629,700
Monia Brett PSVP, Antisense Drug Discovery04/19/201327,800
Monia Brett PSVP, Antisense Drug Discovery04/22/2013189,040
Monia Brett PSVP, Antisense Drug Discovery04/22/2013361,420
Monia Brett PSVP, Antisense Drug Discovery04/19/201353,125
CROOKE STANLEY TChairman, CEO and President04/22/2013145,200
CROOKE STANLEY TChairman, CEO and President04/19/2013217,800
CROOKE STANLEY TChairman, CEO and President04/23/2013662,901
CROOKE STANLEY TChairman, CEO and President04/22/2013209,900
CROOKE STANLEY TChairman, CEO and President04/22/2013419,800
CROOKE STANLEY TChairman, CEO and President04/19/2013600,180
HOUGEN ELIZABETH LSVP, Finance & CFO04/22/2013262,592
HOUGEN ELIZABETH LSVP, Finance & CFO04/22/2013378,814
Geary Richard SSVP, Development04/19/201322,707
Geary Richard SSVP, Development04/19/201342,474
O'NEIL PATRICK R.SVP, Legal and General Counsel04/12/201377,751
O'NEIL PATRICK R.SVP, Legal and General Counsel04/12/2013107,096
Geary Richard SSr VP, Development04/11/201377,840
Geary Richard SSr VP, Development04/11/2013136,640
Geary Richard SSr VP, Development03/21/201311,120
Geary Richard SSr VP, Development03/21/201319,500
O'NEIL PATRICK R.SVP, Legal and General Counsel03/21/2013127,620
O'NEIL PATRICK R.SVP, Legal and General Counsel03/21/2013173,340
HOUGEN ELIZABETH LSVP, Finance and CFO03/20/2013159,861
HOUGEN ELIZABETH LSVP, Finance and CFO03/20/2013260,637
KLEIN JOSEPH IIIDirector03/20/201353,357
KLEIN JOSEPH IIIDirector03/20/201370,632
KLEIN JOSEPH IIIDirector03/19/201344,196
KLEIN JOSEPH IIIDirector03/20/2013146,118
KLEIN JOSEPH IIIDirector03/20/2013238,864
KLEIN JOSEPH IIIDirector03/19/201322,095
KLEIN JOSEPH IIIDirector03/19/2013134,154
KLEIN JOSEPH IIIDirector03/20/2013213,138
KLEIN JOSEPH IIIDirector03/20/2013355,608
KLEIN JOSEPH IIIDirector03/19/201367,068
KLEIN JOSEPH IIIDirector03/13/201336,046
KLEIN JOSEPH IIIDirector03/13/201372,098
KLEIN JOSEPH IIIDirector03/13/2013124,842
KLEIN JOSEPH IIIDirector03/13/2013249,702
HOUGEN ELIZABETH LSVP, Finance and CFO03/05/201334,322
HOUGEN ELIZABETH LSVP, Finance and CFO03/05/201384,960
Monia Brett PSVP, Antisense Drug Discovery03/05/2013124,214
Monia Brett PSVP, Antisense Drug Discovery03/05/2013307,599
O'NEIL PATRICK R.SVP, Legal and General Counsel03/04/2013131,657
O'NEIL PATRICK R.SVP, Legal and General Counsel03/04/2013185,059
BERTHELSEN SPENCER RDirector02/21/201351,700
O'NEIL PATRICK R.SVP, Legal & General Counsel02/19/201316,464
O'NEIL PATRICK R.SVP, Legal & General Counsel02/15/20133,601
O'NEIL PATRICK R.SVP, Legal & General Counsel02/15/20135,185
O'NEIL PATRICK R.SVP, Legal & General Counsel02/19/201323,680
O'NEIL PATRICK R.SVP, Legal & General Counsel02/13/201344,900
O'NEIL PATRICK R.SVP, Legal & General Counsel02/13/201388,407
O'NEIL PATRICK R.SVP, Legal and General Counsel01/30/201320,580
O'NEIL PATRICK R.SVP, Legal and General Counsel01/29/20134,020
O'NEIL PATRICK R.SVP, Legal and General Counsel01/30/201329,640
BENNETT C FRANKSVP, Antisense Research01/16/20134,326
Geary Richard SSVP, Development01/16/20134,830
CROOKE STANLEY TChairman, CEO and President01/16/20132,002
CROOKE STANLEY TChairman, CEO and President01/16/201318,438
Monia Brett PSVP, Antisense Drug Discovery01/16/20134,620
HOUGEN ELIZABETH LSVP, Finance & CFO01/16/20133,388
PARSHALL B LYNNECOO, Secretary01/16/201310,626
O'NEIL PATRICK R.SVP, Legal & General Counsel01/17/20133,427
O'NEIL PATRICK R.SVP, Legal and General Counsel01/04/201313,945
O'NEIL PATRICK R.SVP, Legal and General Counsel01/01/20133,825
Monia Brett PVP, Antisense Drug Discovery01/01/20131,908
Monia Brett PVP, Antisense Drug Discovery01/03/20133,371
BENNETT C FRANKSVP, Antisense Research01/01/20133,967
Geary Richard SSr VP, Development01/01/20137,969
Geary Richard SSr VP, Development01/03/20132,873
Geary Richard SSr VP, Development12/13/201231,500
Geary Richard SSr VP, Development12/13/201257,751
CROOKE STANLEY TChairman, CEO and President09/20/2012190,155
CROOKE STANLEY TChairman, CEO and President09/19/2012157,500
CROOKE STANLEY TChairman, CEO and President09/21/2012201,520
CROOKE STANLEY TChairman, CEO and President09/20/2012450,240
CROOKE STANLEY TChairman, CEO and President09/19/2012444,450
CROOKE STANLEY TChairman, CEO and President09/21/2012414,236
CROOKE STANLEY TChairman, CEO and President09/13/2012142,139
CROOKE STANLEY TChairman, CEO and President09/13/2012393,927
PARSHALL B LYNNECOO, Secretary09/07/201217,141
PARSHALL B LYNNECOO, Secretary09/07/201268,400
PARSHALL B LYNNECOO, Secretary09/07/2012151,200
PARSHALL B LYNNECOO, Secretary09/07/201237,891
PARSHALL B LYNNECOO, Secretary09/04/2012105,000
PARSHALL B LYNNECOO, Secretary09/06/201286,700
PARSHALL B LYNNECOO, Secretary09/04/201252,500
PARSHALL B LYNNECOO, Secretary09/06/201256,465
PARSHALL B LYNNECOO, Secretary09/05/201210,500
PARSHALL B LYNNECOO, Secretary09/06/201234,200
PARSHALL B LYNNECOO, Secretary09/06/2012300,370
PARSHALL B LYNNECOO, Secretary09/04/2012150,010
PARSHALL B LYNNECOO, Secretary09/06/2012150,185
PARSHALL B LYNNECOO, Secretary09/05/201230,000
PARSHALL B LYNNECOO, Secretary09/04/2012300,020
REED JOHN CDirector09/04/201226,367
REED JOHN CDirector09/06/201225,333
REED JOHN CDirector09/06/201274,358
REED JOHN CDirector09/04/201277,367
Monia Brett PVP, Antisense Drug Discovery09/06/201263,163
Monia Brett PVP, Antisense Drug Discovery09/06/2012183,473
CROOKE STANLEY TChairman, CEO and President09/06/201291,287
CROOKE STANLEY TChairman, CEO and President09/05/201278,750
CROOKE STANLEY TChairman, CEO and President09/04/2012157,500
CROOKE STANLEY TChairman, CEO and President09/06/201269,274
CROOKE STANLEY TChairman, CEO and President09/05/2012222,345
CROOKE STANLEY TChairman, CEO and President09/04/2012423,255
CROOKE STANLEY TChairman, CEO and President09/06/2012189,413
CROOKE STANLEY TChairman, CEO and President09/06/2012261,142
BENNETT C FRANKSVP, Antisense Research07/09/201271,670
BENNETT C FRANKSVP, Antisense Research07/09/2012141,855
Geary Richard SSr VP, Development07/09/201229,852
Geary Richard SSr VP, Development07/09/201276,610
REED JOHN CDirector07/09/201239,500
REED JOHN CDirector07/09/2012139,900
Monia Brett PSVP, Antisense Drug Discovery07/01/20121,906
Monia Brett PSVP, Antisense Drug Discovery07/03/20127,584
BENNETT C FRANKSVP, Antisense Research07/01/20123,971
BENNETT C FRANKSVP, Antisense Research07/03/201241,040
BENNETT C FRANKSVP, Antisense Research07/03/201277,460
Geary Richard SSr VP, Development07/01/20127,967
Geary Richard SSr VP, Development07/03/201231,423
BERTHELSEN SPENCER RDirector06/25/201281,500
BERTHELSEN SPENCER RDirector06/25/2012115,669
REED JOHN CDirector06/22/201281,500
REED JOHN CDirector06/22/2012110,600
Geary Richard SSr VP, Development06/14/201217,148
WENDER JOSEPH HDirector06/12/201281,500
BERTHELSEN SPENCER RDirector05/21/201225,671
BERTHELSEN SPENCER RDirector05/22/2012162,329
BERTHELSEN SPENCER RDirector05/21/201225,726
BERTHELSEN SPENCER RDirector05/22/2012165,092
BENNETT C FRANKSenior Vice President01/01/20121,986
Geary Richard SSenior Vice President01/01/20129,959
BENNETT C FRANKSenior Vice President12/01/20111,986
Monia Brett PSenior Vice President01/01/20123,597
Geary Richard SSenior Vice President12/21/20116,635
Geary Richard SSenior Vice President12/21/20117,916
CROOKE STANLEY TChairman, President, CEO12/21/20116,264
CROOKE STANLEY TChairman, President, CEO12/21/201196,976
CROOKE STANLEY TChairman, President, CEO12/21/20117,474
CROOKE STANLEY TChairman, President, CEO12/21/2011115,702
PARSHALL B LYNNEDirector, COO12/21/201125,520
PARSHALL B LYNNEDirector, COO12/21/201113,705
PARSHALL B LYNNEDirector, COO12/21/201116,352
PARSHALL B LYNNEDirector, COO12/21/201130,448
BENNETT C FRANKSenior Vice President12/21/20119,019
BENNETT C FRANKSenior Vice President12/21/201110,761
CROOKE STANLEY TChairman, President, CEO12/16/201187,000
CROOKE STANLEY TChairman, President, CEO12/19/20116,380
CROOKE STANLEY TChairman, President, CEO12/19/201198,600
CROOKE STANLEY TChairman, President, CEO12/20/20119,860
CROOKE STANLEY TChairman, President, CEO12/16/20118,700
CROOKE STANLEY TChairman, President, CEO12/20/2011156,600
CROOKE STANLEY TChairman, President, CEO12/19/20117,511
CROOKE STANLEY TChairman, President, CEO12/19/2011116,086
CROOKE STANLEY TChairman, President, CEO12/20/201111,624
CROOKE STANLEY TChairman, President, CEO12/16/201110,185
CROOKE STANLEY TChairman, President, CEO12/20/2011184,640
CROOKE STANLEY TChairman, President, CEO12/16/2011101,850
BENNETT C FRANKSenior Vice President12/16/20118,700
BENNETT C FRANKSenior Vice President12/20/201114,500
BENNETT C FRANKSenior Vice President12/19/20118,700
BENNETT C FRANKSenior Vice President12/20/201117,100
BENNETT C FRANKSenior Vice President12/19/201110,243
BENNETT C FRANKSenior Vice President12/16/201110,185
Geary Richard SSenior Vice President12/20/201110,440
Geary Richard SSenior Vice President12/19/20116,380
Geary Richard SSenior Vice President12/16/20115,800
Geary Richard SSenior Vice President12/20/201112,306
Geary Richard SSenior Vice President12/19/20117,511
Geary Richard SSenior Vice President12/16/20116,790
PARSHALL B LYNNEDirector, COO12/16/201111,600
PARSHALL B LYNNEDirector, COO12/19/201113,340
PARSHALL B LYNNEDirector, COO12/16/201111,600
PARSHALL B LYNNEDirector, COO12/20/201140,600
PARSHALL B LYNNEDirector, COO12/19/20111,217,687
PARSHALL B LYNNEDirector, COO12/20/201120,880
PARSHALL B LYNNEDirector, COO12/19/201115,706
PARSHALL B LYNNEDirector, COO12/20/201143,036
PARSHALL B LYNNEDirector, COO12/20/20114,844
PARSHALL B LYNNEDirector, COO12/16/201127,160
PARSHALL B LYNNEDirector, COO12/20/201124,622
PARSHALL B LYNNEDirector, COO12/16/201113,580
PARSHALL B LYNNEDirector, COO12/19/201131,411
BENNETT C FRANKSenior Vice President08/04/201152,500
BENNETT C FRANKSenior Vice President08/04/201176,206
BENNETT C FRANKSenior Vice President07/28/20118,600
BENNETT C FRANKSenior Vice President07/01/20111,984
Geary Richard SSenior Vice President07/01/20112,095
BENNETT C FRANKSenior Vice President01/01/20113,843
Geary Richard SSenior Vice President01/01/201118,972
Geary Richard SSenior Vice President12/29/201019,058
Geary Richard SSenior Vice President12/27/201031,763
Geary Richard SSenior Vice President12/29/201020,424
Geary Richard SSenior Vice President12/27/201034,386
PARSHALL B LYNNEDirector, COO12/29/201061,600
PARSHALL B LYNNEDirector, COO12/27/2010103,950
PARSHALL B LYNNEDirector, COO12/27/2010112,536
PARSHALL B LYNNEDirector, COO12/29/201066,016
BENNETT C FRANKSenior Vice President12/29/201044,275
BENNETT C FRANKSenior Vice President12/27/201074,113
BENNETT C FRANKSenior Vice President12/29/201047,449
BENNETT C FRANKSenior Vice President12/27/201080,234
CROOKE STANLEY TChairman, President, CEO12/29/201019,250
CROOKE STANLEY TChairman, President, CEO12/29/201096,250
CROOKE STANLEY TChairman, President, CEO12/27/2010192,500
CROOKE STANLEY TChairman, President, CEO12/29/201020,630
CROOKE STANLEY TChairman, President, CEO12/29/2010103,150
CROOKE STANLEY TChairman, President, CEO12/27/2010208,400
Geary Richard SSenior Vice President12/23/20101,925
Geary Richard SSenior Vice President12/23/20102,105
PARSHALL B LYNNECOO12/23/20107,700
PARSHALL B LYNNECOO12/23/201012,513
PARSHALL B LYNNECOO12/22/2010129,500
PARSHALL B LYNNECOO12/23/20108,420
PARSHALL B LYNNECOO12/23/201013,682
PARSHALL B LYNNECOO12/22/201045,762
Geary Richard SSenior Vice President12/22/201025,025
Geary Richard SSenior Vice President12/23/20103,850
Geary Richard SSenior Vice President12/22/201027,352
Geary Richard SSenior Vice President12/23/20104,210
BENNETT C FRANKSenior Vice President12/23/201014,438
BENNETT C FRANKSenior Vice President12/22/201059,675
BENNETT C FRANKSenior Vice President12/23/201015,787
BENNETT C FRANKSenior Vice President12/22/201065,224
CROOKE STANLEY TChairman, President, CEO12/23/201038,500
CROOKE STANLEY TChairman, President, CEO12/22/2010154,000
CROOKE STANLEY TChairman, President, CEO12/23/201042,100
CROOKE STANLEY TChairman, President, CEO12/22/2010168,320
BENNETT C FRANKSenior Vice President07/23/201010,560
Load More Insider Transactions
FUNDS WITH A POSITION IN IONIS PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.9,057,5300.01%-0.63%Other
ARK INVESTMENT MANAGEMENT LLC1,905,0560.57%-19.49%Growth
GEODE CAPITAL MANAGEMENT, LLC2,275,9310.01%3.7%Other
ORBIMED ADVISORS LLC2,064,7972.09%-4.83%Other
FARALLON CAPITAL MANAGEMENT LLC1,555,0200.39%113.9%Event Driven, Value
ADAGE CAPITAL PARTNERS GP, L.L.C.1,385,3000.15%29.83%Other
CAPITAL WORLD INVESTORS839,4630.00755%No changeGrowth At A Reasonable Price
CANDRIAM S.C.A.629,0670.22%14.57%Other
D. E. SHAW & CO., INC.119,1580.00527%-67.09%Other
RENAISSANCE TECHNOLOGIES LLC112,4140.0088%-58.33%Other
SENATOR INVESTMENT GROUP LP135,0000.29%NewEvent Driven, Value
UBS OCONNOR LLC28,6240.1%-53.88%Value
GOTHAM ASSET MANAGEMENT, LLC6,9890.00656%-13.59%Other
AQR CAPITAL MANAGEMENT LLC4,3000.0004%NewOther
CHANGE IN SHARES OUTSTANDING FOR IONIS PHARMACEUTICALS INC
STOCK BUYBACKS FOR IONIS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.20%
1Q
12/31/2023
06/30/2023
0.35%
2Q
12/31/2023
03/31/2023
0.61%
3Q
12/31/2023
12/31/2022
1.10%
4Q
12/31/2023
09/30/2022
1.17%
5Q
12/31/2023
06/30/2022
1.28%
6Q
12/31/2023
03/31/2022
1.42%
7Q
12/31/2023
12/31/2021
1.70%
8Q
12/31/2023
09/30/2021
1.75%
9Q
12/31/2023
06/30/2021
1.87%
10Q
12/31/2023
03/31/2021
2.01%
11Q
12/31/2023
12/31/2020
2.61%
12Q
12/31/2023
09/30/2020
2.79%
13Q
12/31/2023
06/30/2020
3.05%
14Q
12/31/2023
03/31/2020
2.99%
15Q
12/31/2023
12/31/2019
-6.24%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.20%
1Q
06/30/2023
0.35%
2Q
03/31/2023
0.61%
3Q
12/31/2022
1.10%
4Q
09/30/2022
1.17%
5Q
06/30/2022
1.28%
6Q
03/31/2022
1.42%
7Q
12/31/2021
1.70%
8Q
09/30/2021
1.75%
9Q
06/30/2021
1.87%
10Q
03/31/2021
2.01%
11Q
12/31/2020
2.61%
12Q
09/30/2020
2.79%
13Q
06/30/2020
3.05%
14Q
03/31/2020
2.99%
15Q
12/31/2019
-6.24%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IONIS PHARMACEUTICALS INC
LOADING...